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ABSTRACT 
Translation of mRNA into protein represents the final step in the gene-expression 
pathway, driving the formation of the proteome from genomic information. The 
regulation of this process is a mechanism that is used to modulate gene expression in a 
wide range of biological situations. Protein synthesis is principally regulated at the 
initiation stage, allowing for rapid, reversible control of gene expression. Progress over 
recent years in determining the structures and activities of regulatory factors, and in 
mapping their interactions, have advanced our understanding of the complex translation 
initiation process. These developments have provided a solid foundation for studying 
the regulation of translation initiation by mechanisms that include the modulation of 
initiation factor activity, internal ribosome initiation and through sequence-specific 
RNA-binding proteins. This thesis focused on translational control during viral 
infection, where we investigated the role of Severe Acute Respiratory Syndrome non-
structural protein 1 and Enterovirus 71 Internal Ribosome Entry Site in this process.  
To establish the function of SARS NSP1 protein in translation regulation we attempted 
the identification of NSP1 protein partners using several types of protein affinity 
chromatography. Using a wide range of approaches, we could not detect nor confirm 
the association of NSP1 with any cellular proteins. To dissect the role of FBP2, we 
engineered a wide range of recombinant FBP2 proteins of different lengths and 
analysed their interactions with IRES elements using biochemical techniques. This 
allowed us to characterize the interaction of EV71 IRES with initiation factors eIF4A, 
eIF4E, eIF4G and FBP2. Finally, we used chemical probing of RNA structure in 
solution to establish the secondary structure of the BiP IRES. We identified the 
formation of a structured RNA scaffold of 220 nucleotides comprising 3 major 
domains.   
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Chapter 1 
 
Regulation of Translation in 
Eukaryotes 
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1.0 Introduction 
Eukaryotic messenger RNA (mRNA) translation can be defined as a process in which cellular 
ribosomes decode the information in the mRNA to give rise to proteins. It is an important 
part of the process of gene expression and can be regulated at many levels, including at the 
translation stage of mRNA into proteins. The process of translation  can be simply divided 
into  phases of initiation, elongation, termination and ribosome recycling (Lehninger et al., 
2005, William and Jens, 2000). 
Of these phases, translation initiation is the most complex and sets the overall rate of reaction 
for this multi-step process (Marintchev and Wagner, 2004). Furthermore, the rate of 
translation initiation in mammalian cells is also controlled by mRNA sequence elements 
within the 5′and 3′ UTR regions Figure 1. These elements exert control on this mechanism 
by providing sites of interaction for various regulatory proteins and RNAs. Examples, of 
these control elements in mammalian cells include upstream open reading frames (uORF), 
microRNAs, internal ribosome elements (IRES) and polyadenylation elements. All these 
features control the synthesis of proteins by employing one of many mechanisms that alter 
the stability of the mRNA, its accessibility to the ribosomes, circularisation or interaction 
with the translation machinery. Figure 1 gives an overview of the structural organisation of a 
typical eukaryotic mRNA. The figure shows the different points of possible interaction of 
mRNA with various cellular trans-acting factors. During translation initiation, the start codon 
(AUG) is identified in eukaryotes by a scanning mechanism, first elucidated by Kozak 
(Kozak, 1999). The start codon is then decoded by the methionyl tRNA specialised for 
initiation (Met-tRNAi), ultimately leading on to protein synthesis. Prior to this, other 
eukaryotic specific features help to  facilitate this scanning mechanism  and these are:  a 5′ 
cap structure (5'-7-methylguanosine cap) located at the end of mRNA and a cap binding 
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complex(eIF4F) that is formed of various eukaryotic initiation factors, the composition of 
which will be discussed in detail later on in the chapter.  
 
This first chapter will describe the molecular structures and biochemical functions of the 
cellular translational initiation machinery and summarises the key steps that mediate general 
or gene specific translational control. The principles underlying its regulation, alternate 
mechanisms of translation initiation and control that have evolved in viruses are also 
discussed. It is worth noting that viruses are obligate intracellular parasites and therefore 
depend on host cells for their replication. As a result, they have evolved a number of ways to 
modify the translation apparatus. Consequently, these alternate mechanisms of translation 
initiation and their regulation have enhanced our understanding of many aspects of the 
cellular protein biosynthesis pathway.  
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1.1  A brief Overview of Translation in Eukaryotes 
 
In eukaryotes, decoding the genetic information in the mRNA and the formation of peptide 
bonds are performed primarily by the ribosomes. However, although the ribosomes play a 
key role in this process other factors are necessary for translation to occur and its control. 
Eukaryotic translation initiation relies on a scanning mechanism to locate the start codon and 
involves 13 core initiation factors, some of which are large, multimeric complexes (Table 1). 
Figure 2 gives a brief overview of initiation of translation in eukaryotes,  reviewed in 
(Hinnebusch, 2014).  The first step in the initiation of translation is the assembly of a 43S pre 
initiation complex formed by the 40S ribosomal subunit and eukaryotic initiation factors 
(eIFs). This is then followed by a series of interactions between the mRNA and initiation 
factors which allow for the complex to scan along the messenger mRNA until it encounters a 
start codon. For many eukaryotes this is usually AUG codon and this enables the complex to 
associate with a 60S ribosome subunit producing a functional 80S ribosome which is able to 
translate the mRNA open reading frame.  The next stage is an elongation phase of the protein. 
This phase is catalysed by elongation factors which are responsible for two main processes 
during protein synthesis on the ribosome.  Primarily, these involve eukaryotic elongation 
factor (eEF1A) which is responsible for the selection and binding of the cognate aminoacyl-
tRNA to the A-site (acceptor site) of the ribosome and eukaryotic elongation factor (eEF2) 
which is responsible for the translocation of the peptidyl-tRNA from the A-site to the P-site 
(peptidyl-tRNA site) of the ribosome, thereby freeing the A-site for the next aminoacyl-tRNA 
to bind.  The elongation cycle is repeated until one of the three stop-codons is positioned in 
the ribosomal A-site. When a non-coding codon (UAA, UAG or UGA) enters the ribosomal 
A site, the ribosome signals the polypeptide chain release factors to bind and recognise the 
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termination signal. These stop codons have no corresponding tRNAs but instead, are 
recognised by a release factor eukaryotic release factor 1, (eRF-1). The activity of eRF-1 is 
stimulated by eRF-3. The latter is a GTP-binding protein that forms a complex with eRF-1. 
This complex binds to ribosomes having a stop codon in the A-site. The ribosome-bound 
complex stimulates cleavage of the bond (ester bond) between the peptide and the tRNA 
(peptidyl-tRNA) thereby releasing the nascent peptide from the ribosome. The initiation 
factors are then released from the ribosome following GTP hydrolysis. The ribosome can 
now start a new translational cycle and in most cases the ribosome initiates a new round of 
translation on the same mRNA due to formation of circular mRNA by translation factors 
(Wells et al., 1998). 
 
Ribosomes play a key role in the translation process. Overall they are responsible for the 
synthesis of proteins in cells and are found in all organisms. They are complex in their 
assembly as in their function. Eukaryotic ribosomes are also known as 80S ribosomes, 
referring to their sedimentation coefficients in Svedberg units.  They are composed of the   
small subunit (40S) and large subunit (60S). Both subunits contain ribosomal proteins and 
ribosomal RNAs (rRNAs) (Fromont-Racine et al., 2003, Hage and Tollervey, 2004) arranged 
on a RNA (rRNA) scaffold. The large subunit consists of rRNAs: 28S rRNA (3354 
nucleotides), 5S rRNA (154 nucleotides) and 5.8S rRNA (120 nucleotides) and 47 proteins. 
The small subunits consist of rRNAs: 18S rRNA (1753 nucleotides) and 32 proteins.   The 
small subunit monitors the complementarity between tRNA anticodon and mRNA, while the 
large subunit catalyses peptide bond formation.   
 
Initial structures of eukaryotic ribosomes were determined by electron microscopy. The first 
3 dimensional structures were obtained at 30-40 Å resolution for yeast (Verschoor et al., 
 7 | P a g e  
 
1998) and mammalian ribosomes (Verschoor and Frank, 1990, Dube et al., 1998).  
Subsequently, higher resolution structures of the yeast ribosome using cryo-electron 
microscopy allowed for the identification of protein and RNA structural elements (Spahn et 
al., 2001). In 2011, the first complete atomic structure of the eukaryotic 80S ribosome from 
the yeast Saccharomyces cerevisiae was obtained by crystallography (Ben-Shem et al., 2011). 
The model revealed the precise architecture of eukaryotic-specific elements, their interaction 
with the universally conserved core and all eukaryote-specific bridges between the two 
ribosomal subunits (Ben-Shem et al., 2011). Some general features of the ribosome 
uncovered from x-ray crystallography suggested that the shape of the small subunit was 
subdivided into two large segments, namely the head and the body. Features of the body 
included the left and right feet, the shoulder and the platform. For the large subunit, structural 
landmarks included the central protrusion, the L1-stalk and the P-stalk. The majority of the 
eukaryote-specific RNA and protein elements were found on the solvent-exposed sides of the 
40S (Rabl et al., 2011) and 60S (Klinge et al., 2011) subunits. At the same time, the complete 
model of a eukaryotic 40S ribosomal structure in Tetrahymena thermophila was published 
and described the structure of the 40S subunit as well as its interaction with eIF1 Figure 3. 
Similarly, the eukaryotic 60S subunit structure was also determined from Tetrahymena 
thermophila in complex with eIF6 (Ban et al., 2000).  
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Figure 2: The pathway for the initiation of translation in eukaryotes. 
 
 
 
 
 
 
 
The 80S ribosome dissociates, enabling the 40S ribosomal subunit to bind eIF1A, eIF3 
and met tRNA to form the 43S pre-initiation complex. The 43S pre-initiation complex 
binds mRNA (which involves initiation factors eIF4E, eIF4G, eIF4A and eIF4B) at the 5' 
cap structure and scans along the RNA until it reaches the initiating AUG codon. At the 
initiating codon the GTP molecule from eIF2 complex is hydrolysed to GDP, releasing 
the initiation factors and enabling the 43S complex to associate with 60S subunit. This 
produces a functional 80S ribosome positioned at the initiating codon, which is able to 
translate the mRNA open reading frame. The box insert is a schematic of the ribosome 
outlining the acyl(A), peptidyl(P) and exit(E) sites. This figure was originally published in 
Nature Reviews Microbiology (Fraser and Doudna, 2007). 
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Table 1: Eukaryotic core initiation factors and their functions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*eIF3 has 13 subunits (a–m) in mammals, 5 of which (a, b, c, i, g) are universally conserved. 
Table adapted from (Jackson et al., 2010) 
 
  
Initiation 
factor 
Subunits Functions 
   
eIF1 1 (12.7 kDa) Prevents initiation at noncognate codons or in poor 
context.  
eIF1A 1 (16.5 kDa) Cooperates with eIF1 in start codon selection and 
is involved in the recruitment of eIF5B 
 
eIF2 α (36.1 kDa) 
β (38.4 kDa) 
γ (51.1 kDa) 
GTPase that forms a ternary complex (TC) with 
initiator tRNA and GTP. Plays a key role in start 
codon selection 
   
eIF2B α (33.7 kDa) 
β (39.0  kDa) 
γ (50.2 kDa) 
δ (57.6 kDa) 
ε (80.4 kDa) 
Nucleotide exchange factor required for re-
activation of eIF2 
eIF3 a-m
*
 (∼790 kDa) Stimulates binding of ternary complex (TC) and 
attachment of 43S complexes to mRNA and 
participates in scanning 
eIF4A 
1 (46 kDa) DEAD-box ATPase and ATP-dependent RNA 
helicase 
eIF4B 1 (69.1 kDa) Enhances activity of eIF4A 
eIF4E 1 (25.1 kDa) Binds to the mRNA cap structure 
eIF4F 
E, A,G(140.2 kDa) Synonym for a complex of eIF4E, eIF4A and 
eIF4G. 
 
 Mediates unwinding of mRNA and attachment of 
43S complexes 
eIF4G 
 
1 (175.5 kDa) Binds to eIF4E,eIF4A,eIF3,PABP,SLIP1 and 
mRNA  
and enhances the helicase activity of elF4A 
eIF4H 
 
1 (27.4 kDa) Enhances activity of eIF4A, partially homologous 
to eIF4B 
eIF5 
 
1 (49.2 kDa) GAP and GDI regulating eIF2 activity. 
eIF5B 1 (138.8 kDa) GTPase that mediates subunit joining. 
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Figure 3: Model of the 80S eukaryotic ribosome. 
The model was derived from the crystal structure of the eukaryotic 40S and 60S ribosomal 
subunits from Tetrahymena thermophila. The 40S subunit is on the left, the 60S subunit on 
the right. The ribosomal RNA (rRNA) core is represented as a grey tube, eukaryotic specific 
RNA and protein expansion segments are shown in red. Universally conserved proteins are 
shown in blue. These proteins have homologs in eukaryotes, archaea and bacteria. Proteins 
shared only between eukaryotes and archaea are shown in orange, and proteins specific to 
eukaryotes are shown in red. This figure was originally published in Science (Ben-Shem et 
al., 2011). 
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1.1.1 Cap dependent initiation of translation 
 
For eukaryotes, the initiation of translation usually involves interaction of certain key 
proteins with the 5' cap structure (5'-7-methylguanosine cap), as well as interaction with the 
5' untranslated region (UTR) (Mitchell et al., 2010), hence the term ''cap dependent 
translation'' is used to define the process. The 5′ cap has other functions in relation to the 
mRNA molecule such as regulation of nuclear export, prevention of degradation by 
exonucleases, promotion of translation, and promotion of 5′ proximal intron excision (Lewis 
et al., 1996, Lewis and Izaurralde, 1997, Topisirovic et al., 2011), but for the purposes of our 
discussion I will concentrate on its role in the stimulation of translation initiation. 
For eukaryotes, the translation initiation pathway is a highly regulated process comprising of 
a set of reactions that place the start codon (AUG) on mRNA in the P (peptidyl) decoding site 
of the ribosome, base paired with the anti-codon of initiator tRNA (Met-tRNAi) (Kapp and 
Lorsch, 2004). The start codon is identified by a scanning mechanism as described in Figure 
4 (Sachs et al., 1997).  The general features of the pathway from this figure can be briefly 
summarised in to:  
 
1. Formation of a 43S pre-initiation complex  
2. Binding of activated mRNA to the 40S subunit and ATP dependent scanning of 
mRNA to locate the AUG codon. 
3. 60S subunit joining  to form 80S initiation complex 
4. Recycling of eIF2.GDP to eIF2.GTP by eIF2B. 
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1.1.2 Formation of 43S pre-initiation complex 
 
The current model of translation initiation (Sonenberg and Hinnebusch, 2009) begins with the 
assembly  of the 43S pre- initiation complex (43S). The assembly and function of eukaryotic 
pre initiation complexes (PIC) appear to be enhanced by formation of a higher-order 
complex, dubbed the multifactor complex (MFC) (Gilbert et al., 2007a). Formation of this 
complex involves a process that begins with eukaryotic initiation factors eIF1, eIF1A, eIF3 
binding to the 40S subunit (Kolupaeva et al., 2005, Lorsch and Dever, 2010). Eukaryotic 
initiation factor (eIF1) is a small protein (12 kDa) governing fidelity in translation initiation. 
It is recruited to the 40S subunit in a multifactor complex with Met-tRNAi
Met
, eIF2, eIF3, and 
eIF5 and binds near the P-site. Eukaryotic initiation factor eIF1A ranges in size from 17 to 
22kDa and binds either mRNA or rRNA in a non-sequence specific manner. During the 
process of translation initiation eIF1A not only plays a role in the dissociation of 80S 
ribosomes, but is also involved in the binding of the 40S subunit to Met-tRNAi and in mRNA 
binding (Saini et al., 2010). Eukaryotic initiation factor 3 is a scaffolding initiation factor, 
made up of 13 subunits. It is approximately 750 kDa and controls the assembly of 40S 
ribosomal subunit on to mRNA that have a 5' cap or IRES (Internal Ribosomal Entry Site).  
eIF3 interacts with the eIF4F complex  to position the mRNA strand near the exit site of the 
40S ribosome subunit(Siridechadilok et al., 2005). 
 
In eukaryotes, the initiator tRNA Met-tRNAi is believed to be recruited to the 40S subunit as 
an eIF2–GTP–Met-tRNAi ternary complex (TC). However, recent work by Sokabe et 
al(Sokabe et al., 2012), has suggested two other distinct pathways for the delivery of Met-
tRNAi to the 40S ribosomes. Working with components of the MFC, purified from HeLa cell 
extracts, it was found that in vitro, MFC-GTP bound Met-tRNAi delivered the initiator tRNA 
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to the ribosome at the same rate as the TC. Interestingly, it was also found that MFC protein 
components each bound individually to the 40S ribosomes. This result suggested that the 
Met-tRNAi by itself might bind directly to the 40S-factor complexes opening up the 
possibility of an alternate pathway, which is most likely to be used in conditions of stress 
when eIF2 is inhibited. All these data have pointed to novel pathways in the formation of the 
pre-initiation complex but to date, it has not been established which one predominates in vivo. 
In conclusion, it can therefore be stated that the binding of an eIF2/GTP/Met-tRNAi ternary 
complex and initiation factors to the 40S subunit leads to the formation the 43S pre initiation 
complex.  
 
1.1.3 Binding of the 43S complex to mRNA 
 
Translation initiation as previously stated is the rate-limiting step of protein biosynthesis and 
is tightly regulated. The 43S pre-initiation complex is then loaded onto an activated 
messenger RNA-protein complex near the 5' cap. The multi subunit cap binding complex 
(eIF4F) and eIF3 play a key role in this process (Hinnebusch, 2006). The eIF4F complex 
consists of initiation factors: eIF4E, eIF4A and eIF4G. This complex is thought to assemble 
first then bind m
7
GpppG
5
'cap structure, via the eIF4E subunit reviewed in (Pestova et al., 
2007). Subsequently, eIF4A unwinds the mRNA to prepare a ‘landing pad’ for recruitment of 
the 43S pre-initiation complex by the eIF4G reviewed in (Pestova et al., 2007). 
1.1.3.1  Initiation factor eIF4G 
eIF4G is known as the scaffold subunit of the eIF4F complex. In mammals two isoforms of 
eIF4G (I and II) have been identified and both are able to bind eIF4E, eIF4A and eIF3. In 
mammalian cells eIF4GI is much more abundant than eIF4GII. This subunit acts as a protein 
bridge between the cap structure and the 43S pre initiation complex. It has binding domains 
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for eIF4E, eIF4A, eIF3, poly (A)-binding protein (PABP1), and the mitogen-activated protein 
kinase  MNK1(Berset et al., 2003) that are thought to enhance formation of activated 
eIF4F•mRNA•PABP complexes. The activated eIF4F•mRNA•PABP complexes are 
competent to recruit 43S pre-initiation complexes. To this end, multiple elements within the 
eIF4GI N‐terminus were found to promote assembly of eIF4GI•PABP mRNPs in vivo (Park 
et al., 2011). These experiments confirmed the role of the RNA-binding region in the N-
terminal domain of yeast eIF4GI in stabilizing eIF4G-mRNA and PABP binding. Further 
multiple contacts between eIF3 and eIF4G were found to be essential  for mRNA recruitment 
to the human ribosome as has been established by Villa et al (Villa et al., 2013). From their 
investigations it was demonstrated that human eIF4G bound to eIF3 independently of eIF4A 
and that the eIF3-binding domain in eIF4G interacted with eIF3c, -d and -e subunits. Using a 
quantitative binding assay, the authors established that the affinity between eIF4G and eIF3 
was not altered by the presence of eIF4A, at least in the absence of the 40S ribosomal 
subunit.   
1.1.3.2 Initiation factor eIF4A 
The eukaryotic initiation factor-4A family consists of 3 closely related proteins eIF4A1, 
eIF4A2, and eIF4A3 (Lu et al., 2014). eIF4A is also a member of the DEAD box protein 
family (Rogers et al., 2002, Tuteja et al., 2008). It is an ATP-dependent RNA helicase, which 
aids the ribosome in resolving certain secondary structures formed by the mRNA transcript 
according to the current model for DEAD box protein activity reviewed in (Hilbert et al., 
2009, Andreou and Klostermeier, 2013).  In general, eIF4A is considered as a helicase that 
melts the RNA secondary structures and makes the RNA accessible to nucleases or to 
ribosomes. Evidence that the target of eIF4A is secondary structure in the 5′ UTR  was 
obtained from a study utilising a dominant negative mammalian eIF4A with a series of 
substrates containing increasing amounts of 5′ UTR secondary structure (Svitkin et al., 2001). 
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The results showed that the degree of translation inhibition by mutant eIF4A correlated with 
the amount of 5′ UTR secondary structure in the substrate. It is part of the cap-binding 
complex eIF4F but is also found to be present in a free form. The biochemical activities of 
eIF4A are reported to be up regulated by eIF4B, eI4E, eIF4H, eIF4G and eIF4F (Oberer et 
al., 2005, Rogers et al., 2001). It has been established that eIF4A can adopt three different 
conformations, an open state in the absence of ligands (Hilbert et al., 2011, Andreou and 
Klostermeier, 2014), a half-open state when the middle domain of eIF4G is bound  (Oberer et 
al., 2005) and a closed state in the presence of eIF4B and eIF4G  during unwinding of 
secondary structures in the 5'UTR. The underlying mechanisms of this process though are 
still unclear. Recently, it has been proposed that the translation initiation factors eIF4B and 
eIF4G regulate eIF4A activity in translation initiation by modulating the eIF4A 
conformational cycle (Harms et al., 2014).  The authors followed conformational changes of 
yeast eIF4A in the presence of eIF4B and eIF4G in real time by single molecule (sm) total 
internal reflection fluorescence (TIRF) microscopy. They showed that eIF4A only rarely 
undergoes conformational changes on its own and eIF4B additionally accelerates the 
conformational cycling of eIF4A by further accelerating closing. Interestingly, it was also 
observed that the rate constants for eIF4A conformational changes are different for different 
single-stranded RNAs when compared to double-stranded RNAs that are substrates for 
unwinding by eIF4A. They concluded that that eIF4A integrates signals from eIF4B, eIF4G 
and elements in RNA and revealed the conformational cycle as a central element for the 
multi-faceted regulation of eIF4A activity in translation initiation. 
 Thus, it can be stated that eIF4A is  a unique component of the translation initiation factor 
network reviewed in  (Parsyan et al., 2011).  
1.1.3.3 Initiation factor eIF4E 
 
 16 | P a g e  
 
eIF4E is a 24-kD polypeptide that exists as both a free form and as part of a multi-protein 
complex. The conventional view of eukaryotic translation initiation factor 4E’s primary role 
in the eIF4F complex is to direct ribosomes to the 5’terminal cap structure of mRNAs (Kapp 
and Lorsch, 2004) Figure 4. It has however been shown to interact with other proteins: 
eIF4A1 (Ewing et al., 2007), eIF4EBP1 (Connolly et al., 2006), eIF4EBP2 (Mader et al., 
1995) , eIF4EBP3 (Kleijn et al., 2002),  eIF4G1 (Connolly et al., 2006) ,  eIF4G2 (Gradi et 
al., 1998). 
 
eIF4E is often called the cap binding factor; however, a growing body of evidence indicates 
that this paradigm should be revised.  Recent studies are beginning to challenge this widely 
accepted concept that mRNA recruitment to ribosomes is only through the eIF4F complex. 
Moreover, some mRNA species presumably recruit ribosomes to their 5' ends without the 
involvement of either the 5' m(7)G-cap or eIF4F but instead utilise eIF4G or eIF4G-like 
auxiliary factors (Shatsky et al., 2014). For the purposes of this discussion, the long-standing 
view of eIF4E binding to the cap and thus recruiting eIF4G/eIF4A to the 5' end will be held 
(Pestova and Kolupaeva, 2002).   
 
 
 
 
Figure 4: Schematic of cap recognition complex. 
As illustrated the complex is in association with 43S PIC and mRNA prior to scanning for 
the AUG codon.  
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1.1.3.4 Effect of Poly (A)-binding protein (PABP) on translation 
There is another protein associated with the eIF4F complex called the Poly (A)-binding 
protein (PABP), which binds the poly-A tail of most eukaryotic mRNA molecules. 
The Poly-A tail is a long chain of adenine nucleotides that is added to a messenger RNA 
(mRNA) molecule during RNA processing to increase the stability of the molecule. The poly 
(A) tail can also stimulate translation and cooperates with the cap structure in a synergistic 
fashion. The eukaryotic initiation factor eIF4G plays a central part as a multifunctional 
adapter, which brings together various components of the translation apparatus. Through 
simultaneous interactions with the cap-binding protein eIF4E and the poly (A)-binding 
protein (PABP), eIF4G is able to bridge the two ends of the mRNA (Sachs, 2000, Malys and 
McCarthy, 2011). The resulting pseudo-circular structure of the mRNA is thought to have 
important functional consequences for the translation process. The importance of the poly (A) 
tail is further underscored by the fact that the regulated variation of its length on maternal 
mRNAs is an integral part of gene regulation during oocyte maturation and in early 
embryonic development (Guzeloglu et al, 2012). Finally, the majority of cellular mRNAs are 
degraded by processes that are interconnected with translation and are initiated by poly (A) 
tail shortening (Funakoshi et al, 2007). 
 
1.1.4 Ribosome scanning along the 5'UTR 
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The complex formed by the 40S subunit and the initiation factors positioned at the AUG 
codon is referred to as the 48S complex. In this complex eIFs 1, 1A and 3 occupy the 
interface surface of the 40S ribosomal subunit. Therefore, their presence inhibits formation of 
inter-subunit bridges to assemble the 80S ribosome (Jackson et al., 2012). eIF5 induced 
hydrolysis of eIF2- bound GTP and release of Pi causes the dissociation of the 48S complex. 
Other initiation factors are then displaced by eIF5B (Unbehaun et al., 2004) and subsequently 
leading to the joining of the 60S ribosomal subunit reviewed in (Pestova et al., 2007). 
1.1.4.1 Effect of initiation factors on ribosome function during scanning 
Studies have previously suggested that initiation factors eIF1 and eIF1A act cooperatively 
and interact (directly or indirectly) on the ribosome (Pestova et al., 1998); (Maag and Lorsch, 
2003, Majumdar et al., 2003). Recently confirmatory evidence has been presented which 
showed that these factors act together to maintain the initiating ribosome in an ‘open’ 
scanning-competent form until the start codon is located and codon–anti-codon base pairing 
is established (Passmore et al., 2007, Voigts-Hoffmann et al., 2012). Using cryo-EM, 3D 
reconstructions of 40S bound to both eIF1 and eIF1A, and with each factor alone were 
obtained. These structures revealed that together, eIF1 and eIF1A stabilised a conformational 
change that opened the mRNA binding channel. Biochemical data revealed that both factors 
accelerated the rate of ternary complex (eIF2*GTP*Met-tRNAi(Met) binding to 40S but only 
eIF1A stabilised this interaction (Passmore et al., 2007). eIF1 and eIF1A together mediated a 
conformational change in the 40S subunit that opened the mRNA binding channel and 
formed a new h16 ribosomal protein  and  S3 (rpS3) connection on the solvent side of 40S 
ribosome. Figure 5 outlines the proposed model obtained from cryo-EM data for the 
functions of eIF1 and eIF1A in eukaryotic translation initiation. 
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Figure 5: Model for the functions of eIF1 and eIF1A in eukaryotic translation initiation 
(A) Empty 40S (blue) adopts a closed conformation with a closed mRNA entry channel latch 
(dark green). (B) Upon eIF1 and eIF1A binding, a conformational change in the 40S subunit 
stabilizes the latch in an open position. This conformational change involves the formation of 
a new connection between h16 and rpS3 on the 40S solvent side (light green).(C) The open 
conformation facilitates mRNA (orange) and ternary complex (pink) binding.(D) eIF1 and 
eIF1A hold the mRNA binding channel open to allow scanning of the mRNA until a start 
codon (asterisk) is recognized.(E) Upon start codon recognition, eIF1 and Pi (from the 
hydrolysis of GTP by eIF2) are released and a conformational change occurs to prevent 
further scanning. This closed complex likely has closed mRNA entry and exit channels, 
which clamp down on the mRNA, holding it in position until the 60S subunit joins and 
translation can begin. Note, for clarity, some steps are not shown. This figure was originally 
published in Molecular Cell (Passmore et al., 2007). 
 
 
Recently it has also been established in vivo that enhanced binding of eIF1 to the 40S 
ribosome impedes conformational rearrangements of the pre-initiation complex and elevates 
translation initiation accuracy (Martin-Marcos et al., 2014). Previous studies have shown that 
base-pairing of Met-tRNAi with an AUG triplet leads to a rearrangement of factors in the 
PIC, including displacement of eIF1 and the C-terminal tail (CTT) of eIF1A from the P site, 
and movement of the eIF1A CTT towards the GTPase accelerating (GAP) domain of eIF5. 
These rearrangements enable dissociation of eIF1 from the 40S subunit, evoking a closed, 
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scanning-arrested conformation of the 40S subunit, Pi release from eIF2-GDP, and tighter 
binding of Met-tRNAi in the P site. By examining the consequences of eIF1 mutations having 
the opposite effect on AUG selection, Nanda et al, were able to conclude that eIF1 performs a 
dual function in the scanning mechanism of promoting rapid  tenerary complex loading  
while impeding rearrangement  until an AUG codon is recognised by Met-tRNAi (Nanda et 
al., 2013). These findings establish that eIF1 dissociation from the 40S subunit is required for 
the open conformation of the ribosomes for TC binding and AUG recognition and that 
increase eIF1 affinity for the 40S subunit increases initiation accuracy in vivo. The results 
further demonstrated that the GTPase-activating protein eIF5 and β-subunit of eIF2 promoted 
accuracy in AUG selection by controlling eIF1 dissociation and the stability of TC binding to 
the PIC, beyond their roles in regulating GTP hydrolysis by eIF2. 
 
1.1.4.2 Ribosome scanning 
 
Once the pre-initiation complex has bound to the mRNA, the eukaryotic 40S ribosomal 
subunit locates the translation   initiation codon on mRNA via a scanning process that follows 
the binding of 43S to the capped 5' end.  Although this process is referred to   as ribosomal 
scanning it involves not only ribosomal translocation, but also conformational changes in the 
initiation factors as described above. This includes unwinding of secondary structures in the 
mRNA and selection of the start codon. The scanning process itself is either directly or 
indirectly ATP driven. Subsequent unwinding of duplex structures and long structured 5'UTR 
by RNA helicases enables the RNA to thread through the 40S/mRNA binding cleft and 
expose successive triplets in the P site. Analysis of the effects of 5' UTR length on the time 
required for the first round of translation,  showed that scanning occurred  at 8 bases per 
second predominantly  in the 5'-3' direction (Vassilenko et al., 2011), although there was 
evidence that  suggested limited   backward 3'-5' moments also occurred. Interestingly, it was 
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also found that increasing 5' UTR length did not reduce translational efficiency in yeast cells 
which implied that multiple  PIC’s can simultaneously scan the same 5' UTR. 
 
1.1.5 Recognition of the initiation codon 
 
 The outcome of the scanning process, i.e. in terms of start site selection, can be understood 
in terms of a 5'-3' progressive movement along mRNA in search for the start codon (Berthelot 
et al., 2004).  Although recognition of the initiating codon is mainly due to its 
complementarity with the anticodon in the Met-RNAi, other factors are involved. The context 
of the AUG is one of them. According to the Kozak model, AUG codons with a specific 
nucleotide (nt) context (i.e. the nucleotides before and after a codon) surrounding are 
recognised by the pre-initiation complex. Where multiple AUGs appear in a mRNA, the first 
AUG from the 5' end will be chosen as the site for initiation unless it is disadvantaged by 
being too close to the cap or by virtue of a poor context sequence. Kozak suggested that a 
specific context surrounding the initiating AUG codon is required for its recognition by the 
pre-initiation complex; asserting that this context appeared only in the vicinity of the 
initiating (START) AUG codon of the open reading frame (Kozak, 1986, Zur and Tuller, 
2013).  It has been established that most eukaryotic mRNAs contain a short recognition 
sequence that greatly facilitates the initial binding of mRNA to the small subunit of the 
ribosome. The consensus sequence for initiation of translation in vertebrates (also called 
Kozak sequence) is: ACCAUGG, more loosely it is: (GCC) RCCAUGG where R is a 
purine (A or G) Figure 6. A stem–loop structure positioned between the cap and the first 
AUG of a mRNA was found to inhibit initiation at that AUG to a degree that was related to 
the stability of the secondary structure. eIF1 and eIF1A contributes to discriminating against 
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poor AUG context and non-AUG start codons (Martin-Marcos et al., 2011, Martin-Marcos et 
al., 2014), thus enhancing translation initiation fidelity.  
 
 The Met-tRNAi is brought to the P-site of the small ribosomal subunit by eukaryotic 
initiation factor 2 (eIF2). GTP hydrolysis to GDP by eIF2 is then activated by eIF5, a 49-kDa 
polypeptide that interacts specifically with eIF2 and eIF3 (Hinnebusch, 2014, Jennings et al., 
2013, Luna et al., 2013). This hydrolysis of GTP signals for the dissociation of several 
initiation factors from the small ribosomal subunit, which results in the association of the 
large subunit (or the 60S subunit). Displacement of initiation factors from the 48S complex 
and joining of the 60S subunit thus leads to the formation an 80S ribosome, leaving Met-
tRNAi in the ribosomal P site. The complete ribosome (80S) then commences translation 
elongation, during which the sequence between the 'start' and 'stop' codons is translated from 
mRNA into an amino acid sequence.  
 
 
Figure 6: Favourable context of nucleotides. 
An example of a favourable nucleotide context around the AUG codon. Note the A residue of 
the AUG initiation codon is denoted as position +1. A favourable consensus sequence 
generally consists of a purine at position -3, in most cases an A residue. When there is a 
purine at this position, changes in the consensus sequence have an effect on translation. 
However in the absence of a purine at position -3, a G nucleotide at position +4 is required 
for efficient translation. 
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1.3 Elongation and termination of translation 
 
The end of a translational cycle involves another series of steps that culminate in the release 
of a newly synthesised polypeptide from the translating ribosome (the termination phase), 
and in the dissolution of the ribosome:tRNA:mRNA complex (the recycling phase). 
The empty A site of the ribosome can be occupied an aminoacyl tRNA (aa-tRNA) in the form 
of a ternary complex with elongation factor 1A (eEF1A) and GTP. The selection of the 
correct tRNA is initially mediated by codon-anticodon base pairing between the mRNA and 
the aa-tRNA. Correct base pairing results in conformational changes in the small ribosomal 
subunit that triggers GTP hydrolysis by eEF1A. GTP hydrolysis in turn causes dissociation of 
the aa-tRNA from the ternary complex. The ribosomal peptidyl transferase centre then 
catalyses the formation of a peptide bond between the amino acid in the A site with that in the 
P site. The deacylated tRNA is then released in the exit site and then subsequently released 
from the ribosome as a consequence of conformational changes triggered  by the presence of 
a new aa-tRNA in the A site reviewed in (Jackson et al., 2012) . Termination begins when a 
stop codon enters the ribosomal A-site, forming a pre-termination complex (pre-TC) 
(Alkalaeva et al., 2006).When a stop codon (UAA, UAG, and UGA) occupies the ribosomal 
A site, the eukaryotic release factor (eRF1), complexed with GTP enters the ribosome and 
promotes hydrolysis of the peptidyl ester bond of the last tRNA. In eukaryotes, all three stop 
codons are decoded by the eukaryotic release factor 1 (eRF1). Recognition of a stop codon 
triggers GTPase activity of eRF3, which leads to its dissociation from the complex in its GDP 
bound form. eRF1 is then free to activate the ribosomal peptidyl transferase centre (PTC), 
which hydrolyses the bond between the P-site tRNA and the nascent polypeptide. This then 
leads to the release of the newly synthesised polypeptide and deacylated tRNA and ribosome 
dissociation from mRNA. 
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Earlier work had implicated several eukaryotic initiation factors (eIFs) also in ribosomal 
recycling in vitro (Pisarev et al., 2010, Pisarev et al., 2007). Recently, roles for eIF3 and 
HCR1( eIF3j subunit  in yeast), suggesting that these factors play a  key role in mRNA 
dissociation  in translation termination, have been uncovered in vivo (Beznosková et al., 
2013). In their recent paper, Beznosková et al showed for the first time that eIF3 and HCR1 
critically connected initiation of translation with its termination. They showed that eIF3 and 
HCR1 not only promoted the initiation phase but also specifically acted at the other end of 
the translational cycle during termination, linking eIF3 and HCR1 with both eukaryotic 
release factors (eRF1 and eRF3) and the ribosomal recycling factor ABCE1/RLI1. In 
conclusion, they proposed that all these factors co-operate with each other to ensure stringent 
selection of the stop codon (Beznosková et al., 2013). 
  
1.3.1 Translational regulation at the initiation step 
1.3.1.1 eIF2α phosphorylation 
 
eIF2 as part of the ternary complex  is responsible for loading  the initiator Met-tRNA onto 
the 40S ribosomal subunit. Release of eIF2-bound Met-tRNA is triggered by GTP hydrolysis. 
Therefore, after every round of translation eIF2 has to be recharged with GTP in a reaction 
mediated by the GDP-GTP exchange factor eIF2B. eIF2 is formed of three subunits (α,β,γ) 
and it is mainly on the α subunit that translational control occurs. Phosphorylation of the α 
subunit (Ser51) turns eIF2 from a substrate into a competitive inhibitor of eIF2B. This 
prevents eIF2B- bound eIF2 from engaging in translation and more importantly sequesters 
eIF2B, thus preventing it from acting as the GDP-GTP exchange factor. Therefore, 
phosphorylation of eIF2α results in inhibition of translation reviewed in (Donnelly et al., 
2013). Different stimuli can trigger eIF2α phosphorylation via distinct kinases. The eIF2α 
 25 | P a g e  
 
kinases are a family of four well-characterised serine-threonine kinases, namely; PERK 
(PKR-like ER kinase), PKR (protein kinase double-stranded RNA-dependent), GCN2 
(general control non-derepressible-2) and HRI (heme-regulated inhibitor). They perform 
important and often essential functions in response to infection, proteotoxicity, and low levels 
of essential nutrients such as amino acids and heme, and in this way play important roles in 
viral pathogenicity, cancer, and during development. For example, protein kinase R (PKR) 
(or eIF2AK2) is activated by viral dsRNA (Sharp et al., 1997). In this case, PKR- mediated 
eIF2α phosphorylation results in inhibition of translation as a defence mechanism against 
viral infection (Galluzzi et al., 2008). Phosphorylation of eIF2α also protects cells by 
reducing the general rate of protein synthesis and also biases the cell’s translation initiation 
machinery towards translation of the mRNAs of genes with roles in stress responses (Harding 
et al., 2000, Harding et al., 2003). 
 
1.3.1.2 eIF4G cleavage 
 
 The initiation factor eIF4G is part of the eIF4F complex and is responsible for bringing 
together the mRNA, by binding to the cap binding factor eIF4E, and the 40S subunit, via its 
interaction with eIF3. Therefore, the function of eIF4G is strictly related to its ability to bind 
different components of the translational apparatus through distinct domains. In particular, 
the eIF4E binding site is found in the N-terminal one third of eIF4G while the eIF3- binding 
site is located in the C-terminal domain. Therefore, cleavage of the eIF4G, resulting in 
separation of  the eIF4E- binding domain from eIF3- binding site, would be a mechanism of 
translation initiation  inhibition by preventing the formation of the cap- eIF4E/ eIF4G/eIF3-
40S complex. Indeed, proteolytic cleavage of eIF4G by caspase 3 during apoptosis 
contributes to the shutoff of protein synthesis (Marissen and Lloyd, 1998) reviewed in 
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(Morley et al., 2005, Clemens et al., 2000). Similarly, host cell translation inhibition via 
eIF4G cleavage is mediated by viral encoded proteases in HIV and picornavirus infections 
(Álvarez et al., 2003, Lloyd, 2006, Belsham et al., 2000). It was also demonstrated that Feline 
calicivirus (FCV) infection resulted in inhibition of host-cell protein synthesis and shown that 
this shut-off was accompanied by the specific cleavage of the initiation factors eIF4GI and 
eIF4GII (Willcocks et al., 2004).  Phosphorylation of eIF4G has been reported to regulate 
eIF4G activity by enhancing its affinity for the eIF4F complex. It has also been reported that 
the mechanism of phosphorylation of eIF4G1 is by protein kinase Cα  and this was found to 
regulate eIF4G1 binding to Mnk1 an eIF4E kinase (Walsh et al., 2008). 
1.3.1.3 Regulation of eIF4E activity 
The initiation factor eIF4E is responsible for connecting mRNA and the 40S ribosomal 
subunit by binding to the cap structure and eIF4G. This then makes the factor a suitable target 
for regulation of translation. The recruitment of mRNA to the ribosome must be tightly 
controlled in cells because the impairment of protein synthesis in cells has a direct impact on 
cancer formation and development. Thus, the eIF4E component of the eIF4F complex has 
been considered the rate limiting factor in translation initiation; consequently its availability 
is tightly controlled through regulated interaction with eIF4E binding protein (4E-BPs). 
In mammals there are three isoforms 4E-BP1, 4E-BP2 and 4E-BP3. The isoforms share a 
conserved binding domain for eIF4E with a consensus sequence YXXXXLФ, where Y is a 
tyrosine, X is a variable amino acid residue, L is leucine and Ф is a hydrophobic amino acid 
(Mader et al., 1995, Marcotrigiano et al., 1999, Gosselin et al., 2013).  4E-BP competes with 
eIF4G for the same binding site on eIF4E. Therefore the presence of bound 4E-BPs prevents 
interaction of eIF4E with eIF4G, inhibiting the cap dependent translation initiation reviewed 
in (Gingras et al., 1999b, Marcotrigiano and Burley, 2002). The affinity of 4E-BPs for eIF4E 
is regulated by phosphorylation; hypo-phosphorylated 4E-BPs shows a higher affinity for 
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eIF4E, while the hyper-phosphorylated forms of 4E-BPs have little affinity(Gingras et al., 
1999a). 
 These eIF4E-binding proteins competitively inhibit eIF4E from interacting with eIF4G. 
Phosphorylation of 4E-BPs by the kinase mammalian target of rapamycin (mTOR) frees 
eIF4E, making it available to form an eIF4F complex. Once it becomes part of the complex, 
eIF4E can be phosphorylated by the eIF4G-associated kinase MAPK signal integrating 
kinase 1 (Mnk1) or Mnk2 (Buxade et al., 2008).  Work carried out recently (Walsh and Mohr, 
2014) has demonstrated that eIF3e, a core mammalian subunit of eIF3, controlled eIF4E 
phosphorylation by regulating recruitment of the eIF4E kinase Mnk1 to the eIF4F complex. 
An siRNA screen was used by the authors to test whether eIF3 influenced eIF4F activity. The 
screen was executed to investigate how eIF3 subunit depletion impacted eIF4E 
phosphorylation, which occurred as part of the eIF4F complex. It was discovered that 
depleting the core subunit eIF3e significantly decreased eIF4E phosphorylation but also 
reduced the abundance of other eIF3 subunits.  What was concluded from these sets of 
experiments was that, in addition to tethering the 40S ribosome to eIF4F, eIF3e also 
possessed an intrinsic regulatory capacity that prevented premature eIF4E phosphorylation 
until an eIF3-bound ribosome had been engaged. 
 
Recently, it was also determined that eIF4E possessed an unexpected function in translation 
initiation by strongly stimulating eukaryotic initiation factor 4A (eIF4A) helicase activity 
(Feoktistova et al., 2013). As previously discussed eIF4A activity had been shown to be 
stimulated by eIF4B, eIF4H and eIF4G and no evidence to date existed to link the presence 
of eIF4E in the eIF4F complex with the activity of the eIF4A. Previous attempts to study the 
helicase activity of eIF4A in the eIF4F complex did not control for eIF4E abundance, raising 
a fundamental question regarding the possible role of eIF4E in controlling the helicase 
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activity of the eIF4F complex. To reveal the molecular basis by which eIF4E promoted 
eIF4A duplex unwinding, the authors used a real-time fluorescence assay. They were able to 
show that eIF4E stimulated the rate of duplex unwinding independent of its cap binding 
function. This activity of eIF4E has provided a plausible explanation as to how eIF4E 
abundance promoted translation of highly structured mRNAs by maintaining an eIF4E/eIF4G 
interaction throughout the scanning process. Moreover, this activity of eIF4E further clarified 
why uncapped mRNA translation was sensitive to eIF4E availability (Ohlmann et al., 1996). 
Elevated levels of eIF4E found in cancer cells accounted for its ability to restructure mRNA 
independent of its cap binding function. 
 
The induction of phosphorylation of 4E-BPs has been observed in vitro when cells were 
treated with hormones, growth factors and nutrients. Therefore translation inhibition via 
4EBP is prevented when the cells were stimulated for growth. Conversely situations of 
cellular stress like viral infections, nutrient depravation and apoptosis induce de-
phosphorylation of 4EBP, which sequesters eIF4E and thus inhibit cap dependent translation 
reviewed in (Morley et al., 2005, Proud, 2005, Brian and Anne-Claude, 2007). However, 
during infection of cells with picornaviruses such as Encephalomyocarditis virus (EMCV) 
and Poliovirus (PV), the viral RNA is translated despite 4EBP dephosphorylation. This is 
possible because initiation of translation on picornavirus mRNA, through the use of IRES, 
does not require eIF4E reviewed in (Bushell and Sarnow, 2002) . 
 
1.4 Alternate methods of translation initiation  
 
For a long time the “cap-dependent” mode of initiation was considered the only possible 
route through which translation of eukaryotic mRNAs could be initiated.  Early studies of 
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viral gene expression led to the discovery of an alternative mode of translation initiation in 
eukaryotic cells that bypasses the requirement for cap-dependent scanning and allows the 40S 
ribosome to be directly recruited to the vicinity of the initiation codon. It was discovered that 
certain mRNAs, particularly those  found  in viruses, have evolved mechanisms that bypass 
the conventional scanning mechanism and at least a subset of initiation factors (eIF’s) (Firth 
and Brierley, 2012). These unconventional mechanisms allow for the alternate translation of 
open reading frames (ORFs’) contributing to the complexity of gene expression in viral 
genomes.  Examples of these mechanisms include the following: Internal ribosome elements 
(IRES); Leaky scanning; ribosome frame shifting; ribosome re-initiation and ribosome 
shunting which will be discussed in the following subsections. It should be noted however 
that these four methods are presented here are for illustrative purposes and are by no means 
exhaustive. 
 
1.5 Internal initiation of translation (IRES) 
 
About 20 years ago, the study of picornaviral RNA translation led to the characterisation of 
an alternative mechanism of initiation by direct ribosome binding to the 5' UTR. By using a 
bicistronic vector Figure 7, it was shown that the 5' UTR of the poliovirus (PV) or the 
Encephalomyelitis virus (EMCV) had the ability to bind the 43S pre-initiation complex in a 
5' and cap-independent manner (Pelletier et al., 1988, Pellettier and Sonenberg, 1988, Jang et 
al., 1989). This was rendered possible by an RNA domain called IRES for Internal Ribosome 
Entry Site which enabled efficient translation of an mRNA lacking a 5' cap structure. IRES 
elements have now been found in many different viral families where they often confer a 
selective advantage to allow ribosome recruitment under conditions where cap-dependent 
protein synthesis is severely repressed.  
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Figure 7: Experimental demonstration of IRES activity. 
The Bicistronic assay: the candidate sequence is inserted between two open reading frames 
(ORF). Expression of the first ORF is driven by the 5′ cap structure whereas translation of 
the second ORF takes place only if the intergenic tested sequence is able to recruit 
ribosomes internally. Adapted from(Balvay et al., 2009)  
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Internal ribosome entry sites (IRES) are elements found in the 5′ untranslated region of 
mRNAs (both viral and cellular) which enable initiation of translation in a cap-independent 
manner. As discussed previously, in eukaryotes the initial primary transcript needs further 
processing before it becomes a fully functional mRNA on which translation initiation can 
occur, such as the addition of a 5′ cap. However, in internal initiation the IRES function by 
directly recruiting ribosomes for the initiation of translation. The attachment of the 40S 
ribosomal subunit to the IRES is not dependent on the presence of a cap structure; instead the 
ribosome is recruited to structured RNA elements, namely IRES, within the 5′ UTR of the 
mRNA. The distance from the 3′end of the IRES to the initiating codon varies depending on 
the IRES element. Therefore depending on the position of the IRES element the ribosomal 
subunit either attaches or binds to the 3′ end of the IRES structure and scans along the mRNA 
until it reaches the initiating codon. Once the 40S ribosomal subunit reaches the initiating 
codon, the 60S ribosomal subunit attaches and translation begins Figure 8 and this process 
can involve a subset of canonical initiation factors. 
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Figure 8: Mechanisms of IRES translation initiation in eukaryotic cells 
(A) Cap dependent initiation of translation (B) Cellular IRES-mediated translation 
generally does not require the cap-binding protein eIF4E and/or intact eIF4G, but may 
involve circularisation of the mRNA. The requirement for initiation factors and ITAFs 
can vary between different IRES-containing mRNAs. Potential mechanisms of cellular 
IRES-mediated translation: (i) most, if not all, initiation factors and many ITAFs are 
required (top part); (ii) a limited number of canonical factors and ITAFs are required 
(middle); and (iii) canonical factors are dispensable, but some ITAFs may be required 
(bottom). Adapted from (Komar and Hatzoglou, 2011)  
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It has been shown that viral IRES-driven translation initiation is typically utilised when cap-
dependent initiation is compromised. Thus, viral IRES-driven translation has a generally 
reduced requirement for canonical translation initiation factors, particularly members of the 
eIF4F complex (initiation factors eIF4E and eIF4G). Several other initiation factors also 
appeared to be dispensable for the internal initiation pathway. The involvement of canonical 
initiation factors in IRES-driven translation initiation appears to vary for IRESs in different 
mRNAs(Kieft, 2008). Analysis of the structures of viral IRES elements has shown that they 
possess complex secondary and tertiary structures that are believed to direct non-canonical 
interactions between the IRESs and components of the canonical translational apparatus, thus 
allowing for 5' end independent initiation. In addition, a number of proteins have been 
identified that are capable of modulating (typically enhancing) internal initiation. These so-
called IRES trans-acting factors (ITAFs) reviewed in  (Hellen and Sarnow, 2001) and 
(Jackson, 2013, Martínez-Salas et al., 2013) are cellular RNA-binding proteins that have a 
variety of cellular functions in addition to promoting internal initiation; however, they do not 
appear to be involved in cap-dependent translation initiation. 
1.5.1 Cellular IRES 
The discovery that translation of the uncapped picornaviral mRNA was mediated by an RNA 
structure which allowed assembly of the translational machinery at a position close to or 
directly at the initiation codon, broke one of the cardinal rules of translation initiation, that is, 
eukaryotic ribosomes can bind to mRNA only at the 5' end. After the discovery of IRESs in 
viral mRNA, it was also shown that cellular mRNA which encodes for immunoglobulin 
heavy chain binding protein (BiP) contains IRES element (Macejak and Sarnow, 1991). Later 
observations revealed that several cellular mRNAs consists IRES elements in 5′UTR region, 
which play a major role in different cellular functions like cell growth, development, 
differentiation, proliferation, senescence and apoptosis. To date, IRESs have been identified 
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in viral RNAs, cellular mRNAs (Fernandez et al., 2005), plants and yeasts (Dinkova et al., 
2005, Mardanova et al., 2008) making this RNA-driven mechanism an important part of the 
repertoire of translation initiation and regulation. Some examples of these IRES elements are 
presented in Table 2. 
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Table 2: Examples of IRES elements in cellular mRNAs. 
 
Organism Protein function IRES name Reference 
    
 
Mammals 
Apoptotic proteins 
 
 
 
Apaf-1 (Mitchell et al., 2003) 
XIAP 
cIAP2 
DAP5 
(Riley et al., 2010) 
(Graber et al., 2010) 
(Henis-Korenblit et al., 2002) 
Oncogene 
Amino acid starvation 
Nutrient signalling 
Hypoxia 
 
 
Heat shock 
 
Cold shock 
DNA damage response 
 
cymc 
CAT-1 
INR 
HIF1a 
VEGF 
 
BiP 
BAG-1 
CIRP 
P53 
(Le Quesne et al., 2001) 
(Fernandez et al., 2005) 
(Spriggs et al., 2009) 
(Schepens et al., 2005) 
(Morris et al., 2010) 
 
(Macejak and Sarnow, 1991) 
(Pickering et al., 2004) 
(Al-Fageeh and Smales, 2009) 
(Yang et al., 2006) 
Insects 
Aptotic proteins 
Heat shock 
 
Insulin signalling 
Alcohol dehydrogenase 
Rpr,hid 
Hsp70 
 
dFxO 
Adh-Adhr 
(Hernandez et al., 2004) 
(Vazquez-Pianzola et al., 
2007) 
(Villa-Cuesta et al., 2010) 
(Ramanathan et al., 2008) 
Plants 
Heat shock 
Alcohol dehydrogenase 
HSP101 
ADH 
(Dinkova et al., 2005) 
(Mardanova et al., 2008) 
    
Yeast 
Nitrogen assimilation 
Glucose starvation 
URE-2 
GPR1 
(Reineke and Merrick, 2009) 
(Gilbert et al., 2007b) 
Adapted from Martínez-Salas, 2012 
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1.5.2 IRES structure and classification 
 
 At present, IRESs are defined solely by functional criteria and cannot yet be predicted by the 
presence of characteristic RNA sequences or structural motifs (Le et al., 2003, Xia and 
Holcik, 2009, Jackson, 2013). The existence of an IRES in a particular mRNA must be 
experimentally determined in each and every case following a set of stringent defined tests 
(Van Eden et al., 2004).  Functionally, the IRES were first identified by inserting the 
poliovirus (PV) 5' UTR into the intercistronic spacer of a bicistronic construct coding for two 
proteins. Expression of the second cistron documented the ability of the inserted sequence to 
promote internal ribosome binding and translation independent of the first cistron.  
Chemical and enzymatic probing of the structure of a variety of cellular IRESs revealed (as 
found for viral IRES elements) complex structures that often include stem loops and 
pseudoknots (Komar and Hatzoglou, 2005, Baird et al., 2007). In general, as compared to 
their viral counterparts, cellular IRES elements appear to be much more diverse in their 
structures.  Based on experimental evidence there are at least 68 viruses and at least 115 
eukaryotic cellular mRNAs reported to contain IRES as of 2009 (Mokrejš et al., 2010, 
Jackson, 2013).  Viral IRESs are grouped into different types based on their secondary 
structure, the translation initiation factors they require, and whether or not they recruit the 
ribosome upstream of the AUG start codon or directly at it Figure 9. Four Picornavirus types 
of viral IRES have been identified and one class found within the intergenic region (IGR) of 
the Dicistroviridae viral family. Each type of IRES has a different characteristic structure and 
promotes initiation by a distinct mechanism.  
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Figure 9: IRES elements of picornaviruses, HCV and CrPV. 
 
 
 
Type I:  
This is a type of IRES RNAs that require some canonical eIFs, Met-tRNAi and IRES trans-
acting factors (ITAFs). They function efficiently in rabbit reticulocyte lysate (RRL) only 
when supplemented with extracts from other cell types and also initiate at an AUG codon 
somewhat downstream of the IRES. This type include Enterovirus genus poliovirus (PV) and 
rhinovirus. In the Dicipivirus genus, there are two Type I IRESes, one in the 5′UTR and the 
other is intergenic (Woo et al., 2012). 
Type I–III picornavirus IRES elements with structural similarities that are shown 
between (A–C). Type IV IRES (D), HCV-like IRES (E) and the structurally different 
IRES of Cricket paralysis virus (CrPV) is as (F).*represents the central domain, py 
represents oligopyrimidine tract, dotted box represents initiation factor binding 
domains (Lin et al, 2009). 
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Analysis of the secondary structure of type I IRES elements revealed that they are 
approximately 450 nucleotides long and consist of five domains, namely II to VI and that 
stem loops II and V are required for IRES activity (Pelletier et al., 1988, Burrill et al., 2013) 
see Figure 9 A.  
The initial binding of the ribosome to the RNA is at an AUG about 25 nucleotides 
downstream of the oligopyrimidine tract, but this AUG is not usually the site of translation 
initiation. This is believed to be due to the poor context of the AUG codon at this 
point(Kaminski et al., 2010), hence initiation occurs about 65 nucleotides and 185 
nucleotides downstream in rhinoviruses and enteroviruses respectively. The ribosome is 
believed to move from its entry site to the initiating codon via a scanning mechanism 
reviewed in (Belsham and Jackson, 2000). For enteroviruses the AUG  thought to be the 
putative entry site is found at the base of a stem loop, but deletion of the stem loop was found 
to have no adverse effect on virus infectivity suggesting that that this was not a determinant 
of IRES activity. The inefficiency of enterovirus IRES elements observed in RRL systems 
and its restoration upon supplementation with HeLa cell extracts suggested that factors absent 
in RRL, but present in the HeLa extract were necessary for IRES activity. Therefore, the 
function of the IRES element was influenced to some extent by the availability of non-
canonical translation factors. Indeed it has been proven that cellular proteins not usually 
involved in translation are required for enterovirus IRES activity (Belsham, 1992). All type I 
IRESs that have been characterized to date are dependent on ITAFs which, apart from PTB, 
are distinct from those used by type II IRESs (Niepmann, 2009) described below. 
 
Type II: 
This group of IRES occur in the Aphthovirus, Cardiovirus, and Parechovirus 
genera(Belsham and Jackson, 2000); divergent members occur in the Erbovirus and 
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Cosavirus genera (Hollister et al., 2008, Kapoor et al., 2008). They are 450 nucleotides long 
and also have a 3’terminal Yn-Xm-AUG motif. The AUG triplet may be the initiation codon. 
Their five principal domains (H, I, J, K, and L) are unrelated to domains in type I IRESs, with 
the exception of domain I, which, like domain IV of type I IRESs, contains a C-rich loop and 
a functionally important GNRA tetraloop (Belsham and Jackson, 2000) (Figure 9 B).  They 
can function without eIF4E and factors implicated in ribosomal scanning, such as eIF1 and 
eIF1A, although some additionally require one or more IRES trans-acting factors (ITAFs), 
which are cellular RNA-binding proteins, such as the pyrimidine tract-binding protein (PTB) 
(Niepmann, 2009, Pacheco and Martinez-Salas, 2010). 
 
Type III: 
This group of IRES occurs only in hepatitis A virus (HAV). It has a 410 nucleotide long core 
comprising of two major domains (IV and V) followed by a Yn-Xm-AUG motif, but its 
function is significantly enhanced by the upstream 175 nucleotide long domains II and III 
(Lukavasky et al, 2009). There are major structural and mechanistic differences between it 
and type I and type II IRESs, such as the length and sequence of core structural elements and 
the exceptional requirement of HAV IRES for the cap-binding protein eIF4E (Ali et al., 
2001). 
 
Type IV, HCV-like IRES 
Hepatitis C virus (HCV) initiates translation of its polyprotein under the control of an internal 
ribosome entry site (IRES) that comprises most of the 341-nucleotide (nt) 5′ non translated 
RNA (5′UTR) (Honda et al., 1999). The IRES RNA functionally replaces several large 
initiation factor proteins by directly recruiting the 43S particle. The Hepatitis C virus (HCV) 
mRNA contain an internal ribosome entry sites (IRESs) that promote 5′-end independent 
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initiation of translation (Figure 9E), requiring only a subset of the eukaryotic initiation 
factors (eIFs) needed for canonical initiation on cellular mRNAs. The hepatitis C virus 
(HCV) 5′ untranslated region (5′ UTR), is 332 bases long. Nucleotides 1-40 of the HCV 
mRNA are thought not to contribute to translation, and are rather required for genomic RNA 
replication. The remainder of the HCV 5'-UTR, consists of three domains, namely domains 
II-IV (domain I is located on the 5'-end of the mRNA) are necessary for protein synthesis 
(Hershey et al., 2012). Initiation of translation on HCV-like IRESs relies on their specific 
interaction with the 40S subunit (Kieft et al., 2002, Wells et al., 1998, Raina and Ibba, 2012) 
which places the initiation codon into the P site, where it directly base-pairs with eIF2-bound 
Met-tRNAi to form a 48S initiation complex (no ribosomal scanning is required). HCV-like 
IRESs also specifically interact with eIF3 (Raina and Ibba, 2012, Hershey et al., 2012, Berset 
et al., 2003).  The role of this interaction in IRES-mediated initiation has been shown to 
induce a ribosome conformational change upon hepatitis C viral IRES binding and was found 
to be necessary for correct mRNA positioning (Rogers et al., 2001, Andreou and 
Klostermeier, 2013). The mechanism of HCV IRES function to date is better characterised. 
Assembly studies have suggested that the IRES binds first to 40S subunits and that this 
complex then recruits eIF3 and the ternary complex (TC) of eIF2-GTPMet-tRNAi
met
 
(Verschoor et al., 1998, Verschoor and Frank, 1990). However, in contrast it was discovered 
that in HeLa extracts (Verschoor and Frank, 1990), the HCV IRES  bound to the 40S subunits 
that were pre-associated with eIF3 and/or the TC in cells. GTP hydrolysis by the TC, 
mediated by eIF5, enabled the 60S ribosomal subunit joining with the help of eIF5B, forming 
an elongation-competent 80S ribosome (Dube et al., 1998, Spahn et al., 2001). The IRES may 
also facilitate an alternative, eIF2-independent pathway of translation initiation under 
conditions of increased eIF2α phosphorylation during infection (Berry et al., 2010).  
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Type V 
A fifth IRES type recently characterized in members of Kobuvirus, Salivirus, and 
Paraturdivirus genera of Picornaviridae: Aichi virus (AV), bovine kobuvirus (BKV), canine 
kobuvirus (CKoV), mouse kobuvirus (MKoV), sheep kobuvirus (SKV), salivirus A (SV-A), 
turdivirus 2 (TV2), and TV3. The 410-nucleotide (nt)-long AV IRES comprises four domains 
(I to L), including a hairpin (L) that overlaps a Yn-Xm-AUG (pyrimidine 
tract/spacer/initiation codon) motif (Sweeney et al., 2012). The IRES is structurally distinct 
from the different classes of IRESs described above and also has distinct factor requirements: 
unlike all other IRESs that have been characterized to date. 48S complex formation on it is 
dependent on DHX29, a ribosome-associated DExH-box helicase that has been implicated in 
the correct accommodation of structured mRNA in the mRNA-binding channel of the 40S 
subunit. 
 
Dicistrovirus: 
The simplest IRES to date is found within the intergenic region (IGR) of the Dicistroviridae 
viral family (Kieft, 2008, Nakashima and Uchiumi, 2009). The dicistroviruses contain a 
positive single-stranded RNA genome encoding non-structural and structural proteins within 
two open reading frames, which are separated by the IGR IRES. The IGR IRES (Figure 9F) 
can bind directly to 40S subunits and 80S ribosomes, without the aid of initiation factors or 
initiator Met-tRNAi, but not 60S subunits (Jan et al., 2003, Nishiyama et al., 2003, Wilson et 
al., 2000). The IRES then sets the reading frame by occupying the ribosomal P-site to 
position a non-AUG codon in the ribosomal A-site (Jan, 2006, Jan et al., 2003, Nishiyama et 
al., 2003, Pestova and Hellen, 2003, Sasaki and Nakashima, 2000, Wilson et al., 2000, Sasaki 
and Nakashima, 1999). Subsequent biochemical and structural studies have revealed that the 
IRES recruits, positions, and sets the ribosome in an elongation mode, indicating that this 
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∼200-nucleotide (nt) RNA acts as an all-RNA translation factor. (Jan, 2006, Jan et al., 2003, 
Nishiyama et al., 2003, Pestova and Hellen, 2003, Sasaki and Nakashima, 2000, Wilson et 
al., 2000). Phylogenetic analyses have also revealed that all Dicistroviridae IGR IRESs adopt 
a similar secondary structure consisting of three overlapping pseudoknots, PKI, PKII, and 
PKIII(Jang and Jan, 2010). 
This has led to the hypothesis that distinct domains of the IRES interact with specific regions 
of the ribosome to direct IRES translation. Consistent with this, structural and biochemical 
studies have revealed that stem loops SLIV and SLV interact with ribosomal proteins rpS5 
and rpS25 to mediate 40S binding, whereas the conserved L1.1 region is predicted to interact 
with the L1 stalk of the 60S subunit to direct 80S assembly(Pfingsten et al., 2006, Schuler et 
al., 2006, Nishiyama et al., 2007, Costantino et al., 2008). In conclusion it can be said that the 
IRES primarily occupies the P- and E-sites of the ribosome, confirming that it mimics a 
tRNA. 
 
 
In summary, Picornavirus IRES elements belonging to types I and II require the C-terminal 
end of eIF4G, eIF4A, and eIF3 to assemble 48S initiation complexes(Andreev et al., 2007, de 
Breyne et al., 2009, Lopez de Quinto et al., 2001) whereas type III IRES require an intact 
eIF4G. In contrast, the type IV IRES do not need eIF4G to assemble 48S complexes (Pisarev 
et al., 2004). In addition to eIFs, auxiliary factors termed IRES transacting factors (ITAFs), 
contribute to modulate (either stimulate or repress) IRES activity (Pacheco and Martinez-
Salas, 2010, Weinlich et al., 2009).  However, a wide functional range of IRES may also exist 
as recent studies have demonstrated that lentiviruses IRES share functional properties with 
both HCV-like IRES and type II IRES (Locker et al., 2011). 
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1.5.2.1 IRES Trans Acting Factors (ITAFs) 
 
Variation in IRES efficiency within different cell types has led to the identification of factors 
required for the efficiency IRES mediated translation in addition to the canonical initiation 
factors (Belsham and Jackson, 2000, Livnah et al., 1993). A number of proteins have been 
shown to act as IRES trans acting factors. All ITAFs that were found to promote IRES 
activity contained multiple RNA binding domains that were likely to interact with more than 
one part of the IRES at once, acting as RNA chaperones. These factors held the IRES in 
special conformations contributing towards the optimal structure function relationship of the 
IRES.  
Type I and type III IRES elements were found to differ from type II elements in their 
inability to function in cell free translation systems, such as RRL system (Garcia-Mayoral et 
al., 2007). However IRES activity of enteroviruses/ rhinoviruses could be rescued by the 
addition of HeLa cell cytoplasmic extracts, while HAV IRES activity in the RRL is 
stimulated by the addition of mouse liver cytoplasmic extracts. This suggested that the HeLa 
extracts and liver extracts contained translation factors or higher concentration factors that 
were missing or not abundant in RRL.  
Thus far, cellular proteins identified to be involved with picornavirus IRES elements are 
polypyrimidine tract binding protein (PTB), the autoantigen La,  poly(rC)-binding protein  
(PCBP1) and (PCBP2), Upstream of N-ras(Unr), Unr interacting proteins (Unrip), IRES trans 
acting factor 45 (ITAF 45), heterogeneous nuclear ribonucleoprotein hnRNP K, hnRNP A1, 
Far Upstream binding protein 1 (FBP1) and (FBP2).  Most ITAFs identified to date are RNA 
binding proteins but the exact role they play in the IRES mediated translation remains 
elusive. 
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In conclusion, in order to replicate and propagate, all viruses are strictly dependent on the 
host cell translational apparatus for protein production. Viruses have over time evolved 
mechanisms that hijacked the eukaryotic translational machinery for their own benefit 
(Valverde et al., 2008). In cells infected with most viruses, proteolysis or changes in 
phosphorylation of key factors induce a shut off of the host cell cap dependent protein 
synthesis and several viral mRNAs lack the 5’cap structure. Therefore, IRES elements confer 
a selective advantage to allow internal ribosome recruitment and maintain viral proteins 
under conditions where cap dependent translation is depressed (Sarnow et al., 2005).  
Although the mechanisms of initiation of IRES differ from one to another, they all by pass 
the need for the cap and some, or all of the factors involved in cap independent translation. 
Therefore, structured RNA domains replace the cap and some elFs are crucial for IRES 
function (Garcia-Mayoral et al., 2007). 
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Chapter 2 
 
Analysis of Translational 
Control by SARS Coronavirus 
NSP1 protein 
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2.1 INTRODUCTION 
 
The 2002–3 pandemic of Severe Acute Respiratory Syndrome (SARS) and the ongoing 
emergence of the Middle East Respiratory Syndrome coronavirus (MERS-CoV)  have 
demonstrated that coronaviruses are a significant public health threat (Ksiazek et al., 2003) 
(Zaki et al., 2012, C.D.C, 2012). SARS appeared in the Guangdong Province, mainland 
China, in November 2002 (Zhong et al., 2003). The causative agent was unknown at that time 
(Heymann, 2004). Within months after its emergence in China, it had affected more than 
8000 people and caused 774 deaths in 26 countries on five continents (W.H.O, 2003a, 
2003b). The World Health Organization estimated the mortality rate of SARS to be up to 
15% and there is currently no approved therapeutic treatment for SARS. The causative agent 
was later identified as a coronavirus (Peiris et al., 2003). Coronavirus biological vectors were 
not known however, serological and genetic evidence from various studies supported a 
zoonotic origin of SARS-CoV (Wang and Hu, 2013, Field, 2009, Ge et al., 2013). The 
complete genome sequence of SARS-CoV Tor2 (Toronto) isolate was published in April 
2003, which established it as a novel member of the family (Marra et al., 2003). 
SARS-CoV is a member of the Coronaviridae family, which are enveloped single-stranded 
RNA viruses primarily causing respiratory and enteric diseases in vertebrates (Weiss and 
Navas-Martin, 2005, de Groot et al., 2011, 2001). Most human coronaviruses cause mild 
respiratory tract diseases. The genome of SARS-CoV consists of 29,751 nucleotides. 
Phylogenetic analysis revealed that it was only moderately related to other known 
coronaviruses, including human coronaviruses, HCoV-OC43, HCoV-229E and HCoV-NL63  
known to cause common colds, lower respiratory tract infections and diarrhoea in humans 
(Marra et al., 2003, van der Hoek et al., 2004). The five coronavirus types which affect 
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humans are alpha (229E and NL63), beta (OC43), HKUI1 and SARS-CoV (de Groot et al., 
2011). 
Clinical symptoms of the syndrome include fever, chills, rigors, cough, and headache. The 
pathological aspects of infection include lymphopenia, thrombocytopenia, elevated lactate 
dehydrogenase, and creatine kinase levels (Drosten et al., 2003, Christian et al., 2004, Hon et 
al., 2003). Currently the spread of the virus seems to be contained due to rigorous and timely 
quarantine measures (Baric, 2008, W.H.O, 2006.). It is believed that the virus may still be 
circulating in animal reservoirs and it is impossible to predict when another outbreak will 
occur. Therefore, the potential of recurrence of a SARS pandemic still exists. The 
developments of effective antiviral therapies are urgently required. Research towards the 
understanding of the SARS virus at a molecular level is of vital importance to combat SARS-
CoV infection if another SARS pandemic is to be prevented in the future. 
Recently, a novel CoV named Middle East respiratory coronavirus (MERS-CoV), that is 
closely related to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5 
has emerged as a cause of severe respiratory infections associated with high rates of mortality 
(Zaki et al., 2012, de Groot et al., 2013, Milne-Price et al., 2014). Its isolation supported the 
suggestion that coronaviruses are important causes of major epidemics. Therefore, continuous 
discovery of novel coronaviruses and their functional characterisation are of crucial 
importance. 
 
2.1.1 Coronaviridae 
 
The coronaviruses (order Nidovirales, family Coronaviridae, and genus Coronavirus) Figure 
10 are members of a family of large, enveloped, positive sense single-stranded RNA viruses 
that replicate in the cytoplasm of animal host cells (Siddell et al., 1983, de Groot et al., 2011). 
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Viruses from each coronavirus genus have been found in diverse host species, including 
mammals and birds (Chan et al., 2008). The Coronaviridae family have been traditionally 
divided into three genera (I to III) usually referred to as groups (Table  3) (Brian and Baric, 
2005, Ziebuhr, 2004). This classification was originally designed on the basis of serological 
cross-reactivity, but it was later confirmed by sequence homology (Gonzalez et al., 2003, 
Knipe and Howley, 2001). Phylogenetic analysis has also enabled the classification of SARS-
related coronavirus (SARSr-CoV). These were categorised as a subgroup of group 2, group 
2b, coronavirus; as well as the discovery of group 2c, 2d, 3b and 3c coronaviruses (Woo et 
al., 2007). In 2011, The Coronavirus Study Group of the International Committee for 
Taxonomy of Viruses proposed that the three genera, Alphacoronavirus, Betacoronavirus and 
Gammacoronavirus, be used to replace the three traditional groups of coronaviruses (I.C.T.V, 
2012). However, the terminology is still used interchangeably. Recently a fourth genus of 
coronavirus, Deltacoronavirus was discovered (Woo et al., 2009, Woo et al., 2012). 
According to this new classification the coronavirus groupings are as follows: 
Alphacoronavirus (Group 1) coronaviruses include animal pathogens. (Canine, feline 
infectious peritonitis, porcine transmissible gastroenteritis and porcine respiratory viruses, 
human coronavirus 229E). Betacoronavirus (Group 2) includes pathogens of veterinary 
relevance, as well as human coronaviruses. It also includes viruses that infect both mice and 
rats (Bovine, murine hepatitis, rat sialodacryoadenitis viruses, human coronavirus OC43). 
Gammacoronavirus (Group 3) contains only avian viruses (avian infectious bronchitis, 
turkey coronavirus). A fourth group, Deltacoronavirus, which includes bulbul coronavirus 
HKU11, thrush coronavirus HKU12 and munia coronavirus HKU13, is emerging (Wang et 
al., 2014). In animals, coronaviruses can lead to highly virulent respiratory, enteric, and 
neurological diseases as well as hepatitis.  Several coronaviruses can cause fatal systemic 
diseases in animals, including feline infectious peritonitis virus (FIPV), heamagglutinating 
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encephalomyelitis virus (HEV) of swine, and some strains of avian infectious bronchitis virus 
(IBV) and mouse hepatitis virus (MHV). These coronaviruses can replicate in liver, lung, 
kidney, gut, spleen, brain, spinal cord, retina, and other tissues (Holmes, 2003). 
Coronaviruses also cause economically important diseases in domestic animals. 
 
 
 
 
Figure 10: Phylogenetic relationships in the order Nidovirales 
The evolutionary relationships between the major nidovirus lineages inferred by using 
multiple nucleotide sequence alignment of the RdRp-He1 region of representative members 
of nidovirus families and genera. Adapted from (Knipe and Howley, 2001).  
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Table 3:  Coronavirus species. 
 
Species Virus Natural 
hosts 
Disease 
    
Alphacoronavirus 
Transmissible gastroenteritis virus 
Human coronavirus HCoV-229E 
Human coronavirus NL63 
Miniopterus Bat coronavirus 
Pig Gastroenteritis 
Man 
Man 
Bats 
Pneumonia 
Pneumonia 
Gastroenteritis 
    
Betacoronavirus 
Human coronavirus HKU 1 
SARS-related coronavirus 
Murine hepatitis virus 
MERS-CoV 
Bovine coronavirus (BCV) 
Haemagglutinating encephalomyelitis 
 
Man 
Bats 
Mouse 
Bats 
Cattle 
Pig 
 
Gastroenteritis 
Pneumonia 
Hepatitis 
Pneumonia 
Gastroenteritis 
Encephalomyelitis 
wasting disease 
    
Gammacoronavirus 
Beluga whale coronavirus 
Infectious bronchitis virus (IBV 
Bottlenose dolphin coronavirus 
HKU22 
Whale 
Chicken 
Dolphin 
 
 
Pig                 
Birds 
Birds 
Birds 
 
Pneumonia 
nephritis 
Pneumonia 
 
 
Gastroenteritis 
Pneumonia 
Pneumonia 
Pneumonia 
  
Deltacoronavirus 
Porcine coronavirus HKU15 
Bulbul coronavirus HKU11 
Thrush coronavirus HKU12 
Munia coronavirus HKU13 
    
    
 
 
 
Human coronaviruses (HCoVs) are usually associated with mild diseases. They are found in 
both group 1 e.g. (HCoV-229E) and group 2 e.g. (HCoV-OC43) and are a major cause of 
normally mild respiratory illnesses (Makela et al., 1998, Myint, 1995). They can occasionally 
cause serious infections of the lower respiratory tract in children and adults and necrotizing 
enterocolitis in new-borns (El-Sahly et al., 2000). Human coronaviruses are known to be able 
to survive on environmental surfaces for up to 3 hours. Coronaviruses may be transmitted 
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from person-to-person by droplets, hand contamination and small particle aerosols (Ijaz et al., 
1985). 
 
2.1.2 Virion Morphology 
 
Coronavirions are pleomorphic, although generally spherical, 60nm to 220 nm in diameter 
and bear widely spaced, club-shaped surface projections about 20 nm in length Figure 11. 
Complete virions have a density in sucrose of about 1.18 g/ml. The genomic RNA is 
complexed with the basic nucleocapsid (N) protein to form a helical capsid found within the 
viral envelope (Masters, 2006). The envelope of all coronaviruses contains at least three viral 
proteins (Liu et al., 2007). The M protein is the major component of the envelope and is 
responsible for virion morphogenesis by recruiting the small membrane protein (E) and the 
spike protein (S) (Neuman et al., 2011).  Studies also propose that the M protein is involved 
in recruiting the genome during encapsidation (Narayanan and Makino, 2001). The S protein 
is a glycoprotein that forms the peplomers on the virion surface, giving the virus its corona- 
or crown-like morphology in the electron microscope. It binds to species-specific host cell 
receptors to trigger a fusion event between the viral envelope and a cellular membrane. The 
virion envelope also contains phospholipids, glycolipids, cholesterol, di- and triglycerides 
and free fatty acids in proportions approximately corresponding to those in the host cell 
membrane (Liu et al., 2007).  
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Figure 11: Coronavirus morphology 
A negatively stained preparation of infectious bronchitis virus.  Bar marker represents 200 
nm.  (From (Siddell et al., 1983); J. Almeida©). 
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2.1.3 Genome organisation and life cycle of coronaviruses 
 
The genome structure is conserved among all known coronaviruses. Coronaviruses contain a 
single stranded, 5′-capped 3' poly(A) tailed, positive strand RNA molecule ranging from 26–
32 kilobases that contains at least 6 open reading frames (ORFs) Figure 12.  The first ORF 
(ORF1a/b) comprises approximately two thirds of the genome and encodes replicase proteins. 
The majority of the remaining one third of the genome encodes four structural proteins: S, E, 
M and nucleocapsid (N) proteins. A subset of group 2 coronaviruses encodes an additional 
haemagglutinin-esterase (HE) protein.  
Coronaviruses are a diverse family of viruses that bind to host cells primarily through specific 
interactions between viral spike glycoproteins and host cell surface glycoproteins. The virus 
gains entry into the target cells by direct membrane fusion at the target cell surface. However, 
SARS-CoV may gain cell entry via a pH-dependent endocytosis mechanism involving the 
spike protein (Yang et al., 2004). A low pH in the receptor-containing vesicles triggers a 
conformational change to the spike protein which then mediates fusion between the viral and 
cell membranes which results in the release of the nucleocapsid into the cell (Wang et al., 
2008). Upon entry into the cell, the 5' end of the genome RNA is translated and processed 
through multiple enzymatic activities speculated to play a role in the metabolism of 
coronavirus RNA and/or in interfering with host cell processes. During infection with 
coronaviruses, as with all other RNA viruses, replication of genome and transcription of viral 
mRNAs must occur. Replication of the genome involves the synthesis of a full-length 
negative-strand RNA that is present at a low concentration and serves as template for 
production of full-length genomic RNA. 
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Figure 12: Genome structure of SARS-CoV. 
Schematic of the genome structure of SARS-CoV. The N-terminal two-thirds of the genome 
encodes the non-structural proteins, also called the replicase proteins (orange box). The C-
terminal one-third of the genome encodes the structural (red boxes) and accessory (gray 
boxes) open reading frames (ORFs). The structural ORFs encode the spike (S), envelope (E), 
membrane (M), and nucleocapsid (N) proteins. Each coronavirus has similar structural ORFs 
in their genomes. The accessory ORFs (3a, 3b, 6, 7a, 7b, 8a, 8b, 9b) in grey, are unique to 
each coronavirus. From (Frieman and Baric, 2008). 
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2.1.4 The clinical disease 
SARS affects persons in all age groups. The early symptoms of SARS-CoV disease usually 
include fever, chills, rigors, myalgia, and headache (Peiris et al., 2003). In some patients, 
myalgia and headache may precede the onset of fever by 12-24 hours. Respiratory symptoms 
often do not appear until 2-7 days after the onset of illness and most often include shortness 
of breath and/or dry cough. Diarrhoea, sore throat, and rhinorrhea may also be early 
symptoms of SARS-CoV disease. SARS is a viral pneumonia that progresses rapidly. The 
initial manifestations of SARS are not specific, and it cannot be clinically differentiated from 
other acute community-acquired pneumonias (Peiris et al., 2003). About 20 to 30 percent of 
patients infected require admission to an intensive care unit, and most of them require 
mechanical ventilation.  Death is usually due to severe respiratory failure, multiple organ 
failure, sepsis, or intercurrent medical illness such as acute myocardial infarction.  
 
2.1.5 SARS Genome 
The SARS-CoV genome has been predicted to contain 14 functional open reading frames 
(ORFs). The comparison of different SARS-CoV ORFs with those of other CoVs revealed a 
similar pattern of structural gene arrangement with the replicase and protease genes (gene 1a-
1b) and the spike (S), envelope (E), membrane (M), and nucleocapsid (N) genes in a 5’ to 3’ 
order of  appearance. Interspersed between these well-characterized genes is a series of 
ORFs, many of whose functions are yet unknown. There are two ORFs situated between the 
S and the E genes and three to five ORFs between the M and N genes Figure 12. The SARS-
CoV genomic sequence does not contain a gene for the haemagglutinin-esterase (HE) protein, 
which is present in most group II coronaviruses. Two-thirds of the SARS-CoV RNA 
corresponds to the ORF1a and ORF1b. Overall, ORF1 of most coronaviruses encodes 16 
non-structural proteins (NSP) that are involved in viral replication; ORF1 of group 3 
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coronaviruses lacks NSP1 and thus encodes only 15 proteins. The predicted functions were 
later confirmed for many of these proteins (Perlman and Netland, 2009) Table 4. The 
sequence of these genes is highly conserved among all CoVs with the exception that SARS-
CoV lacks the sequence coding for papain-like protease (nsp3 or PL1
pro
), one of the two 
papain-like proteinases operating on cleavage sites at the N terminus of the polyproteins.  
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Figure 13: Schematic of genome structure of SARS-CoV 
The non-structural proteins, also called the replicase proteins (orange box; ORF1a and 
ORF1b) as shown are expanded in the schematic to illustrate the sixteen known non-
structural proteins (NSP1 to NSP16) that form the replicase of SARS-CoV. The structural 
open reading frames (red boxes) encode the spike (S), envelope (E), membrane (M), and 
nucleocapsid (N) proteins. Accessory open reading frames encoding accessory proteins (3a-
9b) are shown as grey boxes.  Adapted from (Frieman and Baric, 2008). 
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Table 4:  Coronavirus non-structural proteins and their functions.  
 
Protein Functions                 References 
  
NSP1 Host mRNA degradation; translation 
inhibition; cell cycle arrest; inhibition of IFN 
signaling                                                             
(Narayanan et al., 2008, 
Lokugamage et al., 2012) 
NSP2 Unknown (Graham et al., 2005, Graham et 
al., 2006) 
NSP3  Papain-like proteases (PL1
pro
, PL2
pro
) 
(polyprotein processing); poly(ADP-ribose) 
binding; Double membrane vesicle  formation; 
IFN antagonist; nucleic acid binding; 
deubiquitinating activity 
(Angelini et al., 2013, Harcourt 
et al., 2004)                          
NSP4 Double membrane vesicle formation (Angelini et al., 2013, Oostra et 
al., 2007) 
NSP5 Main protease (M
pro
, 3CL
pro
); polyprotein 
processing 
(Anand et al., 2003) 
NSP6 Double membrane vesicle formation (Angelini et al., 2013) 
NSP7 Single-stranded RNA binding (Zhai et al., 2005) 
NSP8  Primase (Zhai et al., 2005) 
NSP9 Part of replicase complex (Egloff et al., 2004) 
NSP10 Multi-functional protein, RNA synthesis, 
polyprotein processing and RTC* assembly 
(Donaldson et al., 2007b, 
Donaldson et al., 2007a) 
NSP11 Helicase; nucleoside triphosphatase activity; 
RNA 5' -triphosphatase activity 
(Adedeji et al., 2012) 
NSP12 RNA-dependent RNA polymerase (Adedeji et al., 2012) 
NSP13 Helicase; nucleoside triphosphatase activity; 
RNA 5' -triphosphatase activity 
(Ivanov et al., 2004)                       
NSP14 3' → 5' exoribonuclease; RNA cap formation 
(guanine-N7)-methyltransferase 
(Eckerle et al., 2007, 
Minskaia et al., 2006) 
NSP15 Endonuclease (Bhardwaj et al., 2004) 
NSP16 RNA cap formation (2' O-methyltransferase)  (2011)                                                              
  
*RTC- replication/transcription complex. Adapted from (Perlman and Netland, 2009) 
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2.1.6 SARS-CoV NSP1 
The search to understand the high virulence of SARS-CoV compared with related 
coronaviruses, which cause lesser respiratory illnesses, has recently focused on the unique 
NSP1 protein of SARS-CoV. Whereas other SARS-CoV non-structural proteins 3–16 are 
conserved in all groups of coronaviruses, analyses show that the SARS-CoV NSP1 has a 
unique and novel sequence that bears no similarity to any other coronaviruses or non-
coronavirus nucleotide sequences (Stadler et al., 2003). The SARS-CoV NSP1 consist of 179 
residues and is the N-terminal cleavage product of the viral replicase polyprotein that 
mediates RNA replication and processing. Work done to characterize the SARS NSP1 
protein shows that it is present in infected cells as a 20kDa protein, localised in the cytoplasm 
of infected cells (Frieman and Baric, 2008). Structural studies using nuclear magnetic 
resonance Figure 14 showed that NSP1 adopts a previously unknown complex β-barrel fold 
with several unique structural features (Almeida et al., 2007). It was suggested that the 
uniqueness of this irregular β-barrel fold may be related to the yet unknown, biological 
function(s) of NSP1. Thus, the SARS-CoV NSP1 is unique among coronaviruses and could 
contribute to the exceptional pathogenesis of SARS-CoV in humans. Previously it has been 
shown that NSP11 promotes mRNA degradation (Kamitani et al., 2009), therefore the area of 
positive charge on the molecular surface formed by residues K48, R125, and K126 is of 
particular interest as a potential site for a direct interaction with mRNA. 
Several studies have proposed that NSP1 influences host gene expression and plays a role 
during translation. The following sections therefore describe the effects of SARS CoV NSP1 
on eukaryotic translation initiation and the potential mechanism driving these.  
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Figure 14: Nuclear Magnetic Resonance structure of   SARS NSP1.  
The blue colour area of positive charge on the surface formed by K48, R125, and K126 is of 
interest as a potential site for a direct interaction with mRNA (Almeida et al., 2007). 
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2.1.7 Effects of SARS NSP1 on translation 
Coronavirus NSP1 proteins have an inherent biological function to inhibit host gene 
expression by employing a variety of strategies (Huang et al., 2011, Kamitani et al., 2009, 
Kamitani et al., 2006, Tohya et al., 2009, Lokugamage et al., 2012). Several studies have 
suggested that the NSP1 protein is a major virulence factor of coronaviruses (Narayanan et 
al., 2008, Tohya et al., 2009, Wathelet et al., 2007, Zust et al., 2007). For SARS-CoV, it was 
found that NSP1 suppresses the host innate immune functions by inhibiting type I interferon 
expression (Narayanan et al., 2008) and host antiviral signalling pathways (Zust et al., 2007) 
in infected cells. 
Host innate immunity functions, including production of IFN-α/β, are one of the first lines of 
defence against micro-organism invasions. Therefore, many viruses have developed 
defensive mechanisms to suppress and/or evade host innate immune functions (Finlay and 
McFadden, 2006, Katze et al., 2008). Early studies showed that NSP1 can impair the innate 
immune response during SARS infection, blocking IFN-β mRNA induction without 
antagonizing the IRF3 signalling pathway (Narayanan et al., 2008). Further studies 
demonstrated that NSP1 over expression not only induced the degradation of IFN-β mRNA 
but also of several endogenous cellular mRNAs. Transfected NSP1 RNA (capped and 
polyadenylated) decreased host protein synthesis, and the inclusion of actinomycin D (to 
block ongoing transcription), showed a much stronger inhibition of protein synthesis. This 
indicated that while translation of new transcripts was proceeding (in cells not treated with 
actinomycin D); translation from pre-existing transcripts was blocked by NSP1 (Narayanan et 
al., 2008). As degradation of cellular mRNA was also observed in SARS-CoV-infected cells, 
the authors proposed that the NSP1 degradation of host mRNA is an important mechanism of 
blocking host antiviral defences. Subsequently, an NSP1 mutant was described with impaired 
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ability to degrade host mRNA while inducing a large amount of IFN-β during infection 
(Narayanan et al., 2008). 
Other work suggested that SARS-CoV NSP1 could directly antagonize IFN induction. 
Wathelet et al. demonstrated that NSP1 inhibits the signal transduction pathways involving 
IRF3, STAT1, and NF-κβ by blocking STAT1 phosphorylation and IRF3 dimerization 
(Wathelet et al., 2007). Recent work by Zust et al. also showed that NSP1 in MHV affects 
virus survival in vivo (Zust et al., 2007). They found that the deletion of the first 99 amino 
acids of NSP1 in MHV produced a virus that replicated efficiently in tissue culture but not in 
mice. In fact, 100% of the wild type (wt) virus-infected mice died, while the mutant virus-
infected mice all survived. IFN induction in the NSP1 mutant-infected macrophages was 
increased compared to that in wt virus-infected macrophages. The authors showed that in 
type I IFN receptor knockout mice, the NSP1 mutant virus replicates to wild type levels. 
These data suggested a role for NSP1 in MHV pathogenesis in mice; however, its exact 
mechanism of action was unknown (Zust et al., 2007).  
Finally, Kamitani et al demonstrated that NSP1 could suppress the function of the 40S 
subunit by blocking translation at a post-initiation stage. Using bicistronic mRNAs, Renilla 
Luciferase (rLuc)-HCV IRES-Firefly Luciferase (fLuc) and rLuc-CrPV IRES-fLuc, and 
luciferase reporter assays, it was discovered that NSP1 efficiently suppressed translation of 
the fLuc cistron under the control of the CrPV IRES (Kamitani et al., 2009). Since it was 
previously known that CrPV-IRES recruit the 40S ribosomal subunit in the absence of any 
initiation factors (Wilson et al., 2000), the authors suggested that NSP1 binds to the 40S 
subunit. Moreover, NSP1 induced RNA cleavage in templates carrying the EMCV IRES but 
not those carrying HCV and CrPV IRES, demonstrating that the NSP1 induced RNA 
modification was template dependent or dependent on the specific eIFs required during 
IRES-mediated translation. 
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To further analyse the effect of NSP1 on 80S formation, 
32
P-labeled rLuc RNA template was 
incubated with NSP1, GST, or NSP1-mt in RRL in the presence of cycloheximide (CHX). 
CHX treatment inhibits the elongation step, but does not affect 80S monosome assembly. 
Hippuristanol, which blocks eIF4A function and inhibits 48S complex formation (Novac et 
al., 2004) was used as a control.  It was found that NSP1 did not inhibit 48S complex 
formation, but suppressed 60S subunit joining. Furthermore, the NSP1-40S ribosome 
complex induced modification of the 5’ region of cap labelled rLuc RNA template and 
rendered the template translationally incompetent (Lokugamage et al., 2012).  
These studies have suggested that SARS CoV NSP1  inhibits host protein synthesis and 
promotes the degradation of host mRNAs using a two-pronged strategy (Kamitani et al., 
2009); by binding to the 40S ribosomal subunit, NSP1 suppresses translation and induces 
template-dependent endonucleolytic RNA cleavage of mRNA templates Figure 15. 
Experiments carried out by Huang et al, using bicistronic mRNAs carrying different IRESes 
showed that NSP1 induced endonucleolytic RNA cleavage within the ribosome loading 
region of type I and type II picornavirus IRES elements, but not that of classical swine fever 
virus IRES, which is characterized as a hepatitis C virus-like IRES. It was concluded that the 
NSP1 induced RNA cleavage in non-viral capped mRNAs and mRNAs carrying picornavirus 
type I and type II internal ribosome entry sites (IRESes), whereas it did not induce the RNA 
cleavage in SARS-CoV mRNAs and RNA transcripts carrying IRES of cricket paralysis virus 
(CrPV), hepatitis C virus (HCV), or classical swine fever virus. However, NSP1 was able to 
suppress the translation of all of the tested mRNAs, which suggested that the translation 
inhibition activity of NSP1 was not only dependent on its ability to induce RNA cleavage and 
inactivate the translational competence of the mRNA template. 
To further dissect the translation inhibition functions of NSP1 and identify the step(s) in 
translation that were inhibited by the protein, an NSP1 mutant lacking the RNA cleavage 
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function was isolated and  characterized by Lokugamage et al (Lokugamage et al., 2012). The 
mutants carried alanine substitution(s) of the charged amino acid residue(s) exposed on the 
surface of NSP1 (R124A and K125A mutations). These mutants allowed for a description of 
the mechanism of NSP1-mediated translation inhibition in the absence of NSP1-induced 
template mRNA cleavage. From their results it was concluded that NSP1, through its 
association with the 40S ribosomal subunit, inhibited the translation of both cap-dependent 
and IRES-driven template mRNAs at the translation initiation step Figure 15. Interestingly, 
NSP1 was found to exhibit a novel mode of action, wherein it inhibited multiple steps of 
translation initiation. The initiation step targeted by NSP1 was mRNA template-dependent. 
Furthermore, the study suggested the presence of multiple mechanisms by which mRNA 
templates were resistant to NSP1-induced RNA cleavage. 
 
NSP1 from other coronaviruses groups were also found to have an effect on protein synthesis 
in mammalian cells (Wang et al., 2010). The NSP1 protein of transmissible gastroenteritis 
virus (TGEV), alphacoronavirus, efficiently suppressed  protein synthesis in mammalian 
cells, but in contrast to NSP1 SARS-CoV (active in RRL extract) it was found to require 
HeLa cell extract for proper mRNA degradation activity, which could reflect an interaction 
with different partners during  host mRNA degradation (Huang et al., 2011). 
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Figure 15: Inhibition of translation by SARS-CoV. 
A two-pronged strategy to suppress host protein synthesis is employed by SARS 
coronavirus NSP1. (A) Schematic representing normal cellular translation of proteins (B) 
Translation in SARS-CoV infected cells. During infection NSP1 protein interacts with the 
40S ribosomal subunit and inhibits 80S assembly. NSP1 modifies and renders the capped 
mRNA translationally inactive. 
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2.2 CHAPTER AIMS AND OBJECTIVES 
 
Thus far, evidence has been presented that SARS-CoV NSP1, a novel protein unique to 
SARS-CoV, induces degradation of RNA and diminishes subsequent protein synthesis. 
However, the specificity and biochemical mechanism of action is still to be elucidated. The 
possible hypotheses for NSP1 function are that NSP1 might: (i) have nuclease activity, either 
alone or as part of a complex with host proteins; (ii) alter RNA-interacting proteins or RNA 
to make it more nuclease sensitive; (iii) be required for the formation or activity of a cellular 
RNase; (iv) recruit a protein involved in RNA degradation pathways. To address these 
hypothesis we aimed at identifying NSP1 partners responsible for mRNA cleavage and 
validate the molecular mechanism(s) driving SARS pathogenesis. Based on the proposed 
mode of action of NSP1 we undertook the characterisation of the NSP1 interactome using 
protein affinity chromatography in collaboration with the group of Prof Shinji Makino at the 
University of Texas Medical Branch. 
 
 Upon partner identification, functional validation was to be carried out with a siRNA knock 
out assay and cleavage assay. Therefore the specific objectives were: 
 
•  To design and purify affinity-tagged NSP1 constructs. 
•  To conduct affinity-based identification of NSP1 binding partners in vitro. 
•  To generate cell lines expressing NSP1 to identify partners in cell cultures. 
•  To generate siRNA knockout mutants of candidate RNAse(s). 
• To design IRES mediated bicistronic reporter to recapitulate in vitro an RNAse 
cleavage assay. 
•  To design and purify tagged constructs of candidate RNAse(s). 
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2.3 MATERIALS AND METHODS 
2.3.1 Plasmid construction 
For expression of NSP1 wild type and mutant NSP1 in bacterial cells, SARS CoV plasmids 
pGEX3x6 NSP1 wt-mycHis; pGEX3x6 NSP1 mt-mycHis and pGEX3x6 NSP1 mt7-mycHis 
were kindly donated by Prof Shinji Makino, of the University of Texas Medical Branch. 
These plasmids contained either the wild type (wt), or two mutant NSP1 protein carrying 
R124A/K125A (mt7) and K164A/H165A (mt) mutations Figure 16, and allowed for the 
expression of fusion proteins containing N-terminal GST and C-terminal myc and 6XHis 
affinity tags Figure 17A.  To allow for expression of NSP1 in eukaryotic cells, and the 
subcloning of a tandem affinity purification tag, an eukaryotic expression vector pcDNA 
vector containing the TAP tag was kindly donated by Prof Ian Goodfellow, University of 
Cambridge Figure 17B.  
Using these plasmids as starting material standard cloning protocols were followed to 
engineer the different NSP1 proteins designated in Table 5, allowing for the expression of 
either GST-NSP1-mycHIS or NSP1-cTAP in bacterial cells or NSP1-cTAP in eukaryotic 
cells.  
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Figure 16: Schematic for NSP1 mutants generated for testing 
Plasmids with mutations generated in RNA binding domains of NSP1(a) Wild type, (b) 
K164A, H164A mutation (c) R124A, K125A mutation of NSP1 plasmids for expression in 
bacterial cells.  pGX3x6 NSP1 vectors, carrying these mutations were used to construct, 
mRNA cleavage defective mutants as illustrated in the schematic. The mutants were 
subsequently designated SM3 and SM4 respectively Table 5. 
A 
 
 
 
 
B 
 
 
 
C 
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Figure 17: Schematic for expression vectors used in the assay. 
(a) Vector pGE3X6X for expression in bacterial cells, coding for NSP1 protein with N-
terminal GST and c-terminal myc for rapid protein purification His affinity tags. (b) Vector 
pcDNA for high level protein expression in mammalian cells, with CTAP affinity tag for 
rapid protein purification. 
 
 
 
 
Table 5: Plasmid designation of affinity-tagged NSP1 constructs.  
 
 
Code Plasmid Fusion protein description 
   
SM1 pGEX-GST-NSP1 binds 40S, mRNA cleavage, GST tag 
SM2 pGEX-GST-NSP1-mycHis binds 40S, mRNA cleavage, GST/His tag 
SM3 pGEX-GST-NSP1-mt-mycHis binds 40S, no mRNA cleavage GST/His tag 
SM4 pGEX-GST-NSP1-mt7-mycHis no 40S binding, no mRNA cleavage 
SM9 pcDNA-NSP1-cTAP binds 40S, mRNA cleavage, TAP tag 
SM10 pcDNA-GST-NSP1-mt-cTAP binds 40S, mRNA cleavage, GST/TAP tag 
SM11 pcDNA-NSP1-mt7-cTAP No 40S binding, no mRNA cleavage, TAP tag 
SM15 pGST-cTAP TAP tag control 
   
 
          GST             BamHI          NSP1           XbaI            myc -6xHis     EcoRI 
pGEX3x6-NSP1 wt MH 
     
 
   Tet Op       Hind III          BsiWI             CTAP             Xba I 
pcDNA4TO CTAP 
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2.3.2 General cloning procedures. 
Polymerase Chain reactions 
The PCR reactions consisted of 30 ng template DNA, 5 µl of 10X PCR buffer (Promega), 2µl 
of dNTPs (5 mM Promega), 1µl of each primer (100 µM; Sigma) and 5 units of Taq enzyme 
(5 U/µl; Promega).  The reactions were made up to 50 µl with milliQ water. 
The cycle conditions were: 
94
o
C  1 min 30 s 
94
o
C  30 s 
55
o
C  30 s 
72
o
C  1 min 
72
o
C  4 min 
8
o
C  end 
 
Restriction enzyme digestions 
Analytical digests were carried out in a final volume of 20 µl. Reactions consisted of plasmid 
DNA (1 µg), 2 µl of 10X restriction buffer (Promega) and 10 units of restriction enzyme 
(Promega). The volume was made up to 20 µl in milliQ water and reactions incubated at 
37
o
C for 2h. 
 
Dephosphorylation of digested plasmid DNA 
Calf intestinal alkaline phosphatase (1 µl; 2 U/µl; Boehringer Mannheim) was added directly 
to restriction digests and incubated at 37
o
C for 30 min. The reactions were stopped by 
incubation on ice for 5mins. 
 
Ligation reactions 
Ligation reactions were performed in a final volume of 10 µl. The reactions consisted of 20 
ng vector, 5-20 ng purified vector inserts, 2 µl T4 DNA ligase buffer 10X (Promega) and 1 µl 
30 cycles 
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T4 DNA ligase (5 U/µl; Promega). The volume was made up to 10 µl with milliQ water. 
Ligation reactions were incubated at 16
o
C overnight. 
 
Small scale plasmid purifications (plasmid mini prep) 
Small scale plasmid purification was carried out using a Plasmid Mini Kit (Qiagen) according 
to the manufacturer’s instructions. From overnight cultures 1.5 ml of bacterial culture was 
pelleted at 13,000 rpm for 1 min. The pellets were resuspended in 250 µl solution (Appendix 
1). The cells were lysed by adding 250 µl lysis solution (Appendix 1). To stop the reaction 
350 µl neutralising solution (Appendix 1) was added and the samples cooled on ice for 5min 
and then spun at 14,000 rpm for 10 min. The supernatants were transferred into new spin 
columns and the plasmid was eluted using milliQ water, 
 
Purification of DNA by gel extraction 
DNA was separated through an agarose gel. The bands of interest were excised and the DNA 
extracted using QIAquick gel extraction kit (Qiagen) following the manufacturer’s 
instructions. 
 
Sequencing of plasmid DNA 
DNA sequencing was performed by Eurofins using primers as detailed in the chapter. 
 
2.3.3 Cloning CTAP affinity tag into pGEX NSP1 expression vector. 
 
 
To enable purification of the NSP1 proteins using tandem affinity purification (TAP), the 
affinity tag was cloned into the pGEX expression vector using the strategy outlined in Figure 
18. Standard DNA cloning protocols  were followed (Green and Sambrook, 2012).  
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pcDNA4TO CTAP plasmid was linearized with XbaI and used as template for PCR 
amplification using primer sequences below: 
  
NLP81  5′-(CTCTTCTAGA GATGGACGAGAAGACCACCGGG)-3′  
NLP82  5′-(CTCTGAATTCCTACTATTCAGTGACAGTGAA)-3′ 
 
Underlined are XbaI and EcoRI restriction enzyme sites included for cloning purposes. The 
PCR product was then double digested with restriction enzymes XbaI and EcoRI and ligated 
into the pGEX3x6-NSP1 vector which had previously been digested with the same restriction 
enzymes. The inserts were confirmed by sequence analysis and plasmids then used to 
transform competent Rosetta™ cells for the overexpression of NSP1 protein.  
73 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18: Overview of cloning CTAP into pGEX NSP1 expression vector  
 
Tet Op   Hind III  BsiWI    CTAP     Xba I 
pcDNA4TO CTAP 
   GST      BamHI     NSP1     XbaI                              EcoRI 
pGEX3x6-NSP1 wt MH 
 
        GST      BamHI     NSP1     XbaI    myc -6xHis       EcoRI 
pGEX3x6-NSP1 wt MH 
XbaI         CTAP      EcoRI 
 
        GST      BamHI     NSP1     XbaI    CTAP     EcoRI 
pGEX3x6-NSP1 wt CTAP 
1. Digestion Xba I/ EcoRI 
2. Gel purification 
1. Linearisation Xba I 
2. PCR amplification NLP81/NLP82 
primers 
3. PCR clean up 
4. Digestion XbaI/EcoRI 
5. Gel purification/ extraction 
1. Ligation 
2. Transformation 
3. Miniprep sequencing 
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2.3.4 Cloning NSP1 into eukaryotic expression vector    
To allow for the determination of NSP1 interacting partners in cell culture, NSP1 was cloned 
into pcDNA expression vector using the strategy outlined in Figure 19. 
The pGEX NSP1 plasmid was first linearized with restriction enzymes EcoRI and used as a 
template for PCR amplification using primers:  
 
NLP79  5′-(AATCGTACGCATGGAGAGCCTTGTTCTTGGT)-3′ 
NLP83  5′-(AAAAGCTTACCATGGAGAGCCTTGTTCTTGGT)-3′ 
 
Underlined are HindIII and BsiWI restriction enzyme sites included for cloning purposes. 
The PCR product was then double digested with restriction enzymes HindIII and BsiWI and 
then ligated into the pcDNA4TO CTAP vector which had previously been digested with the 
same restriction enzymes. Sequence analyses of the plasmids confirmed the presence of the 
expected inserts. 
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Figure 19: Overview of cloning NSP1 into pcDNA4TO CTAP expression vector 
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2.3.5 Transformation of competent Rosetta cells 
 
A vial of competent Rosetta™ cells (Novagen), which is a bacterial strain designed to 
enhance the expression of eukaryotic proteins in Escherichia coli by optimising codon usage, 
was thawed on ice and mixed with plasmid DNA (1 ng) in a pre-cooled microfuge tube and 
incubated on ice for 30 min. The cells were heat-shocked at 42
o
C for 45 seconds and then 
placed on ice for 2 min to recover. Luria-Bertani (LB) broth (500 μl) was added and the 
bacteria were incubated at 37
o
C for 1 h. The cells were centrifuged at 3500 g for 5min and 
the supernatant discarded. The pellet was re-suspended and spread onto LB agar plates 
containing ampicillin (50 μg/ml) plates and grown at 37oC. 
 
2.3.6 Over-expression of NSP1 proteins in Escherichia coli 
 
From the transformation plates single colonies were isolated and grown overnight at 37
o
C in 
5 ml LB broth plus ampicillin antibiotic (50 μg/ml) at 225 rpm. The Optical Density (OD) of 
the starter culture was measured using WPA Biotech Photomer, version 2.4(λ 660nm), and a 
one litre culture was inoculated at 0.02 OD into LB broth plus ampicillin antibiotic (50 
µg/ml). The culture was incubated at 37
o
C in a rotary shaker set at 225 rpm for 3 h 
monitoring the OD every hour. When the OD reached a range of 0.4 to 0.6, 0.1mM 
Isopropyl-β-D-thiogalactopyranoside (IPTG) was added for gene induction. The induced 
bacterial culture was further grown at 37
o
C on shaker (225 rpm) for another 3 h and then 
centrifuged at 2,500 rpm for 10 min at 4
o
C. The resultant pellets were stored at -80°C and 
supernatants discarded.  
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2.3.7 SDS PAGE analysis of NSP1 over expression 
 
500 μl aliquot samples of bacterial culture before induction (B.I) and after induction (A.I) 
were prepared for SDS PAGE gel loading by centrifuging at 6000 rpms for 5 min. The 
resulting pellets were re-suspended in 50 μl (2X SDS) loading buffer and boiled at 94oC for 5 
min. 12% SDS-PAGE gels were prepared (see Appendix 1 for gel recipe) and equivalent 
quantities of samples were loaded with equal amounts of protein (estimated from O.D 
readings). The gels were run in Mini Protean III blocks (Biorad) at 140V in 1% SDS running 
buffer for 2 h and visualised using Simplyblue® staining protocol (Invitrogen). 
 
2.3.8 GST purification of over expressed NSP1 proteins 
 
Stored NSP1 bacterial pellets were thawed on ice and lysed in 10 ml of Bugbuster® 
(Novagen) protein extraction reagent. 100 μl of 10 mM PMSF protease inhibitor were added 
to the suspension and kept at room temperature for 10 min. The samples were transferred into 
30 ml Corex® tubes and centrifuged at 21000 g (Beckman J2/E centrifuge) for 30 min at 4
o
C. 
The supernatant was collected and passed through a 0.45 μm filter unit (Steriflip®) and the 
filtrate was stored on ice until use. Glutathione Sepharose beads (GST-bind resin™, 
Novagen) were prepared by adding 2 ml of beads into a 15 ml tube and adding 10 ml 
phosphate buffered saline (PBS) to the tube. The mixture was centrifuged for 2 min at 500 g, 
PBS was discarded, and another 10 ml of PBS added.  The sample was centrifuged for 2 min 
at 500 g and most of PBS was discarded, leaving a small amount covering the top of the 
beads. Filtered protein extract was added to the prepared Glutathione Sepharose beads and 
the sample was rotated overnight at 4°C. The re-suspended beads were placed in a 
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chromatography column (Polyprep®, Biorad), the protein sample was added to the column 
and flow through collected. The column was then washed with 10 ml PBS. PreScission™ 
buffer (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl, and 1 mM DTT) was 
prepared and the column was washed with 5ml PreScission™ buffer. A mixture of 3 ml of 
PreScission™ buffer and 30 μl PreScission™ protease (Invitrogen) was prepared and mixed 
with the beads and mixed with the beads and mixed with the beads. After five washing steps, 
the bottom of the column was closed and the PreScission™ mixture poured into the column. 
The sample was then incubated for 4 h at 4°C to initiate protease cleavage. The NSP1 protein 
was eluted into 15 ml tubes and analysed for GST purification efficiency on 12% SDS-
PAGE. 
 
2.3.9 GST purification with glutathione elution 
 
Competitive elution of NSP1 proteins was done with reduced glutathione (Sigma Aldrich). 
The normal GST purification protocol as previously described was followed with minor 
changes. An additional wash step of the packed beads with PBS was included. The column 
was then washed with 2 ml of 1X GST elution buffer collecting the eluates in consecutive 
washes. The samples were then analysed on 12% SDS-PAGE. 
 
2.3.10 NSP1 protein sample concentration  
 
The NSP1 protein is 20 kDa, therefore samples were concentrated down to 500 μl, using an 
Amicon Ultra® centrifugal unit with a molecular weight cut-off of 30 kDa. 3 ml of NSP1 
sample was added to the Amicon Ultra® filter device. The capped device was then 
centrifuged at 4000 g for 15 min at 4
o
C to allow for complete buffer exchange. The filtrate 
79 | P a g e  
 
was stored in a falcon tube on ice and centrifugation repeated of more sample. 1X PBS buffer 
was added to the 4 ml level in the device and final pooled samples concentrated down to 500 
µl.  
          
2.3.11 Histidine nickel affinity purification of NSP1 proteins 
 
Pre-packed HIS-Select® Spin columns were used for further purification of the 6X histidine 
tagged NSP1 proteins. 600 µl 1X PBS was added to the column and the column centrifuged 
at 2000 rpm at room temperature for 2 min. The filtrate was discarded and 600 µl NSP1 (5.9 
µM) protein was loaded on the column and centrifuged at 2000 rpm at room temperature for 
2 min. The spin column was removed from the collection tube and using a new collection 
tube, unbound proteins were washed with 600 µl of Wash Buffer (5 mM imidazole in 1X 
PBS) from the spin column. Using a new collection tube, the target protein was eluted with 
50 µl of Elution Buffer (250 mM imidazole in 1X PBS pH 7.5) by centrifuging at 2000 rpm 
at room temperature for 2 min. All fractions were then analysed on 12% SDS-PAGE and 
visualised using Coomasie blue stain. 
 
2.3.12 NSP1 protein sample dialysis 
 
The final protein containing NSP1 was dialyzed using Slide-A-Lyzer® Dialysis cassettes, 
with a 3.5kDa molecular weight cut-off, against PBS overnight at 4
o
C. Subsequently, the 
protein sample was concentrated down to 250µl using an Amicon Ultra® centrifugal unit 
with 30kDa cut off. 
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2.3.13 FPLC purification of NSP1 proteins 
 
To improve on the quality of  NSP1 fusion protein purification  Diethylaminoethanol 
(DEAE) ion exchange chromatography was carried out using BioRad Dual Flow®  FPLC 
instrument, equipped with Bio-Scale Mini™ Macro-Prep DEAE column, UV detector 
monitoring wavelengths of 280 nm and an auto fraction collector. Isoelectric points of the 
proteins were pre-determined based on protein sequences with ExpaSy bioinformatics 
software (Artimo et al., 1993-2013) to establish buffering conditions for the FPLC. 500ml 
Solution buffer A (20 mM Sodium phosphate, 50 mM NaCl) and buffer B (20 mM sodium 
phosphate, 1 M NaCl) at pH 7.0 were prepared and candidate proteins dialysed against buffer 
A overnight. The ion exchange was achieved over a salt gradient of 50 mM NaCl to 1 M 
NaCl.  12% SDS PAGE analysis of collected fractions with distinct peaks from the resultant 
chromatograph was performed. The gels were run at 140V in 1% SDS running buffer for 2 h 
and visualised using Safeblue™ (Invitrogen) staining protocol. From the results, purified 
samples were identified, pooled, concentrated down to 500 µl in buffer A and then dialysed 
against PBS overnight. 
 
2.3.14 Protein Assay 
Protein concentration was determined using BCA assay kit (Pierce-Thermo Scientific). The 
assay was conducted according to manufacturer’s specifications and measured at 562nm 
wavelength using an ELISA plate reader (Perkin-Elmer).  
 
2.3.15 Growth and maintenance of cell lines 
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For eukaryotic overexpression of NSP1 proteins, 293 T-Rex cells (donated by Prof Ian 
Goodfellow, University of Cambridge) were grown in 25 cm
2
 tissue culture flasks ( Nunc , 
Thermo Scientific) in Dulbecco's Modified Eagle Medium (GibcoBRL) including L-
Glutamine (292 mg/ml), supplemented with 10% foetal bovine serum (FBS, GibcoBRL) and 
penicillin/streptomycin (100 IU/ml, 50 µg/ml). Cells were maintained at 37
o
C with 5% 
carbon dioxide in a Galaxy S+ (RS Biotech) carbon dioxide incubator. When cells were 80-
90% confluent, the growth media was removed and the monolayer cells were washed with 5 
ml of 1:10 (v/v) trypsin/versene. The cells were incubated with 5 ml trypsin/versene for 2-5 
min at 37
o
C until the cells detached from the bottom of the flask. Growth media was added 
and the cells were centrifuged at 2500 rpm for 3 min. The media was removed and the pellet 
was re-suspended in 5ml media and 1ml was used to seed a 75 cm
2
 flask containing 19 ml of 
Blastidicin media (D-MEM supplemented with 10% FBS, penicillin/streptomycin 100 IU/ml, 
Streptomycin 50 µg/ml and Blastacidin 5 µg/ml). 
 
2.3.16 Transfection of 293T cells 
 
To increase transfection efficiency, plasmids designated SM12, SM13 and SM14 were 
linearized with restriction enzyme SpeI, purified (phenol/chloroform) and quantified on a 
nanodrop (Nanodrop 2000, Thermo Scientific). To this end, a 50µl restriction digest reaction 
was prepared as follows:  25 µl DNA, 5 µl buffer B, 18 µl water and 2 µl SpeI. The samples 
were incubated at 37
o
C overnight and run on 1% agarose gel in 1X TBE. Three wells of a six 
well Nunc ™ plates (Thermo Scientific) were seeded with 6x 105 293 T–Rex cells in 3 ml of 
antibiotic free medium. The cells were incubated at 37
o
C, overnight. Once at 80% confluency 
a transfection mixture was prepared as follows: Solution A: 193 µl Optimem (GibcoBRL) 
mixed with 7 µl Lipofectin® reagent (Invitrogen) and incubated at room temperature for 15 
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min; Solution B: Plasmid DNA (2 µg) in 200 µl sterile water. The two solutions were mixed 
and incubated at room temperature for 15 min. The inoculum was removed and cells were 
washed once with 1 ml DMEM supplemented with 2% FCS.  The medium was removed and 
400 µl of the Optimem mixture was plated out onto the cells. The cells were incubated for 5 
hr at 37
o
C and rocked every hour. After 5 h, 2 ml of growth medium without antibiotics was 
added and cells were incubated overnight at 37
o
C.  The following day growth medium was 
replaced with, 3 ml of blastacidin media (D-MEM supplemented with 10% FBS, 
penicillin/streptomycin (100 IU/ml, 50 µg/ml) and blastacidin (Invitrogen) at 5 µg/ml. 
The following day cells were split in conditioned medium and serial diluted into nine 10 cm 
culture dishes. 150 ml of conditioned selection medium was prepared as follows:  120 ml 
Growth medium, 30 ml filtered used 293 medium, 120 µl of 5 mg/ml blastacidin, and 300 µl 
of 100 mg/ml Zeocin™ (Invitrogen). The cells were re-suspended in conditioned medium 
and incubated at 37
oC in the dark, due to light sensitivity of the Zeocin™. The selective 
media was replenished every 4 days until resistant colonies were visible. Cells were split 
from 6 well plates into two twelve well plates and maintained for three days until at 70% 
confluency to be induced for over expression of NSP1 proteins. 
2.3.17 NSP1 Protein induction in clones 
 
Once the cells were at 70%-80% confluency, for each clone NSP1 induction was carried out 
with tetracycline (1 µg/ml) in selection medium in each then incubated at 37
o
C overnight. 
The cells were harvested and washed twice with ice cold PBS at 300g for 5mins.  The cell 
pellet was re-suspended in 50 µl of ice cold RIPA buffer (50 mM Tris, 150 mM NaCl, 0.1 % 
SDS) with 0.5 % Sodium Deoxycholate, 1% Triton, 1 mM PMSF, and Protease inhibitor 
tablet (Roche Complete). The cell suspension was incubated on ice for 5 min, then 
centrifuged at 16000 g at 4
o
C for 5 min and the supernatant harvested and stored at -20
o
C. 
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2.3.18 Western blot 
 
The protein concentration of each cell lysate was measured using BCA assay and 20 µg of 
NSP1 protein sample was used for the subsequent western blot analysis. Samples were 
denatured in 3x Red loading Sample buffer (New England Biolabs) at 95°C for 5mins and 20 
µg of protein loaded and run on 12% polyacrylamide gel. On completion of the run the gel 
was used to transfer the protein to an Immobilon®-P membrane(Millipore) using a wet blot 
transfer system (Biorad) set at 100V for 90 min in transfer buffer (25 mM Tris, 192 mM 
glycine, 20% methanol). The membrane was incubated in blocking buffer (5% Marvel in 1x 
TBS-Tween) for 1 hour prior to incubation with specific primary antibody at concentrations 
shown in Table 6. A Secondary antibody, was applied for 1 hour at room temperature and the 
blot was subsequently washed three times with 1X TBS–Tween. Visualisation of the blot was 
carried out with chemiluminescent substrate SuperSignal®, West Pico, Thermo Scientific) 
and the blot subsequently exposed to radiographic film (Fujifilm). 
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Table 6: Antibodies and dilutions used for western blot analysis. 
 
2.3.19 Tandem Affinity Purification 
 
Tandem  affinity purification of NSP1-TAP fusion protein was carried out, as described in 
the literature with minor adjustments (Puig et al., 2001). The following solutions were 
prepared: Lysis Buffer: 50 mM Tris-HCl, pH 7.5; 150 mM NaCl, 1 mM DTT; TEV-protease 
cleavage buffer: 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.2% NP-40, Cleavage mix: 5% 
TEV Buffer, 0.1 M DTT, 0.5 units TEV Protease. 100 μl of rabbit IgG agarose beads (Sigma-
Aldrich®) were washed three times in chilled lysis buffer. 50 µl of NSP1 (SM9) mixed with 
450 µl of lysis buffer were added to rabbit IgG agarose beads (Sigma-Aldrich®) and 
incubated overnight at 4
o
C on a rotary shaker. The following day, the agarose beads were 
centrifuged at 1600 rpm for 5 min and the supernatant removed and washed 3 times with 1 ml 
lysis buffer. The beads were then washed twice with 1ml TEV-protease cleavage buffer.  500 
µl of TEV cleavage mix was added after the final washed and the beads were incubated 
overnight at 4
o
C. The following day the IgG beads were centrifuged at 1600 rpm and the 
supernatant transferred to a clean eppendorf tube containing 100 µl Immobilized Streptavidin 
agarose beads (Novagen®) and incubated for 3 h at 37
o
C. The beads were centrifuged at 
1600 rpm to remove supernatant and then washed 3 times with lysis buffer. The protein was 
eluted overnight at 4
o
C with 300 µl biotin buffer. A further elution was carried out by boiling 
the beads in 300 µl of 2X SDS for 5 min.  
Antibody Antibody dilution Manufacturer 
   
 c-myc  1:1000 Cell Signalling Technology® 
HRP-coupled  
goat anti mouse 
1:2000 Dako Denmark A/S 
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2.3.20 Bead binding assay 
 
NSP1 protein was immobilised on various affinity ligands ( Ni-NTA His-Bind®  resin ; Ni-
NTA His-Bind®  magnetic beads, GST-Bind™  slurry and GST-Bind™  magnetic beads) 
and incubated with either  HeLa cell lysate or  Rabbit Reticulocyte Lysate (Promega)  that 
contained putative interacting partners. All purifications with associated buffers were 
according to the manufacturer’s specifications (Novagen® user protocol, 2009). The proteins 
were eluted using 2X SDS buffer and the resulting eluates from all assays were analysed on 
12% SDS gels. 
2.3.21 Pull-down Assay using the TAP tag 
 
A variation of the pull down assay using the TAP tag of NSP1 protein was attempted 
(schematic in Figure 20). The NSP1 protein was first incubated with either HeLa cell lysate 
or Rabbit Reticulocyte Lysate (Promega) for 1 hour at 4
o
C on a rotary shaker. This was 
followed by tandem affinity purification to identify protein partners bound to NSP1 fusion 
protein. The following buffers were initially prepared; Lysis Buffer: 50 mM Tris-HCl pH 7.5; 
150 mM NaCl;  1mM DTT; TEV-protease cleavage buffer: 10 mM Tris-HCl (pH 7.5), 100 
mM NaCl, 0.2 % NP-40, Biotin buffer: 30 mM biotin. 
Briefly, 500 µg NSP1 fusion protein was bound to 100 μl of rabbit IgG agarose beads 
(Sigma-Aldrich®) by incubating for 4 hr in 450 µl lysis buffer. The beads were then washed 
two times with TEV-protease cleavage buffer and cleaved overnight at 4
o
C with 0.5 units 
TEV protease. The resulting TEV-protease cleaved product was immobilized on 100 µl 
streptavidin agarose beads in lysis buffer by incubating at 4
o
C for 3 h. The beads were spun 
down at 1600 rpm briefly to remove supernatant and bound proteins eluted with 300 µl biotin 
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buffer at 4
o
C for 3 h. A further elution was carried out by boiling the beads in 300 µl of 2X 
SDS for 5 min. The eluates were analysed on 12% PAGE, followed by silver staining. 
 
 
Figure 20: Overview of the TAP purification strategy. 
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2.4 RESULTS 
My objective was to design and purify affinity-tagged NSP1 constructs in order to conduct 
affinity-based identification of NSP1 binding partners in vitro and in cells. Ultimately, these 
proteins were to be used in the identification of cellular factors responsible for NSP1-
mediated gene expression silencing and mRNA cleavage (Kamitani et al., 2009).  
To this end a series of NSP1 protein, wild-type or mutant, containing different affinity tags as 
outlined were purified: GST-NSP1-mycHIS; NSP1-mycHIS; NSP1-cTAP for both bacterial 
and eukaryotic cell expression Table 5. Overall this would us allow to perform either GST 
pull-down assays, HIS pull-down assays or TAP pull-down assays offering a wide variety of 
strategies. Nomenclature NSP1 used referred to a fusion protein eluted following cleavage of 
the GST tag with TEV protease, whereas GST NSP1 referred to fusion proteins eluted 
without cleavage and still retain the GST tag. 
  
 
2.4.1 Overexpression of SARS-CoV NSP1 in E.coli 
 
To enable isolation of sufficient amounts of protein material for functional and structural 
studies, NSP1 constructs designated SM2 SM9, and mutants SM3, SM10 and SM15 
corresponding to expected molecular weights were overexpressed in E.coli (Rosetta strain™). 
The proteins were overexpressed as GST fusion proteins using pGEX3X6 vector. This vector 
contained an origin of replication (pBR322 ori), an ampicillin resistance gene (Amp
r
), and a 
strong promoter (Ptac), which was kept in the “off” state by the lac repressor (lacI q). 
Addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) inactivated the lac repressor and 
permitted activation of the promoter.  
NSP1 constructs were first transformed into Rosetta E.coli strain and 0.5 litre cultures were 
induced for overexpression using (IPTG) induction of NSP1. From the resulting SDS-PAGE 
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analysis it was observed that the NSP1 GST fusion proteins were overexpressed efficiently in 
all the constructs as shown in Figure 21 and Figure 22. Clear distinct bands corresponding to 
the expected 46 kDa molecular weight (GST tag 26 kDa fused to NSP1-mycHIS 20 kDa) 
were observed for all the fusion proteins after staining with Safeblue®. This was confirmed 
on both gels by comparing the lanes for before IPTG (-) vs lanes after IPTG (+) induction. 
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Figure 21: SDS-PAGE analysis of NSP1 overexpression. 
 (+) Lane indicates E.coli lysate after 3hours IPTG induction. (-) Lane indicates E.coli lysate 
prior to IPTG induction (Safeblue® staining). A 46 kDa GST fusion protein was 
overexpressed in constructs SM2 and SM3. 
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Figure 22: SDS-PAGE analysis of NSP1 overexpression. 
 (+) Lane indicates E.coli lysate after 3 h IPTG induction. (-) Lane indicates E.coli lysate 
prior to IPTG induction (Safeblue® staining). A 68 kDa GST CTAP protein was expressed in 
SM9, SM10constructs. SM15 (46 kDa) construct was the control. 
 
91 | P a g e  
 
 
Table 7: Overexpressed SARS-CoV NSP1 in E.coli 
 
 
 
Code Plasmid Fusion protein    Size 
    
SM3 pGEX-GST-NSP1-mt-myc His binds 40S, no mRNA cleavage  46kDa 
SM9 pGEX-NSP1-cTAP binds 40S, mRNA cleavage  68 kDa 
SM10 pGEX-GST-NSP1-mt-cTAP binds 40S, mRNA cleavage  68 kDa 
SM15 pGST-cTAP TAP control  46kDa 
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2.4.2 GST NSP1 fusion protein purification 
 
The overexpressed fusion proteins were purified by affinity chromatography using 
glutathione sepharose resin, which has a high affinity for the GST (Glutathione S 
Transferase) tag that is approximately 26 kDa on the constructs. Subsequently, NSP1 proteins 
(wild types or mutants) were cleaved off from the immobilized GST-NSP1 fusion using the 
PreScission® protease which recognizes the of the cleavage site in between the GST and 
NSP1 proteins. The proteins NSP1 wildtype (Figure 23), NSP1 mutant (Figure 24) and 
NSP1::CTAP wildtype (Figure 25), NSP1::CTAP mutant (Figure 26) were all eluted as the 
main products of the purification step. However, it was observed that the purification 
efficiency was not optimal for all the samples. Firstly, a significant proportion of the fusion 
protein did not bind to the GSH-sepharose (FT lane). Furthermore, the cleavage efficiency of 
the protease was low as evidenced by the high retention on the GST beads of the fusion 
protein (lane 6). From the band intensities, we can estimate that the amount of cleaved and 
uncleaved products is similar (GST-NSP1 vs cleaved GST intensities). Finally, it can be 
noted that in the eluted fraction (lane 7-9), especially for SM9 and SM10 several 
contaminants are still present. Since the eluted NSP1 protein contained a C-terminal 6X 
Histidine tag, I therefore undertook a further round of purification using Nickel affinity 
chromatography. 
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Figure 23: GST purification of NSP1 constructs 
SDS-PAGE analysis illustrates efficiency of GST purification of NSP1 construct SM2. Lane 
(F.T) indicates flow through, lane (SUP) supernatant, lane (W1) first wash, lane (W2) second 
wash, lane (E1) elution lane (E2) second elution and lane (E3) third elution. Note that gels 
were stained with Silver stain    
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Figure 24: GST purification of NSP1 constructs. 
SDS-PGE analysis illustrates efficiency of GST purification of NSP1 construct SM3. Lane 
(F.T) indicates flow through, lane (SUP) supernatant, lane (W1) first wash, lane (W2) second 
wash, lane (E1) elution lane (E2) second elution and lane (E3) third elution. Note that gels 
were stained with Silver stain    
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Figure 25: GST purification of NSP1 constructs. 
SDS-PGE analysis illustrates efficiency of GST purification of NSP1 construct SM9. Lane 
(F.T) indicates flow through, lane (SUP) supernatant, lane (W1) first wash, lane (W2) second 
wash, lane (E1) elution lane (E2) second elution and lane (E3) third elution. Note that gels 
were stained with Silver stain    
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Figure 26: GST purification of NSP1 constructs. 
SDS-PAGE analysis illustrates efficiency of GST purification of NSP1 construct SM10. Lane 
(F.T) indicates flow through, lane (SUP) supernatant, lane (W1) first wash, lane (W2) second 
wash, lane (E1) elution lane (E2) second elution and lane (E3) third elution. Note that gels 
were stained with Silver stain    
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2.4.3 Hexahistidine (His6) tag purification 
We attempted a further round of purification on the SM2 and SM3 proteins obtained 
previously using Nickel affinity chromatography. From Figure 27, it can be observed that the 
majority of the NSP1 protein was lost in the imidazole wash fractions (lane 3 and lane 7), 
when compared to the final elutions (lanes 4 and lane 9). This is likely to reflect a weak 
interaction between the tagged protein and the affinity resin.  A significantly low final yield 
of NSP1 was obtained from the His tag purification and as noted, low molecular 
contaminants were still present in the eluted fractions. Therefore, we concluded that further 
nickel affinity purification was not a useful purification step to be added to our protocol. 
These results suggested that the His6 tag was unavailable for binding. There could be a 
variety of reasons for this; sub-optimal binding conditions or possibility of steric hindrance 
due to protein tertiary structure. 
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Figure 27: Purification of NSP1 proteins. 
Histidine-tagged purification of SM2 and SM3 proteins. An expected 25 kDa protein was 
eluted as indicated in lane 4 and lane 9, but the purification efficiency was low as the bulk of 
the protein was lost in the wash fraction in lane 3 and lane 7. Note, Lane (F.T) indicates flow 
through, lane (W1) first wash, lane (W2) second wash, lane (E1) elution lane (E2) second 
elution and lane (E3) third elution. Gel staining was with Safeblue®. 
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2.4.4 Dialysis and Concentration 
The protein fractions containing purified NSP1 constructs from the GST purification step 
were pooled and dialysed against PBS. This was done for further contaminant removal and 
buffer exchange (from imidazole which was acidic pH (6.0–6.5 to PBS at pH7.4). The dilute 
proteins in PBS were then concentrated (Amicon ultra centrifugation unit with a molecular 
weight cut-off of 30 kDa) and quantified using a nanodrop (Figure 28 and Table 8). From 
the gel analysis it was observed that proteins SM2 and SM3 had fewer low molecular weight 
impurities after dialysis (lanes1-2) and yielded a sufficient amount of protein (22 µM and 48 
µM respectively) to allow for an attempt at affinity purification of interacting partners. 
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Figure 28: Concentrated NSP1 proteins. 
Gel analysis of concentrated SM2 and SM3 proteins indicates expected 23 kDa NSP1 
proteins, with few low molecular weight impurities. The major bands are fairly intense 
suggesting a significantly high protein concentration. The measured concentrations for each 
protein were: SM2 (22 µM), SM3 (48 µM). Note gel was stained with Safeblue® 
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Table 8: Concentration of NSP1 proteins obtained after over expression in E.coli 
 
 
 
 
 
 
Code Plasmid Protein concentration(µM) 
   
SM2 pGEX-GST-NSP1-myc His 22 
SM3 pGEX-GST-NSP1-mt-myc His 48 
SM9 pGEX-GST-NSP1-cTAP 74 
SM10 pGEX-GST-NSP1-mt-cTAP 68 
SM15 GST-cTAP 51 
   
   
102 | P a g e  
 
2.4.5 Purification of uncleaved GST-NSP1 fusion proteins 
 
To complete our arsenal of tagged NSP1 constructs we took advantage of the availability of 
the GST fusion proteins and rather than cleaving the GST tag from NSP1, using protease, we 
eluted the fusion protein using competitive GSH elution Figure 29. This yields GST-NSP1 
fusion that can be used for affinity purification via GST pull-down. 
From the SDS gel analysis, it was observed that GST tagged NSP1 proteins were purified 
efficiently Figure 29, but the proteins had low molecular contaminants, possibly due to 
protein degradation. 
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Figure 29: Glutathione elution of NSP1 proteins. 
SDS-PAGE analysis of eluted NSP1 proteins SM2, SM3. Lane (SUP) indicates supernatant, 
(F.T) indicates flow through, lane (W1) first wash, lane (W2) second wash, lane (E1) elution 
lane (E2) second elution, (E3) third elution with glutathione. Beads* refers to glutathione 
beads used in the elution of SM2 and it was observed that a high proportion of protein was 
retained on the beads, compared to the eluted protein (lane 6 vs lane 7). The gel also indicates 
the presence of a 46 kDA (fractions E1-E3) for SM2 and SM3 respectively. Safeblue® 
staining.  
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2.4.6 FPLC purification of NSP1 proteins using ion exchange chromatography 
  
To further purify recombinant NSP1 proteins we used Diethylaminoethyl (DEAE) ion-
exchange chromatography that allowed for the separation of ions and polar molecules based 
on their affinity to the ion exchange column. The rationale being that this would provide a 
cleaner protein for binding experiments. The isoelectric points (pI) of NSP1 and GST-NSP1 
were 5.29 and 5.72. Following the elution of proteins over an increasing gradient distinct 
peaks were observed on the chromatograph for both SM2 and SM3 Figure 30 and fractions 
corresponding to peaks were pooled for SDS page analysis and verification of protein sizes 
Figure 31. The samples were then concentrated and dialysed against PBS.  
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Figure 30: HPLC chromatograph for NSP1 proteins. 
Representative HPLC chromatograph for SM2 protein. Three distinct peaks were observed on 
the chromatograph. For SM2, fractions corresponding to peaks (22-26), (32-34) and (40-45) 
were collected for SDS page analysis and verification of protein sizes. Following on from this 
analysis, fractions were then pooled together for concentration and dialysis. 
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Figure 31: SDS PAGE analysis of protein fractions collected from HPLC. 
SM2, fractions corresponding to peaks (a) (22-26) (b) (40-45) were analysed and verified by 
SDS PAGE. 
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 2.4.7. Dialysis and Concentration 
The GST-NSP1 fusion proteins (pooled fractions for SM2 and SM3) were each concentrated 
down to 500 µl, then dialysed overnight against PBS at pH 7.4. They were quantified using a 
nanodrop Figure 32 and Table 9. From the gel analysis it was observed that proteins SM2 
and SM3 had fewer low molecular weight impurities after dialysis. The relative band 
intensities of the expected 46 kDa proteins suggested that a sufficient amount of protein had 
been purified to allow for an attempt at affinity purification of interacting partners. 
Confirmation of this was by nanodrop protein concentration measurements of (126 µM and 
87 µM SM2 and SM3 respectively). 
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Figure 32: Concentrated GST-NSP1 proteins. 
Gel analysis of concentrated proteins indicates expected 46kDa GST NSP1 proteins, with few 
low molecular weight impurities observed (such as GST approximately 26 kDa). The major 
bands are very intense suggesting a significantly high protein concentration. The measured 
concentrations for each protein were: SM2 (127 µM), SM3 (87 µM). Note gel was stained 
with Safeblue® 
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Table 9: Concentrations of fusion GST NSP1 proteins obtained after over expression in  
E.coli. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Code Plasmid Protein concentration(µM) 
   
SM2 pGEX-GST-NSP1-myc His 126 
SM3 pGEX-GST-NSP1-mt-myc His 87 
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2.4.8 Pull down assays to reveal NSP1 interacting partners. 
 
Following their purification, NSP1 wild type and mutant proteins were used to identify NSP1 
binding partners from HeLa cell lysate in pull down assays. The pull-down assay is an in 
vitro method used to determine a physical interaction between two or more proteins 
(Einarson et al.). The assay is a small-scale affinity purification technique that utilises a 
tagged protein (His or GST tag, which is captured on an immobilized affinity ligand specific 
for the tag Figure 33. For our pull-down assay, NSP1 proteins were immobilised via a GST-
tag (SM2 and SM3) or His6 tag (SM2 and SM3) on resin or magnetic beads.  The fusion-
tagged protein acts as the "bait" to capture a putative binding partner (i.e., the "prey"). In a 
typical pull-down assay, the immobilized bait protein is incubated with a cell lysate and the 
'interactors" after the prescribed washing steps, are selectively eluted for analysis in a SDS 
gel. 
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Figure 33: Overview of pull down assay. 
A small scale affinity purification technique designed to detect NSP1 interacting partners in 
lysate utilised a tagged protein (His or GST) as ′bait′ that is captured on an immobilised 
affinity ligand specific for the tag and was used to pull-down interacting proteins  in the cell 
lysate. The complex was eluted with appropriate buffer (imidazole for histidine tagged 
proteins and glutathione of GST tagged proteins) and evaluated using SDS PAGE.
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To test our hypothesis for the interaction of NSP1 fusion protein with potential ′interactors′ in 
lysate we conducted a pull-down assay as outlined in Figure 33. Firstly, we investigated the 
potential interactions of NSP1 in HeLa cell extracts using cleaved histidine tagged fusion 
protein as bait in the pull down assay. The replication defective mutant NSP1 (SM3) was 
assayed in the HeLa extract along with the wild type NSP1 (SM2). The experiment was 
designed to confirm the identity of new interactions with NSP1 therefore, if our hypothesis 
was correct, the expected outcomes were that the eluted complex would pull-down specific 
protein(s) from the lysate that would be reflected as unique bands compared to the mutant 
protein, when evaluated by SDS PAGE. Analysis of the 12% SDS PAGE gel using silver 
staining to visualise the bands did not detect the presence of any successful interactions 
Figure 34.  Proteins bands corresponding to the 20 kDa NSP1 fusion protein were detected in 
both the control and experimental lanes (lanes 6 vs lane 7), but despite several repeated 
analysis no significant differences in the banding patterns were noted. The efficiency of the 
assay was monitored by collecting fractions of the flow through and washing steps and these 
were also included in the gel analysis. The pull downs were eluted efficiently as no 
significant proteins were recovered in flow through and wash fractions. It was however, 
noted that there was a high level of background protein binding to the resin, which could 
have led to nonspecific binding. The protocol parameters were then adjusted to optimise bead 
binding by using bead-clarified lysate and increasing the beads to protein ratio that was 
achieved by using magnetic NTA beads with a higher bead binding capacity Figure 35. 
Following on from this, no unique bands were detected in the experimental lanes on visual 
inspection, suggesting that there were no potential ′interactors′ for NSP1 in the HeLa lysate.  
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Figure 34: Bead binding assay of NSP1 proteins. 
SDS-PGE analysis of bead binding assay of NSP1 proteins SM2 with HeLa lysate with NTA 
resin. The gel identifies potential interactors between proteins in the lysate and the tagged 
NSP1 constructs. A comparison of lanes 5 vs lanes 6 and 7 shows no unique bands in the 
experimental lanes. Lane (F.T) indicates flow through, lane (SUP) supernatant, lane (W1) 
first wash, lane (W2) second wash. Note that gels were stained with silver stain.    
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Figure 35 Bead binding assay of NSP1. 
SDS-PGE analysis of bead binding assay of NSP1 proteins SM3 in HeLa lysate with 
magnetic NTA beads. The gel identifies potential interactors between proteins in the lysate 
and the tagged NSP1 constructs. A comparison of lanes 5 vs lanes 6 and 7 shows no unique 
bands in the experimental lanes. Lane (F.T) indicates flow through, lane (SUP) supernatant, 
lane (W1) first wash, lane (W2) second wash. Note that gels were stained with silver stain.    
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We hypothesized that the binding of His tag to the resin was not very efficient and therefore 
resolved to immobilise the GST-NSP1 fusion on GST beads, prior to incubating in the 
presence of the lysate. The detection of protein-protein interactions using the GST fusion 
protein pull-down technique is a widely method (Methods, 2004). To this end the GST tag 
was an alternate tag incorporated into our construct at the cloning stage (Section 2.4.1).  To 
rule out any inhibitory effects on bead binding due to sub optimal temperatures the lysate was 
incubated with the beads at 4
o
C and 37
o
C.  NSP1 was then cleaved off with any potentially 
bound partners using PresScission protease Figure 36, or competitively eluted with 
glutathione Figure 37. Although we could detect potential interacting partners indicated by 
stars on the gel, these results were not reproducible enough to yield conclusive results. To 
reduce the possibility of nonspecific binding due to high levels of background binding of the 
lysate to the beads we attempted to clarify the lysate first, by incubating it with beads, then 
using the supernatant to perform the affinity purification, in order to remove the proteins that 
were attaching  non-specifically to beads in our pull-down assay. Although this significantly 
reduced the non-specific binding, no interesting binding to NSP1 could be detected Figure 37 
after this treatment.  
Finally, rather than cleaving off NSP1 from the GST-NSP1 fusion protein, and separating 
NSP1 and its potentially bound partners, we attempted to isolate NSP1 partners by eluting the 
GST-NSP1 fusion proteins, and any potentially bound partners from the beads using 
competitive elution with reduced GSH Figure 38. Again, this did not yield any informative 
data as no interacting partners could be detected. 
 
A                                                                                              
B 
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Figure 36: Bead binding assay of NSP1 proteins. 
Bead binding assay of GST tagged NSP1 proteins (SM2 and SM3) lanes 5 to lane 8 in HeLa 
lysate. Subsequent cleavage with PreScission protease of NSP1 bound to potential interacting 
partners was analysed for at two distinct temperatures. (*) indicates possible unique bands 
pulled down with NSP1 (on lanes 5 and lane 8) after visualisation with silver staining. Lane 
(SUP) supernatant, lane (W1) first wash, lane (W2) second wash. 
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Figure 37: Bead binding assay of NSP1 proteins using clarified lysate. 
Bead binding assay of GST tagged NSP1 proteins (SM2 and SM3) lanes 5 to lane 8 in 
cleared HeLa lysate. Subsequent cleavage of NSP1 bound to potential interacting partners 
was analysed for at two distinct temperatures revealing a 25kDa protein (lanes 5 and 6 versus 
lanes 7and 8) on visualisation of the gel with silver staining. Lane (FT) indicates flow 
through, lane (W1) first wash, lane (W2) second wash 
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Figure 38: Bead binding assay of NSP1 proteins. 
 Bead binding assay of GST tagged NSP1 proteins (SM2 and SM3) lanes 5 to lane 8 in 
cleared HeLa lysate. Subsequent glutathione elution of NSP1 bound to potential interacting 
partners was analysed for revealing a 46kDa protein (lanes 6 versus lanes 7and 8) and 25kDa 
product, (most likely GST) on visualisation of the gel with silver staining. Lane (SUP) 
indicates supernatant, lane (W1) indicates first wash, and lane (W2) indicates second wash. 
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In summary, no interesting reproducible interactions were observed with the NSP1 after 
several protocol adjustments or trying various pull-down strategies. Previous reports from our 
collaborators had suggested that NSP1 could bind directly to the 40S ribosomes (Narayanan 
et al., 2008). Therefore we used purified 40S ribosomal subunit to test their binding to NSP1 
(SM2 and SM3) immobilised onto NTA beads. The expected outcome was that the 
interaction of the fusion proteins with the 40S subunit would result in the elution of 
ribosomal proteins following affinity chromotagraphy. The results presented below show that 
the ribosomal proteins were indeed pulled down by the NSP1 fusion protein using GST pull-
down (Figure 39 lane 5 and 6).  However because the 40S subunit alone were able to binds 
to the affinity matrix, we could not conclude whether any specific interactions occurred with 
NSP1 (Figure 39 lane 4). The results presented thus far suggested that our system was not 
effective in isolating proteins that specifically interacted with tagged NSP1 in either RRL or 
HeLa lysate.  
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Figure 39: Interaction of NSP1 with 40S ribosome. 
Gel analysis of binding of NSP1 proteins (SM2 and SM3) to 40S ribosome. Interaction of the 
purified 40S ribosome subunit with NSP1 (SM2) was not observed; lane 4 (40S only) vs. 
lanes 5 (40S+SM2) and 6 (40S+SM3). Lane (FT) indicates flow through, lane (W1) first 
wash, lane (W2) second wash. (Silver staining). 
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2.4.9 TAP pull down of NSP1 interacting partners 
 
To further identify the proteins interacting with NSP1, we decided to use more stringent 
conditions using a TAP (tandem affinity purification). The TAP strategy entailed fusion of 
the TAP tag to the target protein, allowing two consecutive steps of affinity purification. The 
TAP tag itself comprised of two IgG binding domains of Staphylococcus aureus protein G 
(ProtG) and a streptavidin binding peptide (SBP) separated by a TEV protease cleavage site 
Figure 40. ProtG binds tightly to an IgG matrix, requiring the use of the TEV protease to 
cleave and further elute the remaining fusion protein under native conditions. The fusion 
protein, as well as associated partners, can then be recovered by immobilizing it to a 
strepatividin-linked matrix that recognizes the SBP, and then competitively eluting them 
using biotin Figure 41. Since it is a two steps strategy, we expected a much more stringent 
efficiency of purification than obtained using one step procedures based on the HIS or GST 
tags. 
 
 
 
Figure 40: Schematic of the construct used for tandem affinity purification. 
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 Figure 41: Overview of TAP pull down strategy 
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To optimise the overall pull-down assay an initial test for the interaction of NSP1 (SM9) with 
potential binding partners in HeLa lysate was conducted Figure 42. Lane 1 represents the 
input material SM9 in HeLa lysate. The presence of proteins in Lane 2 reflected proteins that 
did not bind to the IgG sepharose beads. Subsequently the proteins bound to the IgG beads 
via the ProtG tagged were released from the beads by cleavage it at the TEV protease 
cleavage site (lane 3). Then, the released proteins were immobilised via the SBP tag to the 
streptavidin agarose beads, and any proteins present in lane 4 corresponded to proteins bound 
non-specifically to the IgG sepharose beads but not retained on the streptavidin beads, 
highlighting the stringence of the procedure. Finally, proteins bounds specifically to the 
streptavidin agarose beads were competitively eluted using biotin (lane5) and as expected a 
prominent band of 26 kDa corresponding to NSP1 was identified, while further washes of the 
beads were performed using SDS loading buffer (lane 6). 
It was concluded that the overall efficiency of the TAP pull-down for NSP1 binding partners 
in lysate was much better compared with previous attempts using histidine and GST affinity 
tags. Following on from this result we investigated this interaction further in RRL using the 
same parameters Figure 42. The biotin elution of SBP-NSP1 in RRL was efficient (contrast 
lane 5 with lane 1) and interestingly additional unique protein bands were also noted. 
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Figure 42: TAP pull down assay. 
SDS analysis of TAP pull down of SM9 in HeLa lysate. A 30kDa NSP1 with bound proteins 
was eluted with biotin lane 5. This was contrasted with non-specific elution of NSP1 with 
2xSDS (lane 6).  The efficiency of the assay was assessed by comparing the input protein 
(lane 1) with products obtained at various stages of the assay mainly the IgG SPN-
supernatant (lane 2); TEV protease cleavage products (lane 3). The gel bands were visualised 
by silver staining. 
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Figure 43: TAP pull down assay with RRL. 
SDS-PAGE analysis of NSP1 protein (SM9) pull down assay in rabbit reticulocyte lysate 
(RRL). The 30kDa protein was eluted with biotin and SDS lanes 5 and 6 respectively. The 
efficiency of the assay was assessed by comparing the input protein (lane 1) with products 
obtained at various stages of the assay mainly the IgG SPN-supernatant (lane 2); TEV 
protease cleavage products (lane3). The gel bands were visualised by silver staining. 
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To validate these results a comparison of the biotin elution fraction from a TAP pull down 
performed both HeLa and RRL, in the presence or absence of SM9 was conducted Figure 44. 
Analysis of the gel shows that the protein bands observed in HeLa and RRL were unique.  A 
comparison of experimental lanes (lane2 and lane 4) with lysate controls (lane 3 and lane 5) 
showed no overlap in the proteins from the SM9 control. These unique proteins offered the 
prospect of functional interaction(s) with the target protein and warranted further 
investigation and analysis. Mass spectrometry (gas chromatography coupled MS) was 
therefore applied to the proteins sample and performed at the University of Surrey. This 
analysis separates all of the components in a sample and provides a representative spectral 
output, which is then queried against a data base of known representative proteins. Results of 
the GC-MS for all NSP1-interacting samples submitted were inconclusive owing to the 
presence of keratin contaminants in the sample.  This could also reflect the low abundance of 
the interacting partners in the eluate itself. 
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Figure 44: Pull down assay in HeLa lysate and RRL. 
A comparative analysis of SM9 pull down assay in HeLa lysate and RRL (silver staining). 
Experimental lanes 2 shows 4 potentially interesting bands which were not present in the 
control lane 1. The red dots ( ) indicate unique bands on the gel showing potential interacting 
partners.  
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2.4.10 Transfection of NSP1 plasmids into mammalian cells 
 
The NSP1 protein has previously been shown to be efficiently expressed in human lung and 
liver epithelial cells lines by Law et al (Law et al., 2007). In their assay they also utilised 
myc-tagged expression plasmids encoding NSP1, NSP5 SARS CoV genes. To complement 
our results, we used a similar approach aimed at engineering mammalian cell lines allowing 
for inducible overexpression of TAP-tagged NSP1 to identify interacting partners in cell 
culture. Our objective was to overexpress NSP1 in 293T cells by transfection of NSP1 in the 
expression vector pcDNA4/TO. Following transfection, growth of 293T cells was monitored 
for three weeks with occasional selective media change. Expected growth of resistant 
confluent colonies was not observed following clone selection with Zeocin™. The pattern of 
growth was such that only a few resistant colonies appeared after two weeks of cell growth. 
This result suggested that transfection of our 293T cells was not efficient possibly due to a 
low DNA to lipofectamine ratio which was sub-optimal for the cell line. 
To overexpress tap tagged NSP1 in mammalian cells, we induced the protein expression with 
tetracycline (1µg/ml) in the SARS-CoV NSP1 expressing cells. At 14 h post transfection, the 
nuclear proteins were analysed by Western blot as described previously, using antibodies 
against the C-terminal myc tag. Our results showed that NSP1 was not efficiently expressed 
in 293T cells (data not shown). We postulated that low transfection efficiency could account 
for this. It was also noted that the viability of the transfected cells was also very low 
suggesting that the 293T cells were unhealthy.  
To mitigate low transfection efficiency we considered several options. A known factor that 
could affect transfection efficiency was the health of the 293T cells. We used 293T cells at 
early passages (up to 20 at the maximum) for transfection. We also avoided getting cells too 
confluent between passages as they would start to develop resistance to transfection.  We 
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passaged the cells 1-2 days before transfection so that the cell culture confluency was roughly 
60-70%.  All these interventions still did not yield a positive result, pointing to a more 
fundamental problem requiring further optimisation (DNA concentration, cell density and 
time duration) to find optimal experimental conditions.  
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2.5 DISCUSSION 
 
The present study set out to identify NSP1 partners responsible for mRNA cleavage and the 
molecular mechanism(s) driving the SARS pathogenesis. SARS-CoV NSP1 has been 
proposed to play a significant role in the pathogenesis of the SARS-CoV. The NSP1 protein, 
which is the most N-terminal product of the gene 1 polyprotein,  has previously been found to 
suppresses host gene expression in expressed cells and in infected cells (Kamitani et al., 
2009, Kamitani et al., 2006, Tohya et al., 2009). The expressed NSP1 also suppressed the 
host antiviral signalling pathway and prevented type I interferon production in infected cells 
(Bhardwaj et al., 2004, Wathelet et al., 2007). Furthermore, NSP1 of a closely related mouse 
hepatitis virus was also found to suppress host gene expression and interfered with the type I 
interferon system. It was also determined that the NSP1 was a virulence factor (Zust et al., 
2007). Several studies by the group of our collaborator Prof Shinji Makino demonstrated that 
SARS-CoV suppressed host gene expression by using a novel, two-pronged strategy 
(Kamitani et al., 2009, Kamitani et al., 2006, Tohya et al., 2009). It was shown that NSP1 
binds to 40S ribosomes, leading to the inhibition of host protein synthesis. Furthermore, it 
was demonstrated that ribosome-bound NSP1 induced modification RNA of a capped mRNA 
ultimately rendering it translationally incompetent (Kamitani et al., 2009). They also 
proposed that cellular RNA decay functions most likely influenced the efficient degradation 
of  the host mRNAs that underwent NSP1-induced modification since it had been previously 
observed that NSP1 protein promoted template-dependent host mRNA degradation both in 
transiently transfected cells expressing NSP1 and in infected cells (Kamitani et al., 2009, 
Kamitani et al., 2006, Narayanan et al., 2008, Tohya et al., 2009) 
The SARS-CoV NSP1 could exert its multiple activities by interacting with a single factor 
impacting on multiple pathways or with distinct factors that each account for some of its 
activities. In addition to inhibiting host gene expression and virus- and IFN-dependent 
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signalling, SARS-CoV NSP1 also inhibits cell cycling and decreases cell death in transfected 
cells (Wathelet et al., 2007). We hypothesized that at least one of these pleiotropic activities 
(specifically inhibition of translation initiation) could be the result of interactions between 
NSP1 and specific host proteins. If true, the prediction would be that individual residues in 
NSP1, which if mutated, would differentially affect the ability of NSP1 to inhibit translation 
initiation. To this end our collaborators developed NSP1 mutant lacking the RNA cleavage 
function, to delineate the mechanism of NSP1-mediated translation inhibition and identify the 
translation step(s) targeted by NSP1 (Lokugamage et al., 2012). Prior to this they had 
demonstrated that SARS NSP1 protein induced template-dependent endonucleolytic cleavage 
of mRNAs and that viral mRNAs are resistant to NSP1 induced cleavage (Huang et al., 
2011).  
The present study set out to determine how NSP1 induces mRNA cleavage and host gene 
expression silencing during SARS infection by identifying cellular proteins interacting with 
NSP1. We hypothesised that:  NSP1 proteins (i) have nuclease activity, either alone or as part 
of a complex with host proteins; (ii) alter RNA-interacting proteins or RNA to make it more 
nuclease sensitive; (iii) were required for the formation or activity of a cellular RNase; (iv) 
recruited  protein(s) involved in RNA degradation pathway.  
mRNA degradation is a fundamental cellular process that plays a critical role in regulating 
gene expression by controlling both the quality and the quantity of mRNAs in cells 
(Narayanan and Makino, 2001, Lokugamage et al., 2012, Angelini et al., 2013) . To establish 
a productive infection in the host, viruses must successfully interface with the cellular RNA 
degradation machinery to achieve an optimal balance between viral and cellular gene 
expression (Chang et al., 2007). Studies have discovered many strategies that viruses employ 
to evade the cellular RNA degradation machinery (Imbert et al., 2008, Graham et al., 2005). 
These include mechanisms ranging from inactivating the RNA decay pathways and co-opting 
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the factors governing cellular mRNA stability, to promoting host mRNA degradation that 
leads to selective viral gene. The different pathways of mRNA decay in eukaryotic cells 
involve the coordinated action of exoribonucleases and endoribonucleases that target an 
mRNA substrate for destruction depending on the presence of cis-acting instability elements, 
trans-acting mRNA destabilizing factors and cellular environment (Donaldson et al., 2007b). 
A majority of cellular mRNAs are degraded by the deadenylation-dependent decay pathway 
(Donaldson et al., 2007b). The cellular deadenylase complexes, CCR4-NOT, PARN or 
PAN2-PAN3 removes the poly (A) tail and subsequently, the body of the deadenylated 
mRNA is degraded by 5'-3' or 3'-5' decay mechanisms.  
 
Increasing evidence suggests that viruses have evolved ways of interfacing with the cellular 
RNA decay machinery that aid their survival and replication. Viruses have evolved 
mechanisms to disrupt the cellular decay machinery by inactivating the enzymes and co-
factors involved in both the constitutive and virus-induced mRNA surveillance and 
degradation pathways. The cellular factors involved in deadenylation, decapping and 5'-3' 
mRNA decay are either directly or indirectly targeted by polioviruses for degradation 
(Dougherty et al., 2011). Recently, Lee and Glaunsinger characterized a novel RNA decay 
mechanism induced by Kaposi's sarcoma-associated herpesvirus (KSHV) (Pan et al., 2008). 
It was demonstrated that KSHV initiated global decay of cellular mRNAs via expression of 
virus-encoded Shutoff and exonuclease (SOX) protein through induction of hyperadenylation 
of mRNA. Interestingly, this mechanism was dissimilar to the virion shutoff protein (vhs) of 
the related herpes simplex virus (Adedeji et al., 2012) in so far as the SOX protein itself did 
not possess any demonstrable nuclease activity (Kamitani et al., 2006). 
Based on the data that SARS-CoV NSP1 has no similarities in its primary amino acid 
sequence or protein structure with any known host proteins, including RNases, and that 
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binding of NSP1 to 40S ribosomal subunits is required for the NSP1-induced endonucleolytic 
RNA cleavage (Kamitani et al., 2009), we hypothesised that NSP1 was not an RNase, but 
used a host RNase to induce endonucleolytic cleavage of template mRNAs that interact with 
40S ribosomes. Several host endonucleases are involved in the mRNA surveillance pathways 
to detect stalls in translation and are known to exert their function in association with stalled 
ribosomes. The host cell RNase, SMG6, has been shown to play a central role in nonsense-
mediated mRNA decay by inducing an endonucleolytic RNA cleavage in ribosome-
associated host mRNAs containing a pre-mature termination codon (Tohya et al., 2009). The 
no-go mRNA decay pathway detects stalled ribosomes on mRNAs during translation 
elongation, and the yeast Dom34/Hbs1 complex is involved in the endonucleolytic cleavage 
of mRNAs near the stalled site (Lokugamage et al., 2012). The homolog of the yeast Dom34, 
Pelota, also exhibits an endonuclease activity (Zust et al., 2007). The exosome is involved in 
the decay of nonstop mRNAs that lack a stop codon (Green and Sambrook, 2012), and one of 
the subunits of the core eukaryotic exosome has endonuclease activity (Green and Sambrook, 
2012, Medyouf and Ghysdael, 2008, Belew et al., 2014).  
Previous studies have used a systems biology approach employing a genome-wide yeast-two 
hybrid interaction screen  to identify immunophilins (PPIA, PPIB, PPIH, PPIG, FKBP1A, 
FKBP1B) as interaction partners of the coronavirus non-structural protein 1 (Pfefferle et al., 
2011). These molecules are known to modulate the Calcineurin/NFAT pathway that plays an 
important role in immune cell activation (Medyouf and Ghysdael, 2008). However no RNA-
degradation partners were identified. 
 
Based on these data, we undertook the characterisation of the NSP1 interactome using protein 
affinity chromatography in collaboration with the group of Prof Shinji Makino at the 
University of Texas Medical Branch. We purified affinity tagged NSP1 proteins and used 
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protein affinity-based chromatography methods to isolate putative binding partners in both 
HeLa lysate and RRL.  
To provide a fast and effective purification of recombinant NSP1, wild type and mutant 
proteins were constructed with either 6X-Histidine, Glutathione-S-Transferase and Tandem 
Affinity Purification tags and overexpressed using E.coli, Rossetta strain (Robert et al., 
2001), which supplied tRNA recognizing rare codons, AUA, AGG, AGA, CUA, CCC, GGA, 
and was designed to enhance the expression of eukaryotic proteins. All the different NSP1 
fusion proteins were overexpressed efficiently after IPTG induction. Subsequently, NSP1 and 
NSP1-TAP proteins were purified by affinity chromatography using GSH resin and cleaved 
off with PreScission protease to remove the GST tag. The GST-NSP1 proteins were also 
purified using competitive GSH elution. Overall, the purity of the various NSP1 protein was 
not optimal thus we undertook a further step of purification using nickel affinity 
chromatography. However, only a low final yield of NSP1 could be obtained despite several 
optimization attempts. A major drawback for strong immobilization of the 6XHis/Ni-NTA 
interaction is its relatively low affinity; due to rapid dissociation and this could account for 
the low yields observed (Nieba et al., 1997). The results also suggested that the availability of 
the 6XHis tag might not be optimal for binding. Switching the tag to the N-terminus in the 
construct was not a viable option as this would have an impact on the functionality of the 
NSP1 proteins (Shinji Makino, personal communication). To improve the binding 
characteristics of the 6XHis tag, studies have suggested that double- or triple-6XHis tags at 
can used and this could be implemented in our construct (Khan et al., 2006). To further purify 
recombinant NSP1 proteins we used ion-exchange chromatography (Chen et al., 2011) A 
major feature of ion exchange is its power to concentrate a bound component and exhibits 
high resolving power for both binding and elution selectivity. The predicted isoelectric point 
of NSP1 and GST-NSP1 are 5.29 and 5.72 respectively. At neutral pH the proteins are 
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charged with a net negative charge and an anion exchange chromatography column can be 
used, therefore we optimized DEAE-sepharose separation to purify further the recombinant 
proteins. 
GST and His pull-down assay are in vitro methods used to identify the physical interaction 
between a bait protein and other proteins (Ruch and Machamer, 2012, Smith and Johnson, 
1988). From our results it was noted that the bead binding assays based on either the 6XHis 
or GST tags did not yield any reproducible interactions, despite several optimisations 
attempts, either using HeLa lysate or RRL. We speculated that the purity of our bait proteins 
could have a negative influence on the observed results. We attempted to assess the 
interaction of NSP1 with purified small ribosomal subunit (40S), however these experiments 
were hindered by the non-specific binding of the 40S to the beads. Further optimization could 
be performed using mild detergent in the binding buffer such as Triton or Tween, before 
repeating it. Due to the failure of these initial bead binding attempts, and given the fact that 
the purity of the bait seemed an issue, we concluded that using the more stringent TAP 
protocol would resolve this by using two successive rounds of affinity purification, both by 
purifying the NSP1 protein further during the procedure and allowing separation of 
interacting partners. The TAP pull down attempted showed promising results and allowed us 
to isolate, both in RRL and HeLa extract, several putative interacting partners. As a 
consequence mass spectrometry identification of the NSP1 partners was attempted. Gas 
chromatography mass spectrometry (GC/MS) is an instrumental technique, comprising a gas 
chromatograph (GC) coupled to a mass spectrometer (MS), by which complex mixtures of 
chemicals may be separated, identified and quantified. Results of the GC-MS for all NSP1 
samples submitted were inconclusive owing to the presence of keratin contaminants in the 
sample. We speculated that this result could also have been due to the low availability of the 
NSP1 fusion protein in the sample itself.  The size of a spectral peak is proportional to the 
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amount of the substance that reaches the detector in the GC instrument, with instrument 
detection Limits at 400ng (full scan) and 10ng (outgassing). To overcome these problems we 
planned to scale-up our TAP pull-down in order to isolate more proteins.  
 
To complement this approach with recombinant proteins, we engineered mammalian HeLa 
cell lines to allow for the inducible over expression of NSP1. The most commonly used 
inducible expression systems are the Tet-Off® and Tet–On®. As shown from our preliminary 
data the transfection protocols needed further optimisation as our transfection efficiency was 
very low. An alternative to Lipofectamine such as DreamFect or DreamFect Gold could be 
used to enhance the efficiency. These transfection reagents are biodegradable and have high 
compaction level of nucleic acid and allow using less DNA which should favour cell viability 
(Ho, 2000). 
 
A major drawback of all the pull-down attempted above is that they involve the use of fusion 
proteins to which several affinity tags were added to the NSP1 proteins. There is also a 
possibility that a tag added to a protein might obscure binding of the new protein to its 
interacting partners, thereby altering the function of the protein. In addition, the tag may also 
affect protein expression levels. On the other hand, the tag may also not be sufficiently 
exposed to the affinity beads, hence skewing the results. Potential disadvantages for example, 
of GST-fusion proteins include oligomer formation via the GST moiety; potential steric 
hindrance caused by the large fusion tag, and increased costs associated with protease 
cleavage and removal of the affinity tag. 
Potentially, after having identified putative binding partners by mass spectrometry analysis a 
functional validation of their role would be required. First, the expression in cells would be 
silenced using siRNA mediated knock-down. Then using lysate from these cells the ability of 
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NSP1 to drive mRNA-degradation and inhibit translation initiation would be evaluated. 
Furthermore, we would attempt to recapitulate the function of NSP1 in an in vitro cleavage 
assay, using the RNA reporters described by our collaborators, recombinant NSP1 and 
recombinant NSP1 binding partner, followed by a standard RNA degradation assays.  These 
will ultimately demonstrate the activity of the identified partners in vitro. Given the time 
invested in this part of the thesis project, the low output given by the various pull-down 
attempted, and the lack of RNAse identified in a several study conducted by competitors, it 
was decided to pause this subject in agreement with our collaborators.  
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Chapter 3 
Understanding the role of Far 
Upstream Binding Protein 2 in 
IRES mediated translation 
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3.1 INTRODUCTION 
 
3.1.1 Human enterovirus 71  
 
Human enterovirus 71 (EV71) is a small, non-enveloped, icosahedral virus that belongs to the 
species Enterovirus A, in the genus Enterovirus within the family Picornaviridae. EV71, 
together with coxsackievirus A16 (CVA16), is a common etiological agent of hand, foot and 
mouth disease (HFMD) in children. In cases of severe infection, EV71 can cause 
complications, such as aseptic meningitis, acute flaccid paralysis (AFP), meningoencephalitis 
and cerebellitis, with mortality rate ranging from 10 to 25.7% (Wong et al., 2010, Ho, 2000, 
Sun et al., 2011). In the Western Pacific Region, widespread epidemics have been reported in 
many countries, including Australia, Brunei Darussalam, China, Japan, Malaysia, Mongolia, 
the Republic of Korea, Singapore, and Viet Nam. Several countries have also reported fatal 
cases, with severe central nervous disease or pulmonary oedema. In 2009, for example, an 
outbreak in mainland China involved 1 155 525 cases, 13 810 severe cases and 353 deaths 
(W.H.O, 2011). In recent years, there have also been an increasing number of reports of 
HFMD outbreaks with fatal cases (Zhang et al., 2010, Sun et al., 2011, Liu et al., 2011). In 
2012, EV71 was found to be associated with an unknown disease that resulted in the death of 
most patients shortly after admission to hospital in Cambodia (Seiff, 2012). The virus is also 
known to cause cyclical epidemics every 2 to 3 years in many countries (Tee et al., 2010). 
Although the host receptors for EV71 virus have been identified, including scavenger 
receptor B2 (SCARB2), P-selectin glycoprotein ligand-1 (PSGL-1), sialylated glycan, 
heparan sulfate and annexin II (Anx2) (Herrero et al., 2003, De Jesus et al., 2005, Yamayoshi 
et al., 2014), at present there are no effective vaccines or antivirals against EV71(Kung et al., 
2014). The virus has seriously impacted the Asia-Pacific region(McMinn et al., 2001), but 
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there is an increasing likelihood that it may become a health threat to human populations 
around the world. EV71 epidemiological studies have identified that the global spread of 
EV71 genotype 1 C strains into the UK mainly originated from countries in the Asia-Pacific 
region (Bible et al., 2008).  
3.1.2 The clinical disease 
EV71 infection usually causes HFMD or herpangina (Ho et al., 1999), but it can result in 
more severe illness. It is characterized by high-grade fever (body temperature above 39.8
o
C), 
vomiting, and cardiopulmonary or neurological complications (Ho et al., 1999). Common 
signs and symptoms of the HFMD include fever, feeling tired, malaise, loss of appetite, and 
irritability in infants and toddlers. Skin lesions frequently develop in the form of a 
maculopapular rash followed by vesicular sores with blisters on palms of the hands, soles of 
the feet, buttocks, and sometimes on the lips. The rash is rarely itchy for children (Hoy et al., 
2012), but can be extremely itchy for adults. Painful facial ulcers, blisters, or lesions may also 
develop in or around the nose or mouth (Kaminska et al., 2013, Sarma, 2013). HFMD usually 
resolves on its own after 7–10 days (Sarma, 2013). Diagnosis  of the disease usually can be 
made by the presenting signs and symptoms alone but if the diagnosis is unclear, a throat 
swab or stool specimen is taken to identify the virus by cell culture (Sarma, 2013). The 
common incubation period ranges from three to six days (Hoy et al., 2012). Under normal 
circumstances treatment for HFMD does not require any medical treatment as the disease 
typically resolves on its own. Currently, there are no specific curative treatments or vaccines 
for HFMD (Sarma, 2013). Disease management typically focuses on achieving symptomatic 
relief. Pain from the sores may be eased with the use of analgesic medications (Wang and 
Liu, 2009). For infections in older children, adolescents, and adults the disease progression is 
typically mild and lasts approximately one week, but occasionally run a longer course. A 
minority of individuals with hand, foot and mouth disease may require hospital admission 
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due to neurologic or cardiac complications such as meningitis, encephalitis, inflammation of 
the heart, fluid in the lungs, acute flaccid paralysis (AFP), onychomadesis (fingernail and 
toenail loss) (Li et al., 2012). These complications are uncommon, but if present require 
immediate medical treatment. In 1998, a large epidemic in Taiwan resulted in the death of 78 
patients, most of whom died of severe illnesses, including AFP, aseptic meningitis, 
encephalitis, pulmonary oedema or, and myocarditis, among whom around 80% had 
pulmonary oedema or haemorrhage (Ho et al., 1999). In 2012, at least 240 people, mainly 
children younger than 5 years old, died from HFMD from January to May in China. An 
official tally showed China reported nearly 1.62 million HFMD cases in 2011, including 509 
deaths (W.H.O, 2011). No vaccine is available to protect individuals from infection by the 
viruses that cause HFMD (Sarma, 2013),  but development of vaccines is ongoing (Zhou et 
al., 2014, Han et al., 2014, Liao et al., 2014, Liu et al., 2014, Kuo and Shih, 2013, Tan et al., 
2014, Kung et al., 2014). Amantadine and quinacrine, both protein synthesis inhibitors, and 
ribavirin, a replication inhibitor, are being investigated as treatment options. Two new 
candidate vaccines developed recently have proved to be highly effective. The experimental 
vaccines tested used slightly inactivated forms of enterovirus 71 and both were found to 
trigger the immune system to elicit neutralising antibody  response against enterovirus 71 
(Zhu et al., 2014, Li et al., 2014). In one trial, 12,000 children between 6 months and 6 years 
of age received either two shots of the vaccine four weeks apart or two placebo shots. The 
vaccine was highly effective. While 151 children who got the placebo shots developed illness 
caused by enterovirus 71. Over the next 11 months, only four in the vaccinated group 
displayed symptoms. The follow-up studies spanned two peak epidemic seasons in China 
(Zhu et al., 2014). In the other study, 10,007 children who were 6 months to 3 years old 
similarly received placebo or vaccination shots. Over a year, that vaccine also showed strong 
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protection: 106 of the children who got the placebo, but only 13 of the vaccinated children, 
developed disease from enterovirus 71 (Li et al., 2014).  
HFMD is highly contagious and is transmitted by oropharyngeal secretions such as saliva or 
nasal mucus, by direct contact, or by faecal-oral transmission. Preventive measures include 
avoiding direct contact with infected individuals (including keeping infected children away 
from school), proper cleaning of shared utensils, disinfecting contaminated surfaces, and 
proper hand hygiene. These measures have been shown to be effective in decreasing the 
transmission of the viruses responsible for HFMD (Sarma, 2013). 
3.1.3 Genome organisation  
The EV71 viral particles have an icosahedral structure 30–31 nm in diameter surrounding a 
7.4-kb genome (Plevka et al., 2012). The virus has single-stranded positive-sense RNA 
genome, flanked by 5′ and 3′ untranslated regions (UTRs), capped by a viral protein VPg at 
its 5’ end and a poly(A) tail at is 3’ end. The polyprotein consists of P1, P2, and P3 regions, 
which encodes structural proteins, VP4, VP2, VP3, VP1, and non-structural proteins,2A, 2B, 
2C and 3A, 3B, 3C, 3D, respectively (Figure 45) (Brown and Pallansch, 1995). Based on 
molecular typing using VP4 and VP1 gene sequences, EV71 is classified into three genotype 
1s, A, B (sub-genotype 1s B1-B5), and C (sub-genotype 1s C1-C5) (Tee et al., 2010, Huang 
et al., 2008).  
 
 
Figure 45: Organisation of the Enterovirus 71 genome. 
 Schematic of the structure of the EV71 genome. The single open reading frame (ORF) is 
flanked by highly structured 5′UTR and 3′UTR followed by a poly (A) tail. The 5′ end of the 
viral genome is covalently attached to the viral VPg protein. The ORF is divided into three 
regions. P1 encodes four structural proteins, VP1 to VP4. P2 and P3 encode seven non-
structural proteins, 2A to 2C and 3A to 3D, respectively. (Knipe and Howley, 2001). 
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Of the EV71 strains identified in the UK, genotype 1 C1 is the most prevalent (78% of the 
cases), and genotype 1 C2 is present in 12% of cases. Associated clinical information has 
suggested that there may be more neurological features associated with genotype 1 C2 
infections than genotype 1. Furthermore, the single fatal case (a patient from the Evelina 
Children hospital) had genotype 1 C2 infection. It is therefore important that potential 
pathogenic differences between EV71 genotype 1 are investigated further. 
3.1.4 EV71 replication 
EV71 enters into cells via specific receptors: human P-selectin glycoprotein ligand 1 
(PSGL1) and scavenger receptor B2 (SCARB2) (De Jesus et al., 2005, Herrero et al., 2003). 
After infection of the host cells the viral genomic RNA is released into the cytoplasm, where 
it is directly translated into a polyprotein. The 5′ untranslated region contains an internal 
ribosome entry site (IRES) which mediates translation in a cap independent manner of a 
single polyprotein Figure 46. This precursor polyprotein is subsequently processed into four 
structural (VP1, VP2, VP3 and VP4) and seven non-structural (2A, 2B, 2C, 3A, 3B, 3C and 
3D) proteins by virus-encoded proteases 2A
pro
 and 3C
pro
. The non-structural proteins are 
involved mainly in the replication of the viral RNA. For virus RNA replication, a 
complementary minus-strand RNA is synthesised in the cytoplasm and then this minus-strand 
RNA serves as template for new plus-strand RNA molecules. Newly synthesised virus RNA 
may go into another round of translation and replication, or is packaged into capsid proteins 
to produce infectious viral particles (Zoll et al., 2009).  
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Figure 46: EV71 IRES element. 
Translation initiation of EV71 RNA is dependent on the IRES element within the 5′ UTR, 
which consists of six domains designated I-VI and is mapped between nucleotides 129 and 
636.  
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The IRES-mediated translation initiation of EV71 depends on the recognition of the IRES by 
some of the canonical translation initiation factors.  EV71 IRES is a Type I IRES (Section 
1.5.1); this implies that it also requires eIF4A, eIF2, eIF3, and ATP in order to assemble the 
48S complex for translation initiation. The Type I IRES elements (those of the enteroviruses 
and rhinoviruses; e.g., PV and human rhinovirus (HRV) have also been reported to be 
inefficient in driving translation initiation in the absence of certain cellular proteins 
(Fitzgerald and Semler, 2009). The generation of a proper secondary and ternary structure, 
including several stem-loops, is therefore crucial for internal translation initiation driven by 
the picornavirus IRESs. To this end, IRES-dependent translation requires a number of trans-
acting protein factors, collectively known as IRES-specific transacting factors (ITAFs), to 
recruit the ribosome and initiate translation (Section 1.5.2.1.). These proteins may serve as 
IRES chaperones, binding to RNA across multiple domains and stabilising the entire IRES in 
a structure that is suitable for binding translation initiation factors, and ribosomal subunits 
(Pilipenko et al., 2001).  
3.1.5 The EV71 IRES element 
The EV71 IRES is highly structured and has 745 nucleotides. The boundaries of the IRES 
have been mapped to nucleotides 129-636. Structural analysis has revealed that the EV71 
IRES folds into six domains (I-VI; Figure 46).  The IRES activity is embedded within 
domains II-VI and the authentic initiating codon (AUG) is located 109 nucleotides 
downstream of domain VI. Studies have shown that the virulence associated determinant of 
translation in EV71 5′-UTR in vivo, is located within the SLII of the IRES element (Yeh et 
al., 2011). Virulence associated determinants of other enteroviruses have been reported. For 
example, nucleotide 480, 481 and 472 in poliovirus 5′-UTR were cited as neurovirulence 
determinants of poliovirus Type 1, 2 and 3, respectively (Evans et al., 1985), (Guillot et al., 
1994), (Rezapkin et al., 1999). A single adenine (A) to guanine (G) change at nucleotide 103 
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in 5′ UTR was found to attenuate poliovirus neurovirulence (De Jesus et al., 2005). Also, SL 
II in 5′-UTRs of coxsackievirus (CV) B1 and B3 determined the cardiovirulence (human 
inflammatory heart disease, a condition which may lead to dilated cardiomyopathy and heart 
failure) (Dunn et al., 2003, Tu et al., 1995, Rinehart et al., 1997).   
The EV71 IRES as has been previously stated is a Type I IRES. The interactions of Type I 
elements with initiation factors in translation initiation has been subject to recent study. Work 
done by (de Breyne et al., 2009) has suggested that the binding of initiation factors 
eIF4G/eIF4A onto the IRES is a key step in initiation on Type I IRES. Despite some 
mechanistic conservation, sequence and secondary structures are poorly conserved between 
Type I and Type II IRESs, except for the Yn- Xm-AUG motif at the 3′-border of each IRES, 
in which a Yn pyrimidine tract (n = 8–10 nt) is separated by a spacer (m = 18–20 nt) from an 
AUG triplet. Consequently, the binding sites for eIF4G in domain V in Type I IRESs and in 
domain J in Type II IRESs are not homologous. 
Using directed hydroxyl radical cleavage and enzymatic foot printing techniques, (de Breyne 
et al., 2009) reported that eIF4G recognised several elements within domain V of EV71, and 
that it bound to this domain independently of any other factors, as well as a small element 
within domain IV (Figure 47). It was shown  that domain V of Type I IRESs, which is 
adjacent to the Yn-Xm-AUG motif, specifically interacted  with the central domain of eIF4G 
(de Breyne et al., 2009). The position and orientation of bound eIF4G relative to the Yn-Xm-
AUG motif was found to be analogous in Type I and Type II IRESs. This finding was 
significant in that it seemed to suggest that, as with Type II IRESs, eIF4G could recruit 
eIF4A to Type I IRESs, and eIF4A may in turn enhance the eIF4G Type I IRES interaction. 
Indeed, it was observed that eIF4G promoted the recruitment of eIF4A to Type I IRESs, and 
that together with eIF4A induced conformational changes in domain VI, at their 3′ borders.  
Toeprinting analysis showed that eIF4G and eIF4A together induced strong toeprints at the 3′ 
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border of Type I IRESs and these conformational changes could be essential for subsequent 
attachment of 43S complexes to these regions. The functional importance of this ability of 
IRESs to bind eIF4G/eIF4A was also correlated with their translational activity using in vitro 
translational assay of IRES mutants. From their results, (de Breyne et al., 2009) proposed a 
tentative model for the initiation of in Type I IRES. It was postulated that eIF4G bound to the 
IRES adjacent to the site of ribosomal entry and recruited eIF4A, which then remodelled the 
IRES so that it adopted a conformation to which a 43S complex could attach productively. 
This model was directly analogous to the proposed mechanism of initiation on Type 2 IRESs, 
which was similarly based on binding of eIF4G to a domain of the IRES adjacent to the site 
of ribosomal attachment (Kolupaeva et al., 2003). However, despite strong evidence 
suggesting that binding of eIF4G/eIF4A is a key step in initiation on Type I and II IRESs, it 
is not sufficient for the recruitment of 43S complexes and  additional factors/domains are 
required (Kolupaeva et al., 2003).  
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Figure 47: Interaction of eIF4G with EV71 Type I IRES domain IV and V. 
Binding sites on EV71 determined from hydroxyl radical cleavage of eIF4G highlighted in 
red within domain IV and yellow within domain V. This figure was originally published in 
PNAS (de Breyne et al., 2009). 
 
 
 
Recently, (Sweeney et al., 2014) reported the first reconstitution in vitro of initiation on three 
distinct Type I IRESs from poliovirus (PV), enterovirus 71 (EV71), and bovine enterovirus 
(BEV) (Sweeney et al., 2014). These studies were the first to report identification of initiation 
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factors and ITAFs sufficient for the accurate and efficient 48S complex formation on Type I 
IRESs, establishing the outline of the mechanism of this process.  
Using toeprinting analysis of 48S complex formation on Type I IRESs, the minimal set of 
factors that promote 48S complex formation on three distinct Type I IRESs (PV, EV71 and 
BEV) were determined (Sweeney et al., 2014). It was established that Type I initiation 
required eIF2, eIF3, eIF4A. Additionally, the interaction of the central domain of eIF4G with 
eIF1A and eIF4B stimulate 48S complexes formation. However for EV71, eIF1 increased the 
fidelity of initiation at the authentic start site; but this was accompanied by an overall 
reduction in the level of 48S complex formation. All three IRESs require a single common 
ITAF, poly(C) binding protein 2 (PCBP2). This was consistent with earlier work by  (Walter 
et al., 2002) on PV IRES function obtained by PCBP2 depletion in cell-free translation 
extracts. As previously stated above, a key function of eIF4G in Type I and Type 2 
translation initiation mechanisms is to recruit eIF4A, which in turn leads to the induction of 
conformational changes around the 3′ border of the IRES that then to facilitated recruitment 
of a 43S complex (Kolupaeva et al., 2003). However, Sweeney, posited that a significant 
difference between initiation on these two IRES classes is that, whereas the eIF3-binding 
domain of eIF4G is not strictly required for initiation on Type 2 IRESs, it was essential for 
initiation on Type I IRESs as shown by (Lomakin et al., 2000). In addition to its essential role 
in recruiting eIF3, this eIF3-binding domain was also thought to engage in interactions with 
the IRES that stabilised binding of eIF4G/eIF4A. Although it was observed that eIF4G 
lacking this domain was able to bind to Type I IRESs and promote recruitment of eIF4A, its 
activity in this process was somewhat reduced. This observation supported earlier hypothesis 
by (Lamphear et al., 1995) that interaction of eIF4G with eIF3 was an important determinant 
of the recruitment of 43S complexes to mRNA.  Subsequent translation initiation steps 
mediated by Type I IRES were observed by (Sweeney et al., 2014) to vary between IRESs, 
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depending on the stability of dVI. It was noted that if the dVI was unstructured, for example 
in BEV, ribosomes scanned through dVI to the initiation codon, requiring eIF1 to bypass its 
AUG. However, if the IRES dVI were structured, as in PV and EV71, most initiation events 
occurred without inspection of dVI, implying that the AUG did not determine ribosomal 
attachment (Sweeney et al., 2014). 
3.1.6 Cellular factors interacting with 5′UTR of EV71 
It is well accepted that cellular factors, ITAFs, can mediate IRES activity during viral 
infections (Section 1.5.2.1). Using a pull down assay consisting of streptavidin beads to 
capture cellular proteins, from human glioblastoma cells (SF268), bound to a biotinylated 
EV71 5' UTR,  (Lin et al., 2009) identified 14 cellular proteins which interacted with the 5′ 
UTR of EV71. Further analysis confirmed the interaction between hnRNP K and hnRNPA1, 
which contains respectively three KH domains (KH1 to KH3) and two RRM domains 
(RRM1 and 2), the two most common types of protein RNA-binding domains.  
Amongst the other ITAFs identified, FUSE-binding proteins (FBP) 1 and FBP2 have been 
subjected to the most characterization. FBPs are a family of RNA and DNA binding proteins 
named after their interaction with the far-upstream element (FUSE) of the c-myc gene. Three 
variants are known in humans: FBP1, FBP2, and FBP3, and they display strong primary 
sequence and predicted secondary structure homology displaying distinct functional KH 
domains. 
FBP2, also known as hnRNP K-homology(KH)-Type I Splicing Regulatory protein (KSRP), 
in human and mouse, MARTA1 in rat, VgRBP71 in X. Laevis, and ZBP2 in chicken, is a 
universal single strand nucleic acid binding protein present in both nuclear and cytoplasmic 
compartments of the cell (reviewed in (Gherzi et al., 2004)). It was originally identified as 
both an RNA-binding protein and a transcription factor that affects RNA fates at multiple 
levels. FBP2 is organized in three distinct regions: a structured central region that includes 
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four KH domains responsible for nucleic acid binding and two N- and C-terminal low 
sequence complexity regions that contain several sites for post-translational modifications as 
well as protein-interaction motifs. 
The FBP2-binding sites on the EV71 5′ UTR, were mapped out a using a series of RNA pull-
down assays with various EV71 5′ UTR sequences highlighting that FBP2 interacted with 
several distinct regions within the 5′ UTR, namely, the stem-loop I-II region, the stem loop 
II-III region, and the stem-loop V-VI and linker regions of EV71 5′ UTR. Truncated forms of 
FBP2 were also tested in a similar assay to map the 5′ UTR-binding site(s) on FBP2. The 
results indicated that the KH2 and KH4 motifs were essential for FBP2 to bind to the EV71 5′ 
UTR (Lin et al., 2009). Furthermore FBP2 was identified as a negative regulator of EV71 
IRES activity. Using siRNA targeting FBP2, it was found that viral protein synthesis in 
infected cells was increased when cells were depleted of FBP2 but decreased in cells in 
which FBP2 was overexpressed. The IRES activity of EV71, as indicated by the luciferase 
reporter gene assay carried out, was also increased when FBP2 was knocked down.  
FBP1, another member of the FBP family which shares a highly similar primary sequence 
and structure with FBP2, interacts with the EV71 IRES, but was also reported to interact with 
both the 3′ UTR and with NS5A of HCV(Zhang et al., 2008), and  with the 5′ and 3′ UTRs of 
Japanese encephalitis virus RNA to repress viral protein expression (Chien et al., 2011). 
Using both a RNA pull-down assay and EMSA, (Lin et al., 2009) showed that FBP1 
interacted only with the linker region (nt 637 to 745) of the EV71 IRES. The EV71 IRES-
binding site on FBP1 was mapped to the KH3 and KH4 motifs but in contrast to FBP2, FBP1 
was found to enhance the IRES activity in vitro and in cell culture (Lin et al., 2009). During 
EV71 infection both FBP2 and FBP1 are relocalised from the nucleus to the cytoplasm where 
they would compete for binding onto the EV71 IRES in order to modulate IRES-mediated 
translation in infected cells. However, it is yet unknown whether both proteins binds to the 
152 | P a g e  
 
IRES with similar affinity or whether the binding of one is sufficient to displace the binding 
of another.  Furthermore preliminary studies from the Shih laboratory (Chang-Gung 
University; Taiwan) suggested that FBP1 could act as a general ITAF for other IRES, such as 
the cellular BiP IRES.  
 
3.2 CHAPTER AIMS AND OBJECTIVES 
 
The mechanism underlying the regulation of EV71 IRES activity by FBP1 and FBP2 is 
unclear. It is yet to be elucidated how these two very similar proteins compete with each 
other for binding to the linker region of the EV71 5′UTR (nt 637 to 745) but have opposite 
effects on EV71 IRES activity and presumably on viral replication. The ability to monitor 
and quantify RNA binding in vitro using purified recombinant protein would advance our 
understanding of this process. To understand how the FBP2 acts during internal ribosome 
entry mediated by the EV71 IRES, I will characterize the interaction of FBP2 with IRES 
elements such as EV71 and BiP in an in vitro system.  
Furthermore EV71 infection can be presented as HFMD without any neurological 
complications but can also lead to severe complications and ultimately death. As an RNA 
virus, small genetic changes can occur frequently within the EV71 genome as each 
replication cycle produces an estimated one mutation per new virus copy (Huang et al., 2008, 
Bible et al., 2008). This could suggest that a viral genetic determinant may mediate 
neurological pathogenesis of severe disease caused by EV71. The broad spectrum of clinical 
outcome reflects the existence of multiple strains, suggesting genetically divergent EV71 
strains may possess different pathogenic properties. Support for this view can be found in the 
clinical epidemiology of EV71. Epidemics of HFMD in Malaysia, Singapore and Western 
Australia have been associated primarily with genogroup C1 strains (4), whereas genogroup 
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C2 outbreaks in Malaysia and Taiwan have been associated with severe and fatal 
neurological associated disease (Ho et al., 1999, Herrero et al., 2003). Neurovirulent 
determinants have been found in other enteroviruses. In the best known-example, the 
poliovirus type 3 Sabin oral poliovirus vaccine strain P3/Leon/12a1b differs in nucleotide 
sequence from its neurovirulent progenitor P3/Leon/37 by just 10 point mutations (Westrop 
et al., 1989). In addition, all three Sabin strains are affected by mutational changes occurring 
in the highly structured internal ribosome entry site (IRES) within the 754nt of the 5′ UTR, 
causing translational defects, failure to initiate viral replication, and prevent the Sabin vaccine 
strains from causing poliomyelitis (Guest et al., 2004). Similarly the sequence integrity of the 
5’ UTR is required for the cardiovirulence of Coxsackie B3 virus and replication of 
Echovirus 12 (De Jesus et al., 2005).  
To understand the genetic differences between EV71 strains associated with benign 
cutaneous disease and those with severe neurological complications, I will dissect the effect 
of mutations present in pathological EV71 cases on the recruitment of translation factors and 
ITAFs to the EV71 IRES. 
 
Therefore the specific objectives were:  
 To design and purify affinity-tagged FBP2 constructs. 
 To assess in vitro the binding of recombinant FBP2 to IRES elements.  
 To engineer recombinant EV71 IRES RNA containing mutations found in 
pathological EV71 cases to monitor the effect of these mutations on translation. 
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3.2 MATERIAL AND METHODS 
3.2.1 Clinical samples 
32 full length EV71 isolates from the UK collected by two UK National Reference 
Laboratories since 1998 were characterised at the St Thomas’ Hospital (Pathology 
Department, London) by RNA sequencing. In addition, the full length sequences of 19 
isolates from the Far East which belong to a more recent genetic lineage genogroup C4 were 
also determined (see Appendix 2). 
3.2.2 Plasmid constructs 
 
FBP2 RNA binding domains, KH1-KH4 and KH2-KH3 (Figure 18), were cloned into a 
pET30 plasmid vector (Novagen, EMD Biosciences, Darmstadt, Germany) using 
conventional cloning techniques (Zerbs et al., 2014).  
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Figure 48: Schematic of the EV71 genome showing the KH domains. 
 
3.1.2 Competent cell preparation 
 
 
  
 
      N-term HindIII                  KH2- KH3        6x His       Nco I TEV GST 
C-term 
pETM-30 
 
      N-term HindIII                  KH1- KH4        6x His        Nco I TEV GST 
C-term 
pETM-30 
 (A) Schematic of FBP2, showing KH domains used for preparation of constructs. (B)  
Cloning schematic used for the preparation of tagged full length FBP2 proteins. GST 
represents glutathione S-transferase affinity tag and 6xHis a Histidine affinity tag. Each 
construct had a TEV protease recognition site (C) Cloning schematic for the preparation 
of   tagged proteins with central RNA binding domains of FBP2. 
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3.2.3 Transformation and Over-expression of FBP2 in Escherichia coli 
 
50 μL of competent BL21 DE3 cell suspension and 1 μL of the plasmid DNA were directly 
mixed in an eppendorf tube on ice for 30 min (Section 2.3.7). Heat shock and quick cooling 
steps were subsequently accomplished by placing the tube in 42°C water bath for 45 seconds 
and ice for 2 min, respectively. 500 μL of the fresh LB medium was added and after 
incubation at 37°C for 45 min in a shaker incubator with a rotary speed of 225 rpm, the 
resulting bacterial solution was centrifuged at 3500g for 5 min. The pellet was resuspended 
by pipetting and plated on an agar-LB plate (Section 2.3.7) with kanamycin (50 μg/ml) 
overnight at 37
o
C. 
From the transformation plates single colonies were picked and grown overnight at 37
o
C in 5 
ml LB broth plus kanamycin (50 μg/ml) to generate starter cultures. Subsequently, FBP2 
expression was induced by 0.1mM IPTG (Invitrogen™) of these starter cultures as outlined 
previously (Section 2.3.7), and subsequently confirmed by SDS PAGE analysis. 
3.2.4 GSH affinity purification of overexpressed FBP2 proteins 
Small-scale GST-Tag purification under native conditions of stored (-80
o
C) FBP2 pellets was 
carried out as described previously (Section 2.3.10). Briefly, IPTG-induced cell pellets were 
thawed on ice and lysed in 10 ml protein extraction reagent (Bugbuster® Novagen with 100 
μl of 10 mM PMSF protease inhibitor) and kept at room temperature for 10 min. The cell 
suspension was transferred into 30 ml Corex® tubes and centrifuged at 21,000g (Beckman 
J2/E centrifuge) for 30 min at 4
o
C. The resulting supernatant was filtered through a 0.45 μm 
filter unit (Steriflip®) and the filtrate stored on ice until use. 
Glutathione Sepharose beads (GST-bind resin™, Novagen) were prepared in 15 ml falcon  
tube by mixing 2 ml of the beads with 10 ml phosphate buffered saline (PBS)  and 
centrifuging the suspension for 2 min at 500g.  The supernatant was discarded and filtered 
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FBP2 protein extract was added to the prepared Glutathione Sepharose beads for affinity 
binding overnight at 4°C. Subsequently, elution of the FBP2 and removal of affinity tags 
from the recombinant proteins was achieved, firstly  by site-specific endo-proteolysis, of 
fusion FBP2 protein on the  column using TEV protease™  (Invitrogen, 2 mg/ml in 25 mM 
Tris-HCl, pH 8.0).  
3.2.5 Ni affinity chromatography purification of overexpressed FBP2 proteins 
Purification of cleaved FBP proteins was achieved by Nickel affinity chromatography using  
 6XHistidine tags. This was achieved by affinity-flow chromatography using pre-packed 
nickel-histine, HIS-Select® Spin columns (Sigma-Aldrich) following the manufacturer’s 
protocol. 
For large scale purification, immobilized-metal affinity chromatography, using HisTrap HP 
columns (GE Health Care life Sciences), in a BioRad Dual Flow® FPLC instrument was 
carried out. Binding buffer (300 mM NaCl, 25 mM Tris-HCl pH 7.4, 1 mM DTT, 10% 
Glycerol), Elution buffer (300 mM NaCl, 25 mM Tris-HCl pH 7.4, 1 mM DTT, 10% 
Glycerol, 250 mM Imidazole) for column equilibration and elution were prepared. The 
HisTrap column was initially equilibrated with 5 column volumes of binding buffer at a flow 
rate of 5 ml/min and the sample was then applied. The protein was eluted with five column 
volumes of elution buffer and fractions collected were analysed on SDS-PAGE.  The SDS–
PAGE was carried out based on the procedure of Laemmli and Favre (Laemmli and Favre, 
1973) with some modifications, using a 12% resolving gel and a 4% stacking gel. At the end 
of the electrophoresis, the gel was stained with Coomassie Brilliant Blue. 
3.2.6 In vitro transcription of Enterovirus 71 RNA 
 
DNA plasmid (2 ng/µl) encoding the EV71 IRES (Lin et al., 2009) was linearised with EcoRI 
and used as template for amplification using a 5′ forward primer coding a T7 promoter 
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sequence: 5′-TAATACGACTCACTATAGGG-3′  and a 3′ primer complementary to the 
IRES 3′ end : 5′-AGAGAGGGCTCAGCACGAGTGTAG-3′.  
Subsequently 400 µl PCR reaction mix consisting  of  GoTaq 5X buffer (Promega), Forward 
and Reverse Primers (10 mM), DNA (1 pg/µl), NTP mix (10mM) and GoTaq polymerase 
(0.5 U/ml; Promega) was formulated.  The following thermocycler parameters were used: 
  
PCR parameters  
94
o
C  1 min 30 s 
94
o
C  30 s 
55
o
C  30 s 
72
o
C  1 min 
72
o
C  4 min 
8
o
C  end 
 
The PCR product was phenol/chloroform extracted and used as template for a transcription 
reaction. The synthesis of RNA transcript was based on reaction mix composed of nucleoside 
triphosphates (1.25 mM ATP, 1.25 mM CTP, 1.25 mM GTP, and 1.25 mM UTP), vector 
DNA and 1 U/ml of T7 RNA polymerase, 0.5 U/ml RNase inhibitor (Promega), which was 
incubated at 37
o
C for 2 h. Residual DNA was removed by adding DNase RqI 2U/ml 
(Promega) for 20min at 37
o
C.  Standard ethanol precipitation followed by MicroSpin G-50 
Column (GE Healthcare Lifesciences) purification was used to clean the RNA transcript 
which was then confirmed on a 1% (Tris/Borate/EDTA) agarose gel electrophoresis.  
3.2.7
 32
P-pCp 3' End-labelling of RNA 
 
3’-end labelling  of RNA was achieved following protocols adapted from methods described 
by Uhlenbeck  using  T4 RNA ligase with 3',5'[5'-
32
P]pCp (Uhlenbeck and Gumport, 1982).  
Briefly, the following components were combined in a single RNase-free microfuge tube: 
10xT4 polynucleotide kinase buffer, 26 mM Cp, [γ 32P]-ATP, PNK enzyme, 5 units. These 
25 cycles 
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were incubated 37
o
C for 1 hr, then at 95
o
C for 3 min. Subsequently the following were added 
to the reaction to 3' end-label the RNA; 75 mM MgCl2 , 250 mM HEPES, pH 7.5, 1 µM 
RNA, ATP 1 mM, T4 RNA ligase, 10 units. The components were incubated overnight at 
4
o
C and diluted to 50 µl with water. The resulting radiolabeled RNA was spun through a G-
50 column spin column to remove unincorporated radioactivity. 
3.2.8 Filter binding assay  
 
Filter binding assay, was performed to characterize protein-RNA interactions. Binding buffer 
consisting of 20 mM Tris pH 7.6, 100 mM KCl, 2 mM MgCl2 and 2 mM DTT was prepared.  
Radioactively labelled RNA was diluted 1:200 in binding buffer, and a serially diluted range 
of FBP2 proteins in binding buffer were prepared. Pre-soaked filter membranes (3MM filter 
paper, Nitrocellulose and charged nylon) were placed carefully on the filtration manifold 
ensuring that excess binding buffer is removed. The binding reactions were then applied to 
the 96-well dot-blot apparatus with low vacuum to trap the complexes on the three 
membranes:  The top membrane (Whatman 3MM) traps aggregates, the middle nitrocellulose 
membrane (Life technologies) binds proteins and RNA–protein complexes, and the bottom 
nylon membrane (Millipore) collects free RNA. The blot were then exposed on phosphor 
screen (BioRad) and scanned on a phosphorImager. 
 
3.2.9 EMSA (gel shift assay) 
Electrophoretic Mobility Shift Assay (EMSA) was performed to characterize protein-RNA 
interactions. EMSA is based on the observation that complexes of protein and DNA/RNA 
migrate through a non-denaturing polyacrylamide gel more slowly than free DNA/RNA 
fragments or double-stranded oligonucleotides (Hellman and Fried, 2007). The gel shift assay 
was performed by incubating purified 1 µM FBP2 protein with 1µM. 
32
P end-labelled RNA 
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containing the putative protein binding site for 15 min at 37
o
C, in binding buffer (20 mM 
Tris, 50 mM NaCl, 0.2 mM EDTA and 1g/l tRNA as competitor RNA). A 1% gel in 0.5X 
TBA buffer was run for 2 hr at 100V and subsequently vacuum dried before exposing on 
phosphor screen (BioRad) and scanning the screen on a phosphorImager. 
3.3.10 Biotinylated RNA binding assays 
 
Two strategies were adopted for the preparation of biotinylated EV71 RNA which were then 
used as probes in pull down interactions. The first strategy involved the construction of 
chimeric mRNA–DNA bait harbouring a biotin molecule at its 3' end in a one-step ligation 
process Figure 49. EV71 RNA (100 picomoles) was ligated to equimolar quantities of 
biotinylated DNA oligonucleotide [5'-CTCCTCCTCCTC(A)6-3'] with a single biotin 
molecule bound to the 3'-terminal A, in the presence of two different DNA splints, 5'-
(GAG)4GT(GTT)4-3' and 5'-(GAG)4NGT(GTT)4-3'. EV71 mRNA was heated together with 
the biotinylated DNA and two DNA splints, at 90
o
C for 2 min in 30 mM Tris/HCl (pH 7.8), 
10 mM MgCl2 and 10 mM DTT and cooled progressively for 10 min at room temperature 
(20
o
C). After hybridization, 10 units of T4 DNA ligase (Promega) and 100 mM ATP were 
added and incubated 4 h at 30
o
C. 
For the second strategy biotinylated RNA was prepared using Biotin RNA labelling mix kit 
(Roche Applied Science), following manufacturer’s specified protocol and used as a probe in 
pull down interactions. Briefly, 10X mix of 10 mM each ATP, CTP, GTP, 6.5 mM UTP, 3.5 
mM Biotin-16-UTP, and pH 7.5 was used. A standard labelling reaction; 1 µg linear template 
DNA, 50mM DTT, RNAsin 0.5 U/ml, 10X buffer (100 mM spermidine, 1 M MgCl2, 1 M 
Tris pH8.0) was mixed with T7 polymerase and incubated at 37
o
C for 2 hr. The resulting 
biotinylated RNA was ethanol precipitated and spun through a G-50 column spin column. 
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Figure 49: Biotinylation of EV71 RNA. 
The strategy, involved a one-step ligation of chimeric mRNA–DNA bait harbouring a biotin 
molecule at its 3' end to EV71 RNA. 
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RNA binding proteins were pulled down from HeLa cytoplasmic lysate using biotinylated 
RNA immobilised onto a support containing streptavidin. This was achieved with magnetic 
Streptavidin M280 Dynabeads® Invitrogen, in a bead binding assay as follows: The beads 
were initially blocked for 1 hour in IP buffer (100 mM Tris pH 8.0, 150 mM NaCl, 1 mM 
EDTA, 5% glycerol, 1 mM DTT, 0.1 mg/ml tRNA, Roche Complete mini EDTA free tablet) 
then combined with 10 pmoles of biotinylated RNA and 25 mg/ml HeLa cytoplasmic extract 
in IP buffer supplemented with 2 units of DNAse Rq I (Promega). The bead/lysate mixture 
was incubated at 25 °C for 30min at 950 rpm then washed 4 times with 750 µl of IP buffer at 
4°C.  The eluates were recovered on a magnetic stand in 2X Laemmli loading buffer, and 
then denatured at 95 °C for 5min. Protein RNA interactions were detected using western blot.  
20 µl of protein were used for 12% polyacrylamide gel electrophoresis at 100V for 1 hour. 
Following SDS PAGE, proteins were transferred the  to an Immobilon®-P membrane using a 
wet blot transfer system (Biorad) set at 100V for 90min in transfer buffer (25 mM Tris , 192 
mM glycine, 20% methanol). The membrane was incubated with blocking buffer (5% Marvel 
in 1x TBS-Tween) for 1 hr prior to incubation with specific primary antibodies at 
concentrations shown in Table 10. Secondary antibodies in concentrations outlined in table 3, 
were applied for 1 hour at room temperature and the blot was subsequently washed three 
times with TBS–Tween. Visualisation of the blot was carried out with chemiluminescent 
substrate SuperSignal®, West Pico (Thermo Scientific) and the blot subsequently exposed on 
radiographic film (Fujifilm). 
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Table 10: Antibodies and dilutions used for Western blot analysis. 
 
 
 
 
 
  
Antibody Antibody dilution Manufacturer 
   
S6 ribosome 1:1000 Cell Signaling Technology® 
HRP- coupled 
goat anti-rabbit 
1:2000 Dako Denmark A/S 
   
FBP2 1:1000 Cell Signaling Technology® 
HRP- coupled 
goat anti-rabbit  
1:2000 Dako Denmark A/S 
   
eIF4A 1:2000 Dr Simon Morley 
HRP- coupled 
goat anti-rabbit 
1:2000 Dako Denmark A/S 
   
eIF4E 1:2000 Dr Simon Morley 
HRP- coupled 
goat anti-rabbit  
1:2000 Dako Denmark A/S 
   
eIF4G 1:2000 Dr Simon Morley 
HRP- coupled 
goat anti-rabbit 
1:2000 Dako Denmark A/S 
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3.3.11 Site directed mutagenesis of EV 71 RNA 
Point mutations in the eIF4G binding domains IV and V of EV71 RNA were introduced 
using QuikChange® Site-Directed Mutagenesis Kit (Agilent Technologies) following 
manufacture’s protocol. Table 11 gives details the primer sequences used in the mutagenesis 
protocol.   
Table 11: Primer sequences used in site directed mutagenesis. 
 
Complimentary oligonucleotides containing the desired mutations were synthesised using the 
ds DNA templates, as described in the manufacturers. Briefly, the reaction mixture consisted 
of: 10X reaction buffer, 5–50 ng of dsDNA template, 125 ng of oligonucleotide primer 1, 125 
ng of oligonucleotide primer 2, dNTP mix and 1 μl of PfuTurbo DNA polymerase (2.5 U/μl). 
Each reaction was cycled in a thermocyler using the parameters: 
 
95°C 30 seconds 
95°C 30 seconds 
55°C 1 minute 
72°C 30sec 
  4°C 2 minutes 
 
 
 
 
1.0 µl of Dpn I restriction enzyme (10 U/μl) was added directly to each PCR amplification 
reaction and thoroughly mixed. The reaction mixtures were then incubated at 37°C for 1 hour 
Mutations Primer sequences Primer parameters 
  %GC Tm (bp) 
UCU/CCU 
Forward: 5' GTAACGGGTAACCCTGCAGCGGAAC 3' 
Reverse: 5' GTTCCGCTGCAGGGTTACCCGTTAC 3' 
60 
60 
75.1 
75.1 
25 
25 
   
GCA/GUA 
Forward: 5' CGGGTAACTCTGTAGCGGAACCGAC 3' 
 Reverse: 5' GTCGGTTCCGCTACAGAGTTACCCG 3' 
60 
60 
75.1 
75.1 
25 
25 
   
CGU/CGC Forward: 5' CACGGGCGACCGCGGCGGGGCTGC 3' 
Reverse: 5' GTCCCCGCTGGCGCCGCCCCGACG 3' 
88 
88 
 
71 
71 
24 
24 
   
12 cycles 
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to digest the parental supercoiled dsDNA. 1 μl of the Dpn I-treated DNA from each control 
and sample reaction was transferred to XL1-Blue supercompetent cells. The reactions were 
then incubated on ice for 30 min. The transformation reactions were heat-pulsed for 45 
seconds at 42°C and then placed on ice for 2 min. 0.5 ml of NZY+ broth was added and 
preheated to 42°C. The transformation reactions were incubated at 37°C for 1 hour with 
shaking at 225–250 rpm then plate out on LB agar plates containing the ampicillin (10 
mg/ml). The transformation plates were then incubated overnight at 37°C and resistant 
colonies picked for plasmid DNA extraction. The QIAprep Miniprep system was used for the 
purification of plasmid DNA. A single colony from a freshly streaked LB Amplicilin plate 
was inoculated to a culture of 5ml LB medium containing ampicillin (10 mg/ml) and 
incubated for 12–16 h at 37°C with vigorous shaking. The bacterial cells were harvested by 
centrifugation at (6800 g) in a conventional, table-top microcentrifuge for 3 min at room 
temperature. The pelleted bacterial cells were then subjected to a series of treatments as 
described in the QIAprep Miniprep Handbook to elute purified DNA. The DNA from three 
separate colonies was then sequenced to confirm incorporation of the mutations. 
 
3.4  RESULTS 
 
3.4.1 FBP2 expression in E. coli cells. 
To enable isolation of sufficient amounts of protein material for functional studies FBP2 
constructs designated KH14 and KH23 allowing the overexpression of recombinant protein 
corresponding to KH1-KH2-KH3-KH4 and KH2-KH3 were designed by Dr Nicolas Locker. 
These constructions allow for the overexpression of FBP2 KH domains fused containing a C-
terminal Histidine tag and separated by a TEV cleavage site from a GST tag Table 12. The 
pET30 vector system was developed for the cloning and expression of recombinant proteins 
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in E. coli. It is based on the T7 promoter-driven system originally developed by Studier and 
colleagues (Fitzgerald and Semler, 2009). Our vector backbone contained an origin of 
replication (pBR322 ori), an ampicillin resistance gene (Amp r), and a strong promoter 
(Ptac), which was kept in the “off” state by the lac repressor (lacI q). Addition of Isopropyl β-
D-1-thiogalactopyranoside (IPTG) inactivated the lac repressor and permitted activation of 
the promoter. The GST gene was located downstream of the promoter. 
  
FBP2 constructs were first transformed into Rosetta E.coli strain in 0.5 litre cultures. The 
cells were induced for overexpression of FBP2 fusion proteins by the addition of 200 µl of 
0.1 M IPTG From the resulting SDS-PAGE analysis it was observed that both FBP2 
recombinant proteins were overexpressed efficiently Figure 50. Clear distinct bands 
corresponding to the expected 46kDa KH23 and 58kDa KH14 fusion protein were observed 
after staining gels with Safeblue® when comparing the lanes for before IPTG (-) vs lanes 
after IPTG (+) induction. 
 
 
Table 12: Expected fusion protein sizes from cloning. 
 
 
 
 
 
 
Code Plasmid Fusion protein  Size 
KH14 pETM-FBP2-His-TEV-GST RNA binding domains,KH1-KH4  58 kDa 
KH23 pETM-FBP2-His-TEV-GST RNA binding domains,KH2-KH3     46 kDa 
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Figure 50: Over expression of FBP2 proteins in E.coli. 
SDS-PAGE analysis of FBP2 proteins expression E.coli (A) 46 kDa FBP2(KH2-KH3) fusion 
protein encoding rna binding domains KH2-KH3 was efficiently expressed in E.coli cells 
after IPTG induction (+).(B) 58 kDa FBP2(KH1-KH4) fusion protein encoding rna binding 
domains KH1-KH4 was efficiently expressed in E.coli cells after IPTG induction (+). Lane 1 
is the molecular weight maker; Lane 2 shows the profile of proteins in E.coli cells before 
IPTG induction, Lane 3 shows the profile of proteins after IPTG induction of E.coli cells. The 
gels were stained with Safeblue® stain to visualise the protein bands. 
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3.4.2 Protein purification of FPB2 fusion proteins using GSH affinity chromatography 
 
To enable characterisation of interactions between FBP2 protein and the EV71 IRES, the 
recombinant fusion protein was purified using first GSH-affinity chromatography. This step 
was design to isolate the fusion protein from the total bacterial lysate. SDS PAGE analysis of 
GSH-affinity purification of KH14 shows that the expected 58kDa protein was efficiently 
extracted from the bacterial lysate Figure 51. Subsequently the GST tag was separated from 
the KH14 using a TEV protease cleavage. It can be observed on Figure 51 that the full 
cleavage of the fusion proteins was achieved after 9h. The same purification protocol was 
applied to the fusion protein FBP2 KH23 and gel analysis shows the presence of the cleaved 
23kDa protein Figure 52. It can be noted that for FBP2 KH23 the cleavage of the fusion 
KH23-GST was incomplete despite several addition of TEV protease and increased 
incubation time, which hinted to the fact the accessibility of the TEV cleavage site might not 
be optimal in this construct.  
To further recover the cleaved KH14 and KH23 proteins from the mixture containing either 
the cleaved GST tag, recombinant TEV protease or any uncleaved KH23-GST fusion, the 
samples were applied to a second GSH affinity chromatography purification. This time the 
desired KH14 and KH23 would be present in the unbound fractions while the either proteins 
would remain bound to the beads through their GST tag. SDS-PAGE analysis of the 
purification shows that a significant amount of GST was removed from the FBP2 sample 
(input vs FT lanes), however some GST tag still remained in the flow-through fraction 
contaminating the KH23 protein Figure 53. 
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Figure 52: Extraction of FBP2 protein from E.coli 
Elution of 46 kDa GST-FBP2 protein encoding RNA binding domains KH2-KH3 in lanes 
E1.The efficiency of the extraction was quite high when comparing the input lane to the 
elutions in E1. Lane FT represents flow through and W1, W2 represent the two wash steps in 
the protocol. Lane E2 represents subsequent cleavage of the FBP2 protein eluted in E1 with 
TEV protease. A 23 kDa FBP2 protein encoding rna binding domains KH2-KH3 was 
observed on visualisation of the gel with Safeblue® stain (E2). 
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Figure 53:  Purification of the FBP2 protein. 
SDS-PAGE analysis of strategy employed to the use of GST tag to immobilise the unbound 
GST in the sample on glutathione resin, then collected the FBP2 (KH2-KH3) as flow through 
(FT). The red rectangle indicates GST still retained in the FBP2 sample. Inputs 1 and 2 refer 
to uncleaved and cleaved FBP2 proteins respectively. 
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3.4.3 Purification of overexpressed FBP2 proteins using GSH affinity chromatography 
followed by Ni affinity chromatography 
 
Given that the GSH affinity chromatography did not yield pure enough proteins we 
implemented an additional purification step based on the presence of the 6XHis affinity tag at 
the C-terminal end of the KH23 and KH14 proteins. First, the KH14-GST and KH23-GST 
were separated from bacterial lysate using GSH affinity chromatography as described above. 
Then the GST tag was separated following cleavage of the fusion protein by the TEV 
protease. Subsequently the elution fractions were subjected to Ni affinity chromatography. 
Only the cleaved KH23 and KH14 proteins should be able to bind the Ni-NTA matrix and 
therefore should be selectively eluted upon addition of imidazole. Analysis of the eluted 
fraction indeed shows that much cleaner KH23 and KH14 proteins were obtained with this 
strategy Figure 55. The protocols were then scaled up in a larger culture to enable collection 
of sufficiently large enough quantities for the interaction studies. 
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Figure 54: Schematic for the purification of FBP2 protein. 
1. Strategy employing only the use of GST tag to immobilise the unbound GST present in the  
sample on glutathione resin, then collect the FBP2(KH1-KH4) as flow through. 2. Both GST 
and His affinity tags are were used for protein purification. The protein was first incubated 
with GST resin, then the flow thorough applied to Ni-NTA resin and subsequently eluted 
with imidazole. 
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Figure 55: Affinity tag purification of FBP2 proteins. 
A scaled up two step purification of FBP2 proteins using GST and Histidine affinity tags. (A) 
A 23kDa FBP2 (KH2-KH3) protein was collected as flow through FT. Input refers to cleaved 
FBP2 (KH2-KH3). (B) 46kDa KH1- KH4 was collected as FT after purification steps. Input 
refers to cleaved FBP2 (KH1-KH4) SDS PAGE gel analysis shows that both FBP2 proteins 
were efficiently purified by this strategy as most of the contaminants were removed  
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3.4.4 RNA-Protein interactions assayed by EMSA. 
   
Previous studies using bead-binding assays demonstrated that the EV71 IRES was able to 
bind to FBP2 in cell lysates (Lin et al., 2009). Further assays using overexpressed FBP2 
proteins in cells demonstrated that while FBP2 proteins containing KH1-KH2-KH3-KH4 and 
KH2-KH3-KH4 domains could bind to EV71 IRES, KH1-KH2-KH3 and KH3-KH4 did not 
(Lin et al., 2009). This suggested that the minimal IRES binding domain might reside within 
the KH2-KH3 domains.  
To characterize FBP2-RNA interactions in vitro we first used EMSA in the presence of either 
KH14 or KH23 recombinant proteins, and 
32
P-labelled IRES RNA namely BiP IRES and 
EV71 IRES. The BiP IRES was included in the assay as preliminary experiments from our 
collaborators suggested that BiP IRES activity is enhanced during EV71 infection.  
32
P labelled RNA (0.5 or 1pM; BiP or EV71 IRES) was incubated with 5µM FBP2 at 37
o
C 
for 20 min to allow for RNA/protein complex formation and the reaction was analysed on 8% 
native gel electrophoresis. Analysis of the results shows the formation of low mobility 
complexes upon incubation of KH14 to the EV71 or BiP IRES as indicated in Figure 56.  
These results suggest that FBP2 KH14 interacts with both the EV71 and BiP IRES. 
Subsequently, to evaluate the ability of the central KH23 domains to mediate RNA binding, 
the same experiments were repeated comparing the ability of KH14 and KH23 to form RNA-
protein complexes onto the BiP IRES. Analysis of the results displayed in Figure 57 shows 
the formation of RNA-protein complexes with both KH14 and KH23, and that the amount of 
complexes formed increased upon addition of more recombinant protein (Figure 56, Figure 
57). 
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Figure 56: Interaction of  FBP2 RNA binding domains with IRES elements. Native gel 
analysis of EMSA of FBP2 (KH1-KH4) complexed with BiP and EV71 RNA in lane 2 and 
lane 4 respectively. Lane 1 and lane 3 represent unbound RNA. From the gel we can observe 
the differences in mobility between the complexes and free RNA attributable to RNA/protein 
interactions. 
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Figure 57: RNA protein interactions. 
 EMSA interactions of 5µM FPB2 with 
32
P labelled BiP RNA(0.5 or 1µM) incubated  at 
37
o
C for 20min and analysed on an 8% native gel. Intensity of mRNA bands was analysed 
with Image J software. 
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3.4.5 RNA-Protein interactions assayed by Filter binding assays. 
 
 
In order to quantitatively evaluate the ability of the KH23 protein to mediate IRES binding 
and to evaluate its specificity in vitro, I performed filter binding assays.  Different RNA 
targets were used: the EV71 and BiP IRES found to interact with KH23 by EMSA, the HCV 
IRES as another potential IRES and the CLV RNA corresponding to domain I of the EV71 
5’UTR which is implicated in replication of the EV71 RNA but does not contribute to IRES 
activity, therefore acting as a negative control (Both HCV IRES and CLV RNA were 
provided by Dr Nicolas Locker). RNA-proteins complexes were formed as for EMSA but the 
reactions were then applied to dot blot apparatus containing three different type of 
membranes, first a filter paper to remove aggregate, a nitrocellulose membrane to trap RNA-
protein complexes and a charged nylon membrane to trap free RNA.  Equal amounts of 
32
P-
labelled RNA (1-5 pM) were incubated with increasing KH23 concentrations (0 to 5µM). 
From the results presented in Figure 58, KH23 interacted with EV71, BiP and HCV IRES, 
but not with the CLV RNA, as expected. The intensity of the RNA-protein dots for different 
concentration were quantified using image J and expressed as a function of the total input 
free RNA radioactivity for each reaction. To determine the apparent dissociation constant 
(Kd), the data were fitted to a Langmuir isotherm described by the equation t= P/(P +Kd), 
where t is the fraction of RNA bound and P is either the KH23 concentration using GraphPad 
Prism. The dissociation constants are indicated on Figure 59, Table 13. This analysis 
revealed that KH23 can mediate IRES binding with an affinity in the micromolar range.  
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Figure 58: RNA protein interactions. 
Filter binding assay to characterise quantitatively, the interaction between the central domains 
of   FBP2 with BiP IRES. CLV is the control 5' UTR RNA without the IRES. These results 
suggest a concentration-dependent FBP2 protein interaction with the BiP IRES element as 
well as with its previously known partner the EV71 IRES and the HCV IRES. 
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Figure 59: Determination of dissociation constants for FBP2 IRES interactions. 
 Image densities were measured by Image J software and used to determine the percentage 
intensity of each data point relative to the control well. The Kd for EV71 interaction with 
FBP2 was 0.33µM. The results were from 3 independent experiments Table 13. 
 
Table 13: Dissociation constants of IRES elements. 
 
 
 
  
RNA Dissociation constant (Kd) µM 
  
BiP 0.44 
EV71 0.33 
HCV 0.5 
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3.4.6  Role of point mutations within the EV71 IRES in interactions with the 
translation machinery 
 
The examination of different viral RNA sequences corresponding to fatal EV71 infection 
revealed the existence of numerous differences when contrasted to BrCr reference strain. 
Close examination of two fatal cases (patients from Avelina Children’s hospital) of HFMD 
EV71 genogroup C2, sequenced by our collaborator Dr J.M Bible (St Thomas’ Hospital, 
London) revealed some of the mutations were located within the eIF4G binding site 
previously identified by  (de Breyne et al., 2009). Therefore this raised the question whether 
changes to key functional elements within the IRES could link translational activity to the 
severity of the diseases. To answer this question, site-directed mutagenesis was used to 
introduce within the EV71-BrCr reference sequence the mutations identified in domain V 
(Figure 60) and domain IV (Figure 61). Subsequently, EV71 IRES sequences, wild-type or 
mutants, were in vitro transcribed in the presence of biotinylated uridine to yield biotinylated 
RNA for bead binding assays to probe for interactions with translation factors in HeLa lysate 
(Figure 62). 
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CLUSTAL 2.1 multiple sequence alignment 
 
dV              GCACATGCTCACAAACCAGTGGGTGGTGTGTCGTAACGGGCAACTCTGCAACGGAACCGA 60 
mut2            GCACATGCTCACAAACCAGTGGGTGGTGTGTCGTAATGGGCAACTCTGCAACGGAACCGA 60 
mut1            GCACATGCTCACAAACCAGTGGGTGGTGTGTCGTAACGGGCAACTCCGCAACGGAACCGA 60 
                ************************************ ********* ************* 
 
 
     
Figure 60: EV71 domain V IRES mutagenesis. 
 Highlighted in yellow are nucleotides where point mutations UCU/CCU and GCA/GUA 
were introduced by site directed mutagenesis. Sequence alignment was performed with 
CLUSTAL 2.1 to identify location of the mutations and regions of similarity. dV represents  
part of EV71 domain  V wild type sequence. Nucleotides highlighted in red on the IRES 
indicate regions of interaction with eIF4G(de Breyne et al., 2009).   
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CLUSTAL 2.1 multiple sequence alignment 
 
dIV             CATGGGCGACCATGGCAGTGGCTGCGTTGGCGGCCTGCCCATGGAGAAATCCATGGGACG 60 
mut3            CATGGGCGACCATGGCAGTGGCTGCGCTGGCGGCCTGCCCATGGAGAAATCCATGGGACG 60 
                ************************** ********************************* 
 
 
Figure 61: EV71 domain IV IRES mutagenesis. 
Highlighted in yellow are nucleotides where point mutations CGU/CGC were introduced by 
site directed mutagenesis. Sequence alignment was performed with CLUSTAL 2.1 to identify 
location of the mutations and regions of similarity. Nucleotides highlighted in red on the 
IRES indicate regions of interaction with eIF4G. 
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Figure 62: In vitro transcription of biotinylated RNA. 
Gel analysis of in vitro transcription of biotin RNA from cDNA. EV71 UTR mutants were 
successfully biotinylated in the transcription.  Lane (1) indicates the 1 kb molecular weight 
marker (Promega), lane (2) EV71 dV mutant 1, lane (3) EV71 dV mutant 2. 
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To characterise the differences between EV71 strains associated with benign cutaneous 
disease and those with severe neurological complications, biotin EV71 RNA with mutations 
in the eIF4G binding domains was assayed for interaction with translation initiation factors. 
First the biotinylated wild type EV71 RNA (Figure 62) was initially immobilised with 
streptavidin paramagnetic beads. Eluates from the subsequent pull-down assay in HeLa lysate 
were then probed for interaction with initiation factors and ribosomal proteins by Western 
blot. To validate the results of the western blot appropriate controls were included in the blots 
(lane 1 to lane 3). These were to ensure that; the HeLa lysate was viable; the assay was able 
to detect nonspecific binding to the paramagnetic beads and to provide proof of baseline 
biotin RNA interaction (Figure 62). 
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Figure 63: Western blot analysis of various biotinylated RNA pull downs in HeLa lysate. 
Analysis of interaction of wild type biotinylated RNA with eIF4FG. Appropriate antibody 
dilutions were used to visualise the blots. The wells were arranged as follows;  (lane 1)  HeLa 
lysate, (lane 2) beads, (lane 3) negative RNA control U1 RNA, (lane 4) biotin HCV RNA, 
(lane 5) biotin EV71 RNA, (lane 6) biotin BiP RNA  
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To test for the potential effect(s) of the induced mutations on the recruitment of translation 
factors, bead binding assays comparing the recruitment of different proteins to either the 
wild-type or the two mutated IRESes were performed. Since the mutations are located within 
the eIF4G/eIF4A recruitment site we first evaluated the binding of the eIF4A and eIF4G. As 
shown on Figure 63, mutations within the eIF4G interacting domain did not affect the 
recruitment of eIF4A and eIF4G. It has been shown in the past that eIF4A, eIF4E and eIF4G 
are part of the eIF4F complex. Although eIF4E is not required for Type I IRES activity we 
assessed whether it could be part of the RNP assembled onto the EV71 IRES through its 
interaction with eIF4G and eIF4A. Figure 63 showed that eIF4E is recruited to the EV71 
IRES and that changes in the eIF4G binding domain have no effect on this. Recently eIF4E 
has been shown to play a role in IRES-mediated translation driven by the Kaposi’s sarcoma 
associated herpesvirus (Othman et al, RNA in press). Therefore our observation that eIF4E is 
recruited to the EV71 IRES might be of importance. Subsequently we probed the recruitment 
of the ribosome to the IRES through the detection of ribosomal protein in the bead binding 
assay. Figure 63 shows that ribosome, represented by the ribosomal protein rps6, are 
recruited to the EV71 and that the mutations of the eIF4G binding site have no effect on this 
process.  
Finally, given that FBP2 is a negative regulator of IRES activity we speculated that IRES 
sequences from EV71 isolates of pathological cases might display lower FBP2 binding (thus 
higher potential IRES activity and viral protein synthesis that could drive the high 
pathogenicity). However inspection of the FBP2 pull-down revealed that both wild type and 
mutated IRES recruited FBP2 with similar efficacy Figure 63.  
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Overall I was able to detect the recruitment of several members of the translational machinery 
to the EV71 IRES, probing the assembly of initiation complexes on the IRES, and these 
experiments suggested that the mutations found in the key IRES domains from the clinical 
isolates did not affect the recruitment of the protein synthesis machinery.  
 
Antibodies against components of the eIF4F were used against HeLa pulldown elutes of both 
wild type and mutants EV71 RNA. The blots in Figure 63 show that there was no significant 
difference in terms of the antibody profile for both the wild type and mutant EV71 RNA. 
These results suggested that both wild type EV71 UTR and the mutant EV71 RNA interacted 
with components of the eIF4F complex, elements of the small ribosomal unit and FBP2. In 
essence, it posited that the wild type EV71 when compared to the mutated fatal EV71 strain 
exhibited no significant in difference in terms of translational efficiency. It must however, be 
noted that this result only provided a qualitative overview of the interactions of the eIF4F 
initiation complex with EV71 UTR. Another interesting observation from the blots was the 
specific interaction eIF4G with EV71 domain V. This result seemed to concur with the 
findings of (de Breyne et al., 2009) who previously established that there was a direct 
functional interaction of initiation factor eIF4G with base Type I internal ribosomal entry 
sites (de Breyne et al., 2009). Interestingly, it was also observed that EV71 UTR, interacted 
with FBP2 which validated observations made by (Lin et al., 2009). However, there were no 
significant differences observed as well in terms of the FBP2 interactions with the mutant 
EV71 UTR.  
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Figure 64: Western blot analysis of EV71 UTR pull down in HeLa lysate. 
Analysis of the interaction of biotinylated EV71 RNA with components of eIF4F complex 
including FBP2. Appropriate antibody dilutions were used to visualise the blots. The wells 
were arranged as follows;  (lane 1)  HeLa lysate, (lane 2) beads, (lane 3) negative RNA 
control U1 RNA, (lane 4) biotin EV71 wild type, (lane 5) biotin EV71 mutant 1, (lane 6) 
biotin EV71 mutant 2. Mutant 1 biotin RNA encoded a ACG/AUG mutation in domain V 
whereas Mutant2 encoded RNA with a ACU/UCC mutation in domain V. Ribosomal protein 
S6 (rpS6) is a component of the 40S ribosomal subunit Ribosomal protein S6 (rpS6) is a 
component of the 40S ribosomal subunit. 
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3.5 DISCUSSSION 
 
Internal ribosomal entry site (IRES) directs the initiation of translation by coordinating the 
recruitment of the ribosome in the presence of a subset of initiation factors and through 
interaction mediated by specialized RNA structures. Furthermore, cellular proteins or ITAFs 
can participate in this process to facilitate internal entry of ribosome. The EV71 IRES is a 
Type I IRES, which relies on the presence of eIF4G, eIF4A, eIF3 and eIF2 during initiation. 
In addition several cellular proteins act as ITAFs for the EV71 IRES. Among them, two 
proteins from the same family FBP1 and FBP2, can be recruited to the viral RNA but respond 
differently in relation to it. While FBP1 is a positive regulator of IRES activity, FBP2 
negatively impacts on IRES activity. To date, most of the work done on ITAFs focussed on 
PTB highlighting its key role as a RNA chaperone required for the IRES to adopt the correct 
translation-competent conformation (Kafasla et al., 2010). However little is known about the 
role of FBP proteins as ITAF, their interaction with the EV71 IRES or other IRES and how 
FBP1 and FBP2 could compete for IRES binding. The interaction between FBP2 and the 
EV71 IRES was mapped to the nucleotides 1–167, 91–228 and 566–745 in EV71 5′ UTR and 
to KH2 and KH4 domains in FBP2 (Lin et al, 2009). One hypothesis is that the binding of 
FBP2 to EV71 5′UTR may affect the structure of the IRES and therefore influence binding of 
other cellular factors on the EV71 IRES. Lin et al, identified cellular proteins PTB, hnRNP 
A1 that were mapped as having binding sites in EV71 5' UTR that overlap with that of FBP2. 
An in vitro competition binding assay was performed and the results revealed that FBP2 
outcompeted the binding of PTB. PTB has been previously demonstrated to be a positive 
ITAF for other picornaviruses (Brown and Pallansch, 1995) and therefore, this result 
suggested that FBP2 may compete with other ITAFs to act as a negative regulator of EV71 
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IRES. This finding led to the possibility that FBP2 may compete with other ITAFs to bind 
with specific EV71 IRES and thereby regulate IRES activity in a negative manner. 
FBP2 was originally identified as a component of a protein complex that assembled on an 
intronic c-src neuronal-specific splicing enhancer. Work carried out by (Min et al., 1997) 
showed that a previously unknown protein (FBP2) was an essential component in the 
assembly of the downstream control sequence (DSC) together with other protein factors. This 
DSC/ protein complex was known to be important in enhancing splicing of the neuronal pre 
mRNA. To understand how the Far Upstream Binding Protein 2 (FBP2) acts during internal 
ribosome entry mediated by the EV71 IRES, we first optimized a purification protocol to 
purify both a full length version of FBP2 containing all four KH domains (KH14) or only the 
central two KH domains (KH23) that we hypothesized to be responsible for IRES binding. 
The optimal purification involved the use of two consecutive steps of affinity 
chromatography, the first one based on the affinity of the GST tag to a GSH matrix while 
following the removal of the GST tag, the FBP2 proteins were further purified based on the 
affinity of the 6X histidine tag to a Ni matrix. While affinity chromatography of recombinant 
protein is routinely performed in many laboratories this work highlighted the relevance of 
combining several steps of different affinity chromatography techniques to achieve the best 
purity of recombinant protein.  
Using recombinant KH14 and KH23 I confirmed that FBP2 interacts with the EV71 IRES in 
a reconstituted in vitro EMSA and that FBP2 also bind to the cellular IRES BiP (which will 
be further introduced in the next chapter).  Furthermore the central KH23 domains are able to 
mediate IRES recruitment as shown by the binding to BiP IRES demonstrated by EMSA. 
Using filter binding assays I determined that the apparent affinity of the interaction between 
KH23 and different IRESs, EV71, BiP and HCV, was in the sub-micromolar range. A 
relatively low affinity for an RNA-protein interaction. These findings highlight that FBP2 
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could be considered as a wider ITAF rather than only interacting with the EV71 IRES. 
However this raises further questions. The first to be addressed would be whether FBP2 
modulates the IRES activity of the HCV IRES or the BiP IRES, in order to confirm its role as 
an ITAF. To this end, bicistronic dual luciferase reporter mRNAs, containing a Renilla 
luciferase under the control of the cap-dependent translation mechanism and a Firefly 
luciferase under the control of the IRES, would be transfected into cells in which the 
expression of FBP2 has been silenced using siRNA. This should be completed by a rescue 
experiment in which the expression of FBP2 is driven by an inducible plasmid. Therefore by 
analysing the effect of either impairing or activating FBP2 expression on HCV and BiP 
IRES, its role as an ITAF will be confirmed. Given the limited knowledge about ITAF 
function in IRES activity, another potential study would be to address how FBP2 modulates 
the viral RNA structure. Using chemical probing in solution, the effect of FBP2 on the 
structure on individual RNA domains should be determined and will help to better understand 
the role it plays during translation.  
To date KH domains of FBP2 have been implicated in binding to EV71 UTR but the past 
studies have relied mainly on qualitative analyses (Lin et al., 2009). The KH Type I domains 
have defined consensus sequences normally associated with RNA binding. The nucleic acid 
is bound in an extended conformation across one side of the domain. The binding occurs in a 
cleft formed between alpha helix 1, alpha helix 2 the GXXG loop (contains a highly 
conserved sequence motif) and the variable loop (Roberts et al., 2009). The binding cleft is 
hydrophobic in nature with a variety of additional protein specific interactions to stabilise the 
complex. Valverde and colleagues noted  that, "Nucleic acid base-to-protein aromatic side 
chain stacking interactions which were prevalent in other Type Is of single stranded nucleic 
acid binding motifs, were notably absent in KH domain nucleic acid recognition. It was also 
observed that the structure of the C-terminal KH domains of FBP2 revealed a non-canonical 
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motif important for mRNA degradation (Garcia-Mayoral et al., 2007). The fourth KH domain 
(KH4) was found to be essential for mRNA recognition and decay but required the third KH 
domain (KH3) for its function. It was established that KH3 and KH4 behaved as independent 
binding modules and could interact with different regions of the AU-rich RNA targets of 
FBP. This therefore provided FBP2 with the structural flexibility needed to recognize 
different targets in the context of their 3'UTR structural settings. In future it would be ideal to 
characterise the interaction of FBP2 bound to EV71 RNA in vitro using a pulldown assay to 
extract RNA-protein complexes, followed by mass spectrometry to identify binding partners. 
RNA structure is important for function. A toeprinting analysis of end labelled RNA could be 
performed to examine FBP2 bound to EV71 RNA domains and help to identify any structural 
modulation.  
 
To study the genetic differences between EV71 strains associated with benign cutaneous 
disease and those with severe neurological complications, which have led to the suggestion 
that a viral genetic determinant could be mediating neurological pathogenesis of severe 
disease, I obtained EV71 IRES sequences corresponding to clinical samples of patients who 
had succumbed to severe forms of the disease, details of which are presented in (Appendix2). 
Examination of these sequences revealed mutations in regions that have been proposed to 
play a key role in eIF4G recruitment and IRES activity.  
The IRES RNA was mutated to incorporate point mutations in the eIF4G binding domains IV 
and V and this was confirmed by sequence alignment. Biotinylated EV71 RNA was used as a 
probe in pull down interactions in HeLa lysate. From the results presented it was observed 
from the western blot analysis of pull-down proteins that there were no significant differences 
in the interactions of the EV71 RNA with proteins that constitute the eIF4F complex. Neither 
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the wild type RNA nor mutant RNA (with point mutations in the eIF4G binding domains IV 
and V), displayed any significant differences when probed with antibodies specific for the 
initiation factors. These results also confirmed the findings of de Breyne et al, (de Breyne et 
al., 2009) who reported that domain V of Type I IRES specifically interacts with the central 
domain of eIF4G. The mechanism of initiation on Type I IRESs which has subsequently been 
elucidated (Guillot et al., 1994), where it was established that domain V binds eIF4G, and a 
conserved AUG in domain VI was suggested to stimulate attachment of 43S ribosomal 
preinitiation complexes, which then scan to the initiation codon. Initiation on Type I IRESs 
also requires IRES trans‐acting factors (ITAFs). These data however do not give an account 
of the translation efficiency of the mutants compared to the wild type IRES, which might give 
an indication of the fundamentals at play in severe disease. To this end bicistronic reporter 
assays have been previously used to establish that an RNA element is a functional IRES 
(Rezapkin et al., 1999). Future work using reporter assays, will be used to determine whether 
there are any significant difference in the translation efficiencies of the mutants. The dual 
luciferase reporter assay system provides an efficient means of achieving this. The bicistronic 
luciferase reporter gene system is based on the expression of a bicistronic RNA comprising 
two independent reporter genes in 3′ and 5′cistrons, and the putative IRES inserted into 
intercistronic region.  
In conclusion the KH2-KH3 binding domains have been shown to interact with EV71 UTR. 
This RNA-protein interaction plays an important role in mRNA stability. The observed 
negative effect on EV71 translation by the FBP2 protein may in part be due to interactions of 
the central RNA binding domain (KH) flexibility that allows for recognition of different 
targets in the context of their 5'UTR structural settings. 
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Chapter 4: Characterisation of 
the BiP IRES RNA structure 
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4.1  INTRODUCTION 
Binding immunoglobulin protein (BiP) is a protein involved in response to stress in the 
endoplasmic reticulum. Sensing, responding, and adapting to environmental cues, such as 
nutrient starvation, hypoxia, and temperature changes, are essential for all living organisms. 
To cope with such stresses, all organisms have evolutionarily conserved unique signal 
transduction pathways depending on their biological niches. The endoplasmic reticulum (ER) 
is a membrane-enclosed organelle responsible for the synthesis, folding, modification, and 
quality control of numerous secretory and membrane proteins, reviewed in (Kaufman et al., 
2002, Naidoo, 2009, Zhang and Kaufman, 2006, Cao and Kaufman, 2012). The processes of 
protein folding and maturation are highly assisted and scrutinised, reviewed in (Ron and 
Walter, 2007). Only properly folded proteins can traffic to the Golgi apparatus, whereas those 
misfolded are directed to ER-associated degradation (ERAD) or to autophagy (Matsumoto et 
al., 2013, Romisch, 2005). The accumulation of misfolded proteins in the ER activates 
signalling events to orchestrate adaptive cellular responses (Cao and Kaufman, 2012, Ron 
and Walter, 2007). This unfolded protein response (UPR) increases the ER protein-folding 
capacity, reduces global protein synthesis, and enhances ERAD of misfolded proteins. 
 
Figure 65 illustrates some of the functions of the unfolded protein response. The mechanism 
of UPR has to date been the subject of several studies. Briefly, the first resort of the UPR is to 
try and restore normal cellular function. The UPR achieves this by slowing protein translation 
to allow time to repair the damage, and then it increases production of chaperone proteins 
which assist in protein folding.  
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Figure 65: The Unfolded protein response. 
Schematic of the unfolded protein response in mammals. The three major transducers of ER 
stress namely IRE1, PERK and ATF6 are controlled by molecular chaperone BiP. The BiP 
protein binds to the stress transducers and keeps them in an inactive state. This figure was 
originally published in Current Biology (Cao and Kaufman, 2012) 
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The term protein folding incorporates all the processes involved in the production of proteins 
after the nascent polypeptides have become synthesised by the ribosomes. These proteins 
destined to be secreted or sorted to other cell organelles carry an N-terminal signal sequence 
that will interact with a signal recognition particle (SRP) (Keenan et al., 2001). The SRP 
tethers the whole complex (Ribosome, RNA, and polypeptide) to the ER membrane. The 
protein folding steps also involve a range of enzymes and molecular chaperones that 
coordinate and regulate reactions. The most important of these to note are N-linked 
glycosylation and disulphide bond formation (McGinnes and Morrison, 1997). Favoured by 
the highly oxidising environment of the ER, protein disulphide isomerases facilitate 
formation of disulphide bonds, which confer structural stability to the protein in order for it to 
withstand adverse conditions such as extremes of pH and degradative enzymes. Protein 
misfolding is a common and intrinsic propensity of proteins that occurs continuously. 
Misfolding is influenced by the amino acid composition, and certain mutations are known to 
accelerate the process. Moreover, it also depends on environmental conditions, because once 
proteins are exposed to specific environmental changes such as increased temperature, high 
or low pH, agitation, elevated glucose, or oxidative agents, they can lose their native 
conformation more rapidly. 
 
The ER is capable of recognising misfolded proteins without causing disruption to its normal 
functions. The sugar molecules previously mentioned are the means by which the cell 
monitors protein folding. It has been established that misfolded proteins are characteristically 
devoid of glucose residues, as a consequence targeting them for identification and re-
glycosylation by the enzyme UGGT (UDP-glucose:glycoprotein glucosyltransferase) (Zhang 
et al., 2011). If this fails to restore the normal folding process, exposed hydrophobic residues 
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of the misfolded proteins are bound to BiP, which then prevents the protein from further 
transit and secretion. 
 
In conditions of prolonged stress, the goal of the UPR changes from being one that promotes 
cellular survival to one that commits the cell to a pathway of apoptosis causing the cell to die 
in a programmed way. Thus, the primary aims of the UPR are to control the production of 
molecular chaperones which aid in the correct folding of other proteins; to increase the rate of 
endoplasmic reticulum associated degradation (ERAD) by activating transcription of genes 
that encode ERAD associated proteins. As a result, more unfolded or misfolded proteins can 
be moved out of the ER and into the cytosol where they are degraded by proteasomes and to 
reduce the translation of proteins via the PERK protein kinase pathway giving the ER time to 
remove the build-up of misfolded proteins. The three major transducers of ER stress are 
inositol-requiring kinase 1 (IRE1), pancreatic ER eIF2α kinase (PERK) and activating 
transcription factor 6 (ATF6). Their functions as previously stated are controlled by a 
molecular chaperone BiP (Bole et al., 1986, Haas and Wabl, 1983). IRE1 is a transmembrane 
protein which is an RNase and a kinase (Urano et al., 2000). As such, it contains a 
serine/threonine kinase domain and an endoribonuclease (RNase) domain in its cytosolic 
portion. There are two IRE1 homologues in mammals: IRE1α is expressed ubiquitously, 
whereas IRE1β expression is mostly restricted to the intestinal epithelium. Two models have 
been proposed for the activation of IRE1 (Promlek et al., 2011). The first is a competition-
binding model that suggests that unfolded and/or misfolded proteins in the ER lumen 
compete with IRE1 for binding to the chaperone BiP. This binding to BiP inhibits signalling, 
whereas IRE1 released from BiP forms homodimers and oligomers that promote trans-
autophosphorylation and RNase activation. This results in the processing of mRNA (e.g. 
XBP1 in mammals to the mature form). XBP1 is a transcription factor which regulates 
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response to ER stress at the level of gene expression. As a potent transcription activator, 
XBP1 binds to the UPR element (UPRE) and to the ER stress-response elements I and II 
(ERSE-I and ERSE-II) in the promoter regions of target genes. Previous studies have 
suggested that XBP1 induced the expression of a wide range of genes that orchestrate ER 
protein folding, secretion, quality control and ERAD, and activated phospholipid biosynthesis 
and ER expansion upon ER stress. Alternatively, it was proposed that unfolded/misfolded 
proteins directly bind to the amino-terminal luminal domain of IRE1 to induce dimerization.  
PERK is also an ER transmembrane protein kinase, PERK phosphorylates eIF2α. This 
reduces formation of translation initiation complexes in the cell so that less mRNA is 
translated into protein, in turn reducing the "workload" for the ER. ATF6 is a transcription 
factor which under normal conditions is an ER transmembrane protein. When ER stress 
occurs it is translocated to the Golgi apparatus where it is cleaved to give a cytosolic 
fragment. Like other transcription factors, it is then able to translocate to the nucleus and 
regulate gene transcription. BiP binds to three major ER stress transducers IRE1, PERK and 
ATF6 which are needed to initiate UPR and keeps them in an inactive state. Therefore BiP 
has clearly a central role in the UPR.  
 
4.1.2  Binding immunoglobulin protein (BiP)  
 
Binding immunoglobulin protein (BiP), also known as 78 kDa glucose-regulated protein 
(GRP-78) or heat shock 70 kDa protein, is encoded by the HSPA5 gene in humans (Ting and 
Lee, 1988, Hendershot et al., 1994). BiP is a molecular chaperone located in the lumen of the 
endoplasmic reticulum (ER) that binds newly synthesized proteins as they are translocated 
into the ER, and maintains them in a state competent for subsequent folding and 
oligomerisation. BiP therefore detects aberrant proteins and translocates them for degradation 
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by the proteasome (Dudek et al., 2009). Under normal growth conditions BiP is not an 
abundant protein, but its synthesis is markedly induced under conditions that lead to the 
accumulation of unfolded polypeptides in the ER (Dudek et al., 2009). This accumulation of 
proteins in the ER leads to the cascade of events comprising the UPR as summarised in 
Figure 65. 
 
Therefore, BiP as an ER chaperone is involved in numerous functions, including 
translocation of nascent polypeptides, facilitation of de novo protein folding and assembly, 
targeting of misfolded proteins to ERAD and maintenance of calcium homeostasis. 
 
Thus, the proposed roles for the BiP protein include the mediation of proper folding, the 
assembly of nascent proteins, and the scavenging of misfolded proteins in the ER (Bole et al., 
1986, Rinehart et al., 1997). In addition it has been noted that transcription of BiP mRNA 
was also induced after infection with paramyxoviruses (de Breyne et al., 2009, Siridechadilok 
et al., 2005). Furthermore, several reports have suggested that expression of the BiP protein 
was further regulated at the level of translation (Prostko et al., 1991, Sarnow, 1989, 
Ulatowski et al., 1993). For example, translation of BiP mRNA was increased in poliovirus-
infected cells where translation of most host cellular mRNAs was inhibited (Sarnow, 1989). 
This suggested that the regulation of translation initiation of BiP therefore could play a 
crucial role in cell proliferation.  
4.1.3 BiP IRES 
As previously stated, under normal growth conditions BiP is not an abundant protein, but its 
synthesis is markedly induced under conditions that lead to the accumulation of unfolded 
polypeptides in the ER. It has been established that the initiation of translation of BiP 
messenger RNA is IRES-mediated (Yang and Sarnow, 1997). The 5′ UTR of BiP mRNA 
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contains an IRES element of 255 nt, to which polypyrimidine tract-binding protein (PTB) and 
autoantigen La proteins can bind to modulate its activity (Kim et al., 2001, Kim et al., 2000). 
Studies into the structure of BiP IRES of three different species  have thus far proposed a 
common structural motif was folded within these IRES elements (Le and Maizel, 1997). In 
this paper, RNA sequences and RNA folding were analysed by sequence comparison using 
the NUCALN program (Wilbur and Lipman, 1983). Each group of sequences was then 
aligned by Zuker's MAL program (Le and Zuker, 1990). The alignment data was edited, 
combined and refined in terms of the common structural information. The authors then 
predicted thermodynamically favoured, helical stems in human BiP mRNA by fluctuating 
free energy parameters in the Turner energy rules in the RNA folding simulation (Freier et 
al., 1986, Jaeger et al., 1989). Based on these thermodynamically favoured stems, they 
constructed a stem list using COMFOLD (Le et al., 1995) in which each stem was supported 
by phylogenetic comparative analysis (James et al., 1988) among the BiP mRNA sequences 
from human, rat and Chinese hamster. As a result, they built a theoretical common RNA 
structural motif for the three sequences. Combined with RNA folding simulations and 
statistical tests, they also determined the structural motif of IRES elements in  functionally 
related IRES elements was also conserved  from the BiP, FGF-2 and the FGF family (Le and 
Maizel, 1997). The RNA folding simulations obtained from sequence analysis data of the 
mRNAs suggested that that a Y-type stem–loop structure followed by a small stem–loop 
structure just upstream of the translational initiator, was the conserved property found in 
these IRESes (Figure 66). It was also observed that the structural conservation observed, was 
consistent with the fact that these IRES elements were functionally related to each other (Le 
and Maizel, 1997). An important point to note however is that the IRES sequences used in 
their investigation were based on a shorter 92 nucleotide predicted BiP IRES element (Le et 
al., 1996).     
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These results were peculiar given that most cellular IRES to date have been shown to adopt 
very little structure, (Xia and Holcik, 2009). Current work in Prof Shih laboratory has 
suggested that BiP expression and BiP IRES activity is up regulated during EV71 infection 
(Kung Y.A and Shih S. R, unpublished data). Furthermore our results (Section 3.4.4) have 
suggested that the BiP IRES interacts with FBP2. These observations put together have raised 
questions as to whether BiP IRES and EV71 could share similar RNA structure motifs.  
 
 
 
 
 
 
 
Figure 66: Common structural motif predicted in the IRES elements detected in the 5′UTR 
sequence upstream of the start codon CUG of human (a) and rat (b) FGF-2 mRNAs. The 
IRES element shown in human FGF-2 was supported by experimental data ( Le et al, 1997). 
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 To date, fewer IRESes have been found in cellular mRNAs as compared to viral IRES. It is 
not clear what advantage the IRES-dependent mechanism offers relative to the conventional 
ribosome scanning mechanism in translational initiation of cellular mRNAs. The proposed 
common structural motif of the BiP cellular IRES to date required validation by experimental 
data, but the model was supported by phylogenetic analysis of divergent sequences from BiP, 
FGF-2 and the FGF family. However it must be noted that the human FGF-2 IRES element 
shown in Figure 66 was supported by experimental data established by Vagner et al, using 
RNase protection assay and bicistronic reporter assays (Vagner et al., 1995). 
  
4.2 Chapter aims 
The physiological importance of IRES-mediated translation of cellular mRNAs is 
increasingly being realized in numerous biological settings including development, the cell 
cycle, apoptosis, wound repair, and angiogenesis. 
Previously, it has been estimated, based on truncated BiP IRES element,  that the BiP IRES 
consists of Y type stem-loop close to the initiator AUG using statistical analysis of RNA 
folding. However, so far there is no experimental evidence to support these predicted 
structures. To better understand the role of RNA structure in translation mediated by cellular 
IRESes, and also to determine conservation of motifs with EV71 we analysed the whole 
structure of the BiP-IRES element, using chemical probing of RNA structure in solution, and 
used this experimental data to predict the secondary structure of the BiP IRES. 
Our approach includes the following steps: 
• determining the secondary structure model with experiments using chemical probes 
with different specificities. 
• Prediction of likely secondary structures of BiP RNA based on primary sequence, 
using RNA and structure prediction software. 
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4.3 MATERIAL AND METHODS 
 
4.3.1 BiP 5' UTR Sequence 
In order to determine the secondary structure of BiP RNA, primary 5'UTR sequence data of 
BiP was obtained from a sequence database (GenBank: X87949.1):  
 
5'- AGG UCG ACG CCG GCC AAG ACA GCA CAG ACA GAU UGA CCU AUU GGG 
GUG UUU CGC GAG UGU GAG AGG GAA GCG CCG CGG CCU GUA UUU CUA 
GAC CUG CCC UUC GCC UGG UUC GUG GCG CCU UGU GAC CCC GGG CCC CUG 
CCG CCU GCA AGU CGA AAU UGC GCU GUG CUC CUG UGC UAC GGC CUG UGG 
CUG GAC TGC CUG CTG CUG CCC AAC UGG CUG GCA AGA UGA AGC UCU CCC 
UGG UGG CCG CGA UGC UAU GAG -3'. 
 
It must be noted that the nucleotide sequence of the BiP 5'-UTR investigated here was found 
to be identical to that originally described by Dennis G. Macejak & Peter Sarnow (Macejak 
and Sarnow, 1991). Consequently, differences between the predicted model by Le and Maizel 
and our model could largely be due to sequence variability. The size of the BiP IRES model 
investigated by Le and Mazel was 221 nucleotides, whereas we undertook investigation of 
the full BiP IRES (255 nucleotides). 
4.3.2 In vitro transcription of BiP IRES 
DNA plasmid encoding the BiP IRES was cloned previously by Dr N Locker. Plasmid 
pUC18/BiP-linker/ was constructed by inserting the 5' UTR of the BiP mRNA between the 
Hind III and Eco RI cloning site of the pUC18 vector and placed under the control of a T7 
promoter. A short RNA linker was inserted at 3’ end of the IRES to enable primer annealing 
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for transcription. The plasmid was then used for in vitro transcription of BiP RNA following 
the protocol detailed in Section 3.2.6. 
4.3.3 Modification of RNA 
 
Chemical probes were used to aid in determining secondary structure on the basis that many 
chemicals modify accessible groups of certain nucleotides. Double-stranded regions of the 
secondary structure are known in many cases to react more slowly with chemical probes than 
single-stranded regions (Ziehler and Engelke, 2001). Mapping of the BiP 5′ UTR RNA 
structure in vitro was carried out using nucleobase-specific probes dimethyl sulfate (DMS), 
1-cyclohexyl-3-(2-morpholinoethyl) carbodimide metho-p-toluenesulfonate (CMCT) and 
RNAse V1. The RNA chemical and enzymatic treatments were as outlined in the 
subheadings below.  A standard assay used 1 µmole RNA and 2 mg/ml tRNA as carrier. 
4.3.4 Treatment of RNA with DMS 
 
Dimethyl sulfate (DMS), an alkylating agent, is commonly used on nucleic acids to alkylate 
the N1 of adenine and N3 of cytosine, and to a lesser extent N7 of guanosine. The activity of 
DMS is greatly reduced in double stranded regions in relation to adenine and cytosine. 
Chemical modifications with dimethyl sulphate (Me2SO4) were carried out following 
protocols described by Kieft (Kieft et al., 2007, Wells et al., 2000).  A schematic of the 
reaction and subsequent changes to the modified bases is shown in Figure 68. Briefly, 10µl 
of 7.9 M Me2SO4 dissolved in 10µl 100% Ethanol, in 2X DMS buffer (see Appendix 2 for 
recipe), for 1min, 5mins and 10mins at 20
o
C. Reactions were stopped using 3µl 3M 
ammonium acetate. Modified RNA was recovered by ethanol precipitation and the resultant 
pellet re-suspended in 8 µl milliQ water. 
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4.3.5 Treatment of RNA with CMCT 
1-cyclohexyl-3-[2-(N-methylmorpholinio)ethyl]carbodiimide ptoluenesulfonate (CMCT) is 
known to modify the uracil base at the N3 (less efficiently at the N1 of guanines). Chemical 
modifications with CMCT were carried out with 1 µl, 2 μl, and 5 µl of CMCT (40 mg ml−1) 
in 5X buffer (250 mM Borate-NaOH pH 8.0 mM EDTA) at 20 °C for 20 mins. Figure 68 
outlines a schematic of the reaction and subsequent changes to the modified bases.  
4.3.6 Treatment of RNA with RNase V1 
 
BiP RNA structure was also probed using an enzymatic probe. RNase V1 is non-sequence 
specific for double-stranded RNAs and cleaves base-paired nucleotide residues. Enzymatic 
digestions with RNase V1 (0.1 U/µl) were carried out with 0.5 µl, 1 µl and 2 µl of RNase V1 
in 2X buffer (40 mM Tris pH 7.5, 200 mM KoAc, 400 mM, KCl, 5 mM MgCl2, 2 mM 
DTT) at 20°C for 5mins. All reactions were stopped by precipitation with 2 µl of 3 M sodium 
acetate and 100 µl of absolute ethanol at -80°C for 30 mins. Samples were re-suspended in 40 
µl of 0.3 M sodium acetate, extracted with phenol when necessary, precipitated twice with 
ethanol, washed with 70% (v/v) ethanol and vacuum dried. Pellets were re-suspended in 8 µl 
milliQ water and stored at-80
o
C. 
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Adenine 
Dimethyl sulphate 
Cytosine 
 
Dimethyl sulphate 
Figure 67:  Dimethyl sulphate modification of bases Adenine and Cytosine. 
The schematic shows the methylation (red) of N1 adenosine and N3 of cytosine. 
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Figure 68. CMCT modification of bases Uridine and Guanosine. 
CMCT (red) reacts with N3 of uridine and N1 of guanine, modifying two sites responsible for 
hydrogen bonding on the bases. 
 
CMCT 
Guanosine 
Uridine 
CMCT 
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4.3.7 Primer Extension 
 
Primer extension reactions (Figure 69) were carried out with various primer sequences 
(Table 12), complementary to residues in the following full length BiP IRES sequence 
(Section4.1.0). These primer sequences were 3’-end labelled using T4 RNA ligase (Promega) 
and [γ-32P] ATP as previously described (Section 3.2.7). Subsequently, a mixture consisting 
of equal molar amounts  of modified BiP RNA and  
32
P labelled primer were annealed  for 1 
min at 90
o
C (in heat block); 1 min at 4
o
C and 5 min at 20
o
C in 5X AMV  buffer (Promega). 
The extension reaction was in 5X AMV hybridization buffer at 37°C for 30 mins in the 
presence of 2 unit of AMV reverse transcriptase (Promega) and 2.5 mM dNTP mix. 
 
Figure 69: Schematic for primer extension reactions with DMS modified primers and 
resulting chain termination used for footprinting analysis. It should be noted that for DMS 
modifications if the stop position is on nucleotide (n), then the modified nucleotide is on 
position (n+1). 
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Table 14: Primer sequences used for BiP structure probing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Primer name Primer sequence 5'-3' Annealed to BiP(nt) 
   
NLP125 ggggcccggggtcacaag nt119 to nt136 
NLP126 gggtcacaaggcgccacgaac nt108 to nt128 
NLP136 gcaggtctagaaatacag nt80 to nt97 
NLP137 gccacgaaccaggcgaag nt99 to nt116 
NLP138 gaggtttaggattcgtgc nt255 to nt272 
NLP139 ggcgacggttggtgttac nt288 to nt305 
NLP154 gcacagcgcaatttcgac nt149 to nt166 
NLP155 gagcttcatcttgccagc nt213 to nt230 
NLP156 gccacaggccgtagcacag nt169 to nt187 
NLP197 cgacttgcaggcggcagg nt135 to nt152 
NLP198 ccacgaaccaggcgaaggg nt97 to nt115 
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4.3.8 Sequencing reactions  
Standard sequencing reactions were carried as outlined in Table 12. Primer sequences    
previously 3'-end labelled with [γ-32P] ATP and chemically modified BiP RNA were used in 
these reactions. 
 
Table 15: Preparation of sequencing ladders for cDNA foot-printing reactions 
 
 
NB*  
The buffers for A10, C10, G10 and D10 were each made up by adding the appropriate dNTP 
concentrations. For example for A10: 10 l 10 mM dGTP, 10 l 10 mM dCTP, 10 l 10 mM 
dTTP, 2.5 l 10 mM dATP and H2O added to  make up to100 l. 
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The reactions were stopped by adding 20 µl of 0.3 M NaoAc and 100 µl absolute ethanol. 
Pellets were precipitated with ethanol, washed with 80% (v/v) ethanol and vacuum dried. 
Pellets were re-suspended in 8.0µl of loading buffer (deionized formamide, 0.03%, (w/v) 
xylene cyanol and bromophenol blue) and heated to 90°C for 2 min prior to loading. 
Electrophoresis was carried out on 40 cm x 30 cm x 0.4 cm 10% gels containing 40% (19:1) 
Bis-Acrylamide, 8 M urea, at 2000 V for 2 hrs. On completion of the run the gel was fixed in 
10% acetic acid; 20% ethanol in water for 10 min and vacuum dried on 3MM paper for 90 
min at 70
o
C. The dried gel was then exposed to a Bio-Rad Imaging screen for visualisation.  
 
After primer extension the resulting radiolabeled complementary DNA (cDNA) products 
were analysed by denaturing polyacrylamide gel electrophoresis (Urea 10% PAGE), followed 
by autoradiography. The sizes of the bands detected on the gel, as compared to an adjacent 
sequencing ladder, provided a measure of the distance from the 5′ end of the synthetic 
oligonucleotide to the beginning of the mRNA transcripts.  
 
4.3.9 RNA structure prediction 
 
Sequencing gel foot printing analysis was carried out and the experimental data obtained 
were converted into structural restraints used to predict a model of the BiP IRES with the M-
fold software(Zuker and Markham, 1995, Zuker, 2003). Briefly, the stops identified on the 
sequencing gel were first mapped on to the BiP sequence and colour coded.  Each nucleotide 
was assigned a specific modification site corresponding to it. DMS; (green and red), CMCT 
(yellow and blue), RNaseVI (purple and orange). The colours for each code were assigned 
either a moderate or strong modification scale for each nucleotide depending on observations 
from the gel. After identifying the modifications on the sequencing gel, M-fold restraint rules 
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for folding (Zuker, 2003) were applied to the map and a restraints table was developed  
Appendix 4. This data was then entered into the algorithm to predict the most 
thermodynamically stable structure for the BiP IRES. We used the M-FOLD web server to 
predict secondary structures for the BiP IRES using the default settings and the temperature 
fixed at 37 °C. 
4.3.10 Melting curve analysis 
 
To assess the dissociation-characteristics of cellular IRES elements during heating, several 
IRES elements (BiP, Apaf, XIAP and the tRNA control) were analysed in a UV 
spectrophotometer (Agilent 8453 Spectrophotometer and Agilent UV-Visible ChemStation 
software, Agilent Technologies) set at an absorbance wavelength of 260nm with heating rate 
of 1
o
C/min. Prior to loading the RNA were diluted in buffer to an initial reading of 1.0 Abs. 
The acquired spectra results were processed using statistical software to analyse the folding 
thermodynamics of each IRES element. From these, second derivative plots of absorbance 
against temperature were calculated using GraphPad Prism® to accurately determine the 
melting temperature(Tm) of each IRES element. 
 
4.4 RESULTS 
 
4.4.1 RNA structure probing 
To determine RNA structure of BiP IRES, base-specific reagent, dimethyl sulphate (DMS), 
CMCT, and enzymatic probe RNase VI were used to modify the BiP RNA. Then this was 
followed by primer extension analysis with a complimentary 
32
P labelled primer to map the 
modification sites. Figure 70, Figure 71 and Figure 72 show a part of the sequencing gel 
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obtained from primer extension analysis with corresponding DMS, CMCT and RNAse VI 
modifications respectively. Some of the modified nucleotides are indicated by the arrows. 
From the primers tested in Table 13, it was observed that only primers NLP136, NLP139, 
NLP154, NLP155, NLP157 and NLP197 were able to produce a cDNA footprint that could 
be used for gel analysis. The other primers NLP125, NLP126, NLP137, NLP138 did not 
work for various reasons including suboptimal primer annealing, no primer extension. Using 
this data from the gel analysis, primer stop positions were mapped on the BiP sequence and 
also compared to the previously predicted model Figure 73 and Figure 74. 
From the results presented in Figure 70 is was observed that for  part of the BiP structure 
under analysis, using primer NLP 136 not many of the nucleotides were  modified by DMS, 
overall in terms of the full BiP structure this was a common feature in that DMS modification 
of bases was limited. Figure 71 shows CMCT analysis of the BiP structure using primer 
NLP137. From the figure it was observed that many of the bases were modified by CMCT 
and this was also observed for the full structure BiP suggesting that its structure was 
disordeded. From results presented in Figure71 the BiP structure was comparatively less 
modified by RNAse VI, further confirming this.  Mapping constraints were derived as per M-
fold rules for RNA structure prediction. The constraints from the sequence were then used to 
predict the most thermodynamically favourable secondary structure of BiP using M-fold 
software. A secondary structural model of the BiP IRES was derived by free energy 
calculations using the MFOLD algorithm (Jacobson and Zuker, 1993). A single structure was 
calculated, with free energy (ΔG) calculated at –18.02 kcal/mol. The most stable predicted 
structure is shown in Appendix 5. Results presented show that the structure is not complex 
with one stem loop of undefined structural motif and two smaller stem loops upstream of the 
5' end. Taken together, these data support the notion that BiP contains a bona fide IRES 
element that it is it not highly ordered and has weak secondary structure. Interestingly, this 
216 | P a g e  
 
also revealed a lower degree of RNA structure when compared to the previously proposed 
structure by Shu-Yun Le and Jacob V. Maizel, 1997 of a shorter BiP IRES domain Figure 75 
(box insert). 
 
 
Figure 70: Sequencing gel analysis. 
A representative sequencing gel showing mapping of primer extension stops following 
chemical probing in solution with DMS. The arrows indicate modified bases on the BiP 
sequence and the map highlights the locations of the modified nucleotides. 
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Figure 71: Sequencing gel analysis. 
A representative sequencing gel showing mapping of primer extension stops following 
chemical probing in solution with CMCT. The arrows indicate modified bases on the BiP 
sequence and the map highlights the locations of the modified nucleotides. 
 
 
 
 
 
 
 
 
 
 
 
 
218 | P a g e  
 
 
Figure 72: Sequencing gel analysis. 
A representative sequencing gel showing mapping of primer extension stops following 
chemical probing in solution with RNAse V1. The arrows indicate modified bases on the BiP 
sequence and the map highlights the locations of the modified nucleotides. 
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Figure 73: A comparison of the location of experimentally determined modification sites 
with the previously proposed structure of Human BiP by Le and Maizel.  
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Figure 74: The RNAfold web server was used to predict the theoretical minimum free energy 
structure of the BiP IRES from the GenBank: X87949 sequence without restraints.  
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Figure 75: Proposed secondary structure of  BiP IRES element 
Prediction of the most thermodynamically favourable structure of BiP by the M-fold 
algorithm from experimental data.  Box insert shows schematic of a previously proposed BiP 
structure by Le and Maizel. 
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4.4.2 Melting curve analysis 
To confirm results obtained with chemical probing in solution that suggested a weak structure 
for the BiP IRES, we performed thermal melting curve analysis of different cellular IRESes 
using spectrophotometer UV absorbance 260nm with heating rate of 1.0
o
C/min. First 
derivative plots of these UV absorbance melting curves dA/dT versus T(
o
C) were used to 
determine the melting temperature of the IRES elements. The graph of the negative first 
derivative of the melting-curve made it easier to pin-point the temperature of dissociation 
(defined as 50% dissociation), by virtue of the peaks thus formed (Figure 76). Thermal 
melting curve data Figure 76 shows that all four tested RNAs have different maximum 
stabilities (Tm) with the highly ordered IRES elements having a higher Tm. First derivative 
plots of the data presented in Table 15 shows the melting temperature determined for the 
IRES elements. It was observed that BiP had a Tm of 52
o
C, which was significantly lower  
than that of  cellular IRESes XIAP 63
o
C and Apaf 60
o
C suggesting that the BiP IRES did not 
have a higher secondary structure order when compared to these IRES elements. The melting 
profiles of RNA molecules with complex structures, are often higher. Such RNAs are 
assumed to unfold in a number of transitions, though these may not necessarily correspond to 
specific structural features of each RNA.  
  
223 | P a g e  
 
 
T h e r m a l M e lt in g  c u r v e s
A
b
s
 A
2
6
0
0 2 0 4 0 6 0 8 0 1 0 0
0 .1 5
0 .2 0
0 .2 5
0 .3 0
0 .3 5
A p a f
tR NA
B ip
X ia p
T e m p
o
C
 
Figure 76: Thermal melting curve plots 
Thermal melting curve analysis of different cellular IRESes; Apaf, BiP and Xiap using 
spectrophotometer at UV absorbance 260nm with heating rate of 1.0
o
C/min. tRNA control 
was also analysed alongside the IRES. This data is representative of 3 experiments 
conducted. 
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IRES Melting temperature (
o
C ) 
  
BiP 52 
XIAP 63 
tRNA 58 
Apaf 60 
  
Table 16: Experimental thermal melting data from first derivative plots 
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4.3 DISCUSSION 
 
BiP is a molecular chaperone located in the lumen of the endoplasmic reticulum (ER). It 
binds newly-synthesized proteins as they are translocated into the ER and maintains them in a 
state competent for subsequent folding and oligomerisation. BiP is also an essential 
component of the translocation machinery, as well as playing a role in retrograde transport 
across the ER membrane of aberrant proteins destined for degradation by the proteasome. 
Translation initiation of the human BiP mRNA is directed by an internal ribosomal entry site 
(IRES) located in the 5′ non-translated region (Macejak and Sarnow, 1991). Indeed it has 
been reported that PTB specifically binds to the central region (nt 50–117) of the BiP and acts 
as a negative ITAF (Kim et al., 2000). Although many cellular IRESs have been 
experimentally identified and an IRES database has been created, there has been no sequence 
similarity identified among the IRESs with the exception of mRNAs from closely related 
species (Boehringer et al., 2005, Schuler et al., 2006). This is a marked contrast with viral 
IRES which are grouped into families depending on the structure they adopt, the translation 
factors they require and the potential ITAFs contributing to their function. The lack of 
observable sequence similarity has resulted in a widely held view that IRESs likely possessed 
stable secondary structure that allowed them to interact with the components of the 
translation machinery. While this was true for viral IRESs, this notion has never been 
critically evaluated for cellular many IRESs. In fact, some of the published literature has 
suggested that the lack of secondary structure may be important for cellular IRES activity 
(Hernandez et al., 2004, Terenin et al., 2005). To this end it was established that mutations in 
the IRES element of XIAP that altered the secondary structure of this cellular IRES had no 
impact on the XIAP IRES activity (Baird et al., 2007). Similarly, the activity of Apaf-1 IRES 
was found to be dependent on the binding of two RNA binding proteins, PTB and unr, that 
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also altered the structure of Apaf-1 IRES such that it permitted ribosome landing (and 
consequent translation initiation) to a single stranded region (Mitchell et al., 2003). 
Intriguingly, mutations that forced Apaf-1 IRES into an open configuration resulted in an 
increased IRES activity despite impairing the ability of IRES to bind PTB and unr (Mitchell 
et al., 2003). It should also be noted that for most cellular IRES elements only the IREs 
activity has been characterised and not the eIF requirements. No common sequence and/or 
structural motifs have been identified to allow prediction of cellular IRES elements from an 
mRNA sequence. Therefore, the existence of IRES in a particular mRNA must be 
experimentally determined in each and every case following a set of defined tests. In general, 
as compared to their viral counterparts, cellular IRES elements have been found to be  much 
more diverse in their structures and surprisingly less stable in terms of the Gibbs free energy 
of the folded mRNA (Xia and Holcik, 2009) It was previously observed that all viral IRES 
elements needed to maintain a specific higher-ordered RNA structure to be functional. This 
feature contrasted with some cellular IRESs for which short, noncontiguous segments could 
mediate internal ribosome entry(Hellen and Sarnow, 2001). These observations point to an 
intricate relationship between IRES structure and function which needs to be further 
elucidated for many cellular IRES including BiP.  
To date the BiP secondary structure in solution has not been solved. An analysis of the 5' 
UTR of BiP IRES structure using footprinting techniques has allowed us to derive a 
secondary structure model. The model derived here was experimentally determined by 
investigating the accessibility of BiP IRES RNA to modifications with DMS, CMCT and 
RNAse V1. Here we propose that contrary to previous published data, the structure of the BiP 
IRES is not highly ordered and has weak secondary structure. Using the RNA structure 
prediction software M-fold constrained with experimental data we were able to predict the 
most thermodynamically stable structure obtained from experimental data generated (Zuker, 
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2003). This algorithm allowed for the calculation of RNA folding using free energy rules as 
described in (Mathews et al., 1999). These rules were set for folding at 37°C and were the 
default parameters that were used by the M-fold web server. The features of the BiP IRES 
structure elucidated included a stem loop with an undefined structural motif and two smaller 
stem loops upstream of the 5' end. It was observed that the key features of the derived BiP 
IRES model were; nucleotide 1 to 15 and 76 to 99 comprised of   short stem hairpin loops, 
nucleotide 101-224 comprised a long irregular stem-loop containing an internal bulge and  
two interior loops. The significance of these structures in the functionality of the BiP IRES is 
yet to be elucidated but it has been established that the hairpin loops play a key role in the 
functionality of many characterised RNA systems. For example it is required in the RNA Tar 
region of HIV for transactivation by the Tat protein and several viral coat proteins bind to 
specific hairpin loop structures (Barnett et al., 1993). Our data suggested that the BiP IRES 
may be of an IRES type characterised by a relatively unstructured functional core. This was 
also confirmed by calorimetric data analysis. The melting curve analysis was an assessment 
of the dissociation-characteristics of the BiP RNA during heating. As the temperature was 
raised, the double strand began to dissociate leading to a rise in the absorbance intensity, 
hyperchromicity. The temperature at which 50% of RNA is denatured is known as the 
melting point, though it is an inaccurate term as it has very little to do with a traditional 
melting point. The information gathered was used to infer the presence and identity of 
secondary RNA structure. This was due to the fact that G-C base pairings have 3 hydrogen 
bonds between them while A-T base pairs have only 2. RNA with a higher G-C content wills 
most likely form complex secondary structure and has a higher melting temperature than 
RNA with a higher A-T content. From the thermal data derived from our experiments it was 
observed that of all three cellular IRES investigated BiP had a significantly lower Tm relative 
to the other IRESes and the tRNA control. This was characteristic of unordered IRES 
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structure. It should be noted however, that many factors can influence the melting 
temperature of nucleic acids. Most importantly is the sequence itself, its length and fidelity of 
pairing. The sequence can also dictate the molecule’s ability to form alternate structures. 
Extrinsic conditions, such as the salt concentration, pH, and presence of non-aqueous 
solvents can also greatly influence the thermal stability of nucleic acids. Some of the 
published literature has suggested that the lack of secondary structure may be important for 
cellular IRES activity (Terenin et al., 2005, Xia and Holcik, 2009). Strong eukaryotic IRESs 
were found to have weak secondary structure by Xia and  Holcik, 2009; in their 
investigations of the generality of the hypothesis that eukaryotic internal ribosome entry sites 
(IRES) lacked secondary structures (Xia and Holcik, 2009). They performed a structure-
function analysis on 5 mammalian IRESs that were tested simultaneously and  did not find 
any strong association between IRES activity and structural stability (Xia and Holcik, 2009).  
Interestingly, they found that the 5′-UTR of cellular IRES XIAP exhibited the highest IRES 
activity among the five human genes examined, but its secondary structure was the weakest 
when secondary structure stability was measured. 
 
To date much work has been done to establish secondary structures of cellular IRES 
elements, the initiation factor requirements and their binding sites. However, a true 
understanding of the mechanism of IRES action relies on the elucidation of the intimate 
interactions between the IRES RNA and the protein/ribonucleoprotein factors. Structural 
studies of individual eIFs and their ITAFS, their binding domains and eIF/ITAF-RNA 
complexes are extremely helpful in the explanation of IRES mediated translation initiation 
mechanisms. It has been established that there were differences among IRESes as to which 
proteins were necessary to bind to the UTR in order to recruit the ribosome for translation. 
When this was coupled with the results of different IRESes initiating translation with varying 
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efficiency depending  on which cell type or cellular context they are measured in (Nevins et 
al. 2003), it pointed to the existence of several IRES classes (Section 1.5.1). Many groups 
have pointed out this observation already. Several groups have examined and characterised 
IRESes in several cell lines, comparing them to other IRESes, and found specific IRESes had 
more activity in one specific cell line relative to others (Stoneley et al. 2000; Jopling and 
Willis 2001; Nevins et al. 2003; Jopling et al. 2004). This was postulated to be due to 
different available protein factors in each cell line. Therefore, different subsets of mRNAs are 
able to be translated at any one time by different cells or tissues. 
 
The Apaf-1 IRES was found to be more active in neuronal cell types possibly due to the 
presence of a neuronal isoform of PTB, which conferred greater activity than PTB-1 
(Mitchell et al., 2003). From this it was speculated that this was where the APAF IRES was 
most physiologically relevant. The data correlated well with the developmental problems that 
found in the brains of Apaf-1 knockout mice in an investigation carried out by (Cecconi et al., 
1998)   
 
The functional characterisation of XIAP IRES has also outlined the importance of cellular 
factors to IRES activity. It was determined that translation of XIAP was controlled by a 162-
nucleotide (nt) internal ribosome entry site (IRES) element located in the 5' UTR  region of 
XIAP mRNA. It was established that the La autoantigen specifically binds XIAP IRES in 
vivo and in vitro. The core binding sequence was approximately 28 nt long and located 34 nt 
upstream of the initiation site. The biological relevance of this interaction was further 
demonstrated by the inhibition of XIAP IRES-mediated translation in the absence of 
functional La protein. The results suggested an important role for the La protein in the 
230 | P a g e  
 
regulation of XIAP expression; possibly by facilitating ribosome recruitment to the XIAP 
IRES. 
  
As an initial step in the characterisation of the BiP IRES chemical and enzymatic probes, 
were used to assign double and single-stranded regions of RNA. RNase V1,  which was non-
sequence specific for double-stranded regions, recognising helical and stacked regions  and 
was included to give conclusive evidence for double stranded regions and to exclude single-
stranded regions not potentially cleaved due to steric hindrance. To further enhance accuracy 
of the structure probing, oligonucleotide binding shift assays such as, selective 2′-hydroxyl 
acylation analysed by primer extension (SHAPE) could be performed concurrently with 
nuclease mapping experiments in order to confirm results. SHAPE, takes advantage of 
reagents that preferentially modify the backbone of RNA in structurally flexible regions. 
Reagents such as N-methylisotoic anhydride (NMIA) and 1-methyl-7-nitroisatoic anhydride 
(1M7) (Mortimer and Weeks, 2007) undergo hydrolysis to form adducts on the 2'-hydroxyl 
of the RNA backbone. Compared to the chemicals used in other RNA probing techniques, 
these reagents have the advantage of being largely unbiased to base identity, while remaining 
very sensitive to conformational dynamics. Recently the, secondary structure of maize IRES 
heat shock protein of 101 kDa (HSP101) was characterised by (Jiménez-González et al., 
2014). Using SHAPE analysis of the RNA, it was revealed that maize hsp101 IRES had three 
stem-loops toward its 5′ end, whereas the remainder sequence contained unpaired 
nucleotides. Bi-cistronic reporter assays of deletion mutants of the IRES were used to 
demonstrate that hsp101 IRES comprised the entire 5′UTR sequence, since the deletion of 17 
nucleotides from the 5′ end had a negative impact on translation. Furthermore, pulldown 
assay in RRL was used to identify HSP90 molecular chaperone as potential ITAF, which was 
further confirmed by in vitro translation assays. Therefore, SHAPE probing provides an 
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alternative method for characterisation of IRES structure. The  assay uses wild type IRES 
transcripts and N-methylisatoic anhydride (NMIA) as the modifying agent (Wilkinson et al., 
2006) and has been used effectively to  provide direct information of the RNA structure in 
solution (Merino et al., 2005, Low and Weeks, 2010). For further investigations into BiP 
sequence motif conservation with EV71, SHAPE can similarly be used. The observed 
binding of FBP2 to both BiP and EV71 discussed in the previous chapters can be elucidated 
using SHAPE analysis of the BiP RNA to determine any sequence motif conservation with 
EV71, whose secondary structure is already defined.  
 
In conclusion, the BiP IRES secondary structure has been determined from experimental 
data. The model was shown to be fundamentally different from a previously predicted 
structure in that it was disordered. 
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Chapter 5 
General Discussion 
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Translation initiation in eukaryotes is a complex and highly regulated process requiring the 
action of at least 12 protein factors. The pathway is distinguished by the formation of a pre-
initiation complex that recruits the 5′ end of the mRNA and scans along it to locate the start 
codon. During the past decade, a combination of genetics, biochemistry and structural studies 
has begun to illuminate key molecular events in this critical phase of gene expression. 
Chapter 1 gave a description of the translation initiation processes in eukaryotic cells, the 
key to an accurate protein synthesis. Initiation of translation of most eukaryotic mRNAs 
commences with 5′ end–dependent recruitment of 40S ribosomal subunits to the mRNA. The 
40S subunit carrying the initiator methionine-tRNA and certain eukaryotic initiation factors 
(eIFs) is thought to scan the mRNA in a 5′ to 3′ direction until an appropriate start codon is 
encountered at which stage a 60S subunit joins to form an 80S ribosome that can decode the 
RNA into protein (Kolupaeva et al., 2007, Hellen and Pestova, 2001). For the most part, the 
factors that influence the binding of 40S subunits to the mRNA provide the limiting step in 
translation initiation. In addition, an alternative mode of initiation, namely internal entry of 
ribosomes, has been found to occur preferentially when one or more specific initiation factors 
are limiting. Thus, it is crucial to the understanding of translational regulation to know the 
requirements of each initiation mechanism for translation initiation factors. A critical aspect 
of the scanning mechanism concerns the reactions involved in directing the 43S PIC to the 5′ 
end of the mRNA. The eIF4F complex stimulates this step through interaction of eIF4E with 
the cap structure, recruiting eIF4A to the 5′ UTR (Pestova et al. 2007). eIF4G holds eIF4A in 
its active conformation (Ozes et al., 2011, Nielsen et al., 2010, Hilbert et al., 2011, Oberer et 
al., 2005, Schutz et al., 2008), enabling it to unwind the mRNA and produce a single-stranded 
binding site for the 43S PIC near the 5′ cap. It is believed that eIF4G also helps to recruit the 
43S PIC directly, via physical interactions with eIF3 or eIF5 in the PIC (Asano et al., 2001, 
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Pestova et al., 2007). There is genetic and biochemical evidence implicating eIF4A and eIF4F 
in promoting 43S attachment to mRNAs, in some cases even if they contain relatively short 5′ 
UTRs without obvious secondary structures. As might be expected, a greater requirement for 
these factors has been observed for mRNAs with more structured 5′ UTRs (Svitkin et al., 
2001, Pestova and Kolupaeva, 2002, Mitchell et al., 2010, Hinnebusch, 2011). In addition, 
43S attachment to model mRNAs expected to lack any structure in the 5′ UTR can occur in 
reconstituted systems without eIF4F (Pestova and Kolupaeva 2002; Mitchell et al. 2010). 
 
Several studies have highlighted the role of viral proteins in directly modulated translation. 
For instance, viral proteases from Poliovirus have the ability to cleave cellular initiation 
factors, impairing the host translation. Another example is the vhs protein from Herpes 
simplex virus 1 which has the ability to induce host mRNA degradation to reduce host 
translation. Therefore, it is clear that viruses have evolved many strategies to interfere with 
the host response to infection, by targeting translation. Chapter 2 described the study set out 
to identify NSP1 partners responsible for observed mRNA cleavage in SARS CoV infections 
and the validation of the molecular mechanism(s) driving the SARS pathogenesis. Previous 
studies had proposed that SARS-CoV NSP1 played a significant role in the pathogenesis of 
the SARS-CoV. The NSP1 protein, which is the most N-terminal product of the gene 1 
polyprotein, had previously been found to suppresses host gene expression in cells 
overexpressing NSP1 as well as in infected cells (Kamitani et al., 2009, Kamitani et al., 
2006). The expressed NSP1 also suppressed the host antiviral signalling pathway and 
prevented type I interferon production in infected cells (Bhardwaj et al., 2004, Wathelet et al., 
2007). Several studies had previously demonstrated that SARS-CoV suppressed host gene 
expression by using a novel, two-pronged strategy (Kamitani et al., 2006), (Kamitani et al., 
2009). It was shown that NSP1 bound to 40S ribosomes, leading to the inhibition of host 
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protein synthesis. Furthermore, it was demonstrated that ribosome-bound NSP1 induced 
modification RNA of a capped mRNA ultimately rendering it translationally incompetent 
(Kamitani et al., 2009). It was also proposed that cellular RNA decay functions most likely 
influenced the efficient degradation of  the host mRNAs that underwent NSP1-induced 
modification since it had been previously observed that NSP1 protein promoted template-
dependent host mRNA degradation both in transiently transfected cells expressing NSP1 and 
in infected cells(Kamitani et al., 2009, Kamitani et al., 2006, Narayanan et al., 2008, Tohya et 
al., 2009). 
We therefore hypothesised that at least one of these pleiotropic activities (specifically 
inhibition of translation initiation) could be the result of interactions between NSP1 and 
specific host proteins. To this end we undertook the characterisation of the NSP1 interactome 
using protein affinity chromatography. We set out to purify a diverse range of affinity tagged 
NSP1 proteins and used protein affinity-based chromatography methods to isolate putative 
binding partners in both HeLa lysate and RRL. To allow for fast and effective purification of 
recombinant NSP1, wild type and mutant proteins were constructed with either 6X-Histidine, 
Glutathione-S-Transferase and Tandem Affinity Purification tags and overexpressed in 
E.Coli, Rossetta strain. Our initial results at protein purification were suboptimal despite 
several attempts at optimisation. We speculated that the purity of our bait proteins could have 
a negative influence on the observed results. Successful purification of GST fusion proteins 
requires several strategic decisions. A major drawback of the entire pull-down assays 
attempted above was that they involved the use of fusion proteins to which several affinity 
tags were added. There was also the possibility that one of the tags added to the protein might 
obscure binding of the new protein to its interacting partners, thereby altering affinity of the 
protein. In addition, the tags themselves might also have affected protein expression levels. 
On the other hand, the affinity tags may also not have been sufficiently exposed to the 
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affinity beads hence skewing the results. Some of the potential disadvantages of GST-fusion 
proteins include oligomers formation via the GST moiety; potential steric hindrance caused 
by the large size of the fusion tag, and increased costs associated with protease cleavage and 
removal of the affinity tag. 
An alternative strategy could have been to attempt a two hybrid system. The two-hybrid 
screening (also known as yeast two-hybrid system or Y2H) is a molecular biology technique 
used to discover protein–protein interactions (Young, 1998) and protein–DNA interactions 
(Joung et al., 2000, Hurt et al., 2003) by testing for physical interactions (such as binding) 
between two proteins or a single protein and a DNA molecule, respectively. By determining 
the interaction of unknown proteins, the possible functions of these new proteins may be 
inferred (Young, 1998). The assay can be performed using a single known protein in our case 
the NSP1 against a library of unknown proteins or conversely, by selecting from a library of 
known proteins using a single protein of unknown function (Hurt et al., 2003). The main 
criticism applied to the yeast two-hybrid screen of protein–protein interactions is the 
possibility of a high number of false positive (and false negative) identifications. The exact 
rate of false positive results is not known, but earlier estimates were as high as 70% (Deane et 
al., 2002). The reason for this high error rate lies in the characteristics of the screen: 
- Certain assay variants overexpress the fusion proteins which may cause unnatural 
protein concentrations that lead to non-specific (false) positives. 
- The hybrid proteins are fusion proteins; that is, the fused parts may inhibit certain 
interactions, especially if an interaction takes place at the N-terminus of a test protein 
(where the DNA-binding or activation domain is typically attached). 
- An interaction may not happen in yeast, the typical host organism for Y2H. For 
instance, if a bacterial protein is tested in yeast, it may lack a chaperone for proper 
folding that is only present in its bacterial host. Moreover, a mammalian protein is 
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sometimes not correctly modified in yeast (e.g., missing phosphorylation), which can 
also lead to false results. 
- The Y2H takes place in the nucleus. If test proteins are not localized to the nucleus 
(because they have other localization signals) two interacting proteins may be found 
to be non-interacting.  
Potentially, after having identified putative binding partners by mass spectrometry analysis a 
functional validation of their role would have been undertaken. First, the expression in cells 
would be silenced using siRNA mediated knock-down. Then using lysate from these cells the 
ability of NSP1 to drive mRNA-degradation and inhibit translation initiation would be 
evaluated. Furthermore, we would have attempted to recapitulate the function of NSP1 in an 
in vitro cleavage assay, using RNA reporters. Given the time invested in this part of the thesis 
project, the low output given by the various pull-downs attempted, and the lack of RNAse 
identified in a several study conducted by competitors, it was decided to pause this subject in 
agreement with our collaborators. 
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Early studies of viral gene expression led to the discovery of an alternative mode of 
translation initiation in eukaryotic cells that bypasses the requirement for cap-dependent 
scanning and allows the 40S ribosome to be directly recruited to the vicinity of the initiation 
codon. A subset of mRNAs has been observed to contain internal ribosomal entry sites 
(IRESs), usually in the 5′ UTR, that enable end-independent initiation to occur. IRES-
containing mRNAs are not subjected to many of the regulatory mechanisms that control 
recruitment of most mRNAs to the translation apparatus. Chapter 3 described the study set 
out to understand the role of Far Upstream Binding Protein 2 in IRES mediated translation in 
EV71 as well as to understand the genetic differences between EV71 strains associated with 
benign cutaneous disease and those with severe neurological complications. Previous studies 
had shown that FBP1 and FBP2 were both ITAFs of EV71 with contrasting effects on the 
functioning of the IRES. Thus it was demonstrated that FBP2 was a negative ITAF of EV71 
whereas FBP1 was a positive ITAF (Tu et al., 2007). FBP2-binding sites on the EV71 5′ 
UTR were also mapped out a using a series of RNA pull-down assays with various truncated  
EV71 5′ UTR sequences highlighting that FBP2 interacted with several distinct regions 
within the 5′ UTR, and that these interactions involved the central KH domains of FBP2 (Lin 
et al., 2009). One hypothesis was that the binding of FBP2 to EV71 5′UTR may affect the 
structure of IRES and therefore lead to influence of other cellular factors on the EV71 IRES. 
For our investigations we assessed the interaction of the central binding domains of FBP2 
with the EV71 UTR and engineered recombinant EV71 IRES RNA containing mutations 
found in pathological EV71 cases to monitor the effect of these mutations on translation 
initiation. To allow for fast and effective purification of recombinant FBP2, wild type and 
mutant proteins were designed with either 6X-Histidine, Glutathione-S-Transferase and 
Tandem Affinity Purification tags and overexpressed using E.Coli, Rossetta strain. As with 
previous affinity purification strategies, the initial FBP2 protein purity was suboptimal but 
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after several optimisation strategies, we were able to achieve a satisfactory level of FBP2 
protein purity for the assay. Our results showed that FBP2 interacted with EV71 and BiP 
RNA in an in vitro reconstituted EMSA. Furthermore using filter binding assays it was 
determined that there was interaction between KH23 and different IRESs, EV71, BiP and 
HCV. This affinity was in the sub-micromolar range which was relatively low for RNA-
protein interaction. These findings highlighted that FBP2 could be considered as a wider 
ITAF rather than only interacting with the EV71 IRES. Previous work had already 
established that KH3 and KH4 behaved as independent binding modules and could interact 
with different regions of the AU-rich RNA targets of FBP. This therefore provided FBP2 
with the structural flexibility needed to recognize different targets in the context of their 
3'UTR structural settings. Recently Chen et al, also demonstrated that EV71 infection cleaves 
FBP2 (Chen et al., 2013). This study showed that EV71 infection induced FBP2 cleavage, 
which was associated with caspase, proteasome, and autophagic activities(Bole et al., 1986). 
The cleavage of FBP2 reduced the level of FBP2. In addition, this study also demonstrated 
that truncated forms of FBP2 without C-terminal domains changed their role from that of a 
negative regulator to that of a positive regulator. These results highlighted that not only 
cellular factors can regulate IRES activity, but also the activity of these factors themselves 
were subject to regulation (Chen et al, 2013).  
To study the genetic differences between EV71 strains associated with benign cutaneous 
disease and those with severe neurological complications, which have led to the suggestion 
that a viral genetic determinant could be mediating neurological pathogenesis of severe 
disease, EV71 IRES sequences corresponding to clinical samples of patients who had 
succumbed to severe forms of the disease were obtained. Examination of these sequences 
revealed mutations in regions that have been previously proposed to play a key role in eIF4G 
recruitment and IRES activity. IRES RNA was mutated to incorporate point mutations in the 
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eIF4G binding domains IV and V and biotinylated EV71 RNA was used as a probe in pull 
down interactions in HeLa lysate. From the western blot analysis of pull-down proteins, it 
was observed that there were no significant differences in the interactions of the EV71 RNA 
with proteins that constituted the eIF4F complex. Neither the wild type RNA nor mutant 
RNA (with point mutations in the eIF4G binding domains IV and V), displayed any 
significant differences when probed with antibodies specific for the initiation factors. An 
interesting result however was that eIF4E was found to interact with both wild type and 
mutant RNA in the pulldown analysis. As previously discussed in chapter 1, eIF4E is part of 
the eIF4F pre-initiation complex and its function is to bind an mRNA cap and ultimately 
bring it to the ribosome. To date only the KSHV IRES has been found to require the presence 
of eIF4E for IRES activity (Othman et al., 2014). Therefore this result should be further 
investigated in translation assays, for instance by measuring IRES activity in cellular extracts 
depleted of eIF4E or treated with chemical inhibitor of the eIF4E-eIF4G interaction 
disrupting the eIF4F complex. 
Chapter 4 described the study set out to better understand the role of RNA structure in 
translation mediated by cellular IRESs. To this end we determined the whole structure of the 
BiP IRES element, using chemical probing of RNA structure in solution, and used this 
experimental data to predict the secondary structure of the BiP IRES. To date, fewer IRESs 
have been found in cellular mRNAs as compared to viral IRES. It is not clear what advantage 
the IRES-dependent mechanism offers relative to the conventional ribosome scanning 
mechanism in translational initiation of cellular mRNAs. Studies into the structure of BiP 
IRES of three different species have thus far proposed that a common structural motif was 
folded within these IRES elements (Le and Maizel, 1997), however the model  was derived 
from incomplete BiP RNA sequences and was not experimentally  validated. IRES-mediated 
translation of cellular transcripts was not widely recognized or extensively studied until 
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recently (reviewed in (Haas and Wabl, 1983). This delay in attention was due to a number of 
reasons. First, cellular IRES-mediated translation is typically less efficient than the best 
studied cases of viral IRES-mediated translation (Haas and Wabl, 1983). Secondly, 
substantial concerns about the validity of cellular internal initiation have been raised in some 
cases (Hoy et al., 2012, Kaminska et al., 2013) prompting investigators to perform thorough 
analyses of the integrity of the mRNA in order to support their claims of internal initiation 
(Sarma, 2013). Testing a particular RNA sequence for IRES activity relies on a bicistronic 
reporter construct. When an IRES segment is located between two reporter open reading 
frames in a eukaryotic mRNA molecule (a bicistronic mRNA), it can drive translation of the 
downstream protein coding region independently of the 5'-cap structure bound to the 5' end of 
the mRNA molecule. In such a setup both proteins are produced in the cell. The first reporter 
protein located in the first cistron is synthesized by the cap-dependent initiation approach 
while translation initiation of the second protein is directed by the IRES segment located in 
the intercistronic spacer region between the two reporter protein coding regions. Similar to 
viral IRESs, cellular IRES elements likely participate in multiple interactions with 
components of the translational machinery (canonical initiation factors, ITAFs and 40S 
ribosomal subunits). Together, these interactions are believed to provide (in most of the 
cases) a means for proper positioning of the initiation codon at the ribosomal P-site without 
ribosomal scanning from the 5′ end of the message (Sarma, 2013). However, this remains 
largely hypothetical, since there have not been extensive systematic studies of the ability of 
cellular IRES elements to bind the 40S ribosomal subunit or of the requirements for canonical 
translation initiation factors in cellular internal initiation. To this end we characterised the 
BiP IREs element by determining its structure. From our results it was observed that the BiP 
IRES was highly disordered. The experimentally derived model was in contrast to an earlier 
published model of the IRES, which had predicted a conserved motif in its structure. No 
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common sequence and/or structural motifs have been identified to allow prediction of cellular 
IRES elements from an mRNA sequence. This reinforces the need for experimental 
determination of RNA structures involved in internal initiation of translation. This 
determination of the BiP structure scaffold provides a platform for further studies. For 
examples, footprinting analysis in the presence FBP2 protein will reveal subdomains or 
nucleotides directly involved in the recruitment of FBP2. This structure will also inform 
subsequent mutational studies aiming at identifying which part of the IRES are critical for 
IRES activity. 
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APPENDIX 1 
Appendix 1: 
SDS PAGE gel recipe 
Stacking Gel   Resolving Gel 
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     10ml   10ml  10ml   
1.5M Tris pH 8.8       0ml   2.5ml  2.5ml 
1.0M Tris pH 6.8       1.25ml   0.0ml  0.0ml 
10% SDS    100 µL  100µL  100 µL 
Acrylamide 40 %( 37, 5:1)  1ml (4%)  3ml (12%)     3.75ml (15%) 
Water      7.65ml   4.4ml  3.65ml 
 
 
RIPA buffer 
Tris 50mM 
NaCl 150 mM 
SDS 0.1 % 
Na.Deoxycholate 0.5 % 
Triton X 100 or NP40 1% 
1mM PMSF 
Roche Complete Protease inhibitor tablet  
 
IP buffer recipe 
100 mM Tris pH 8.0 
150 mM NaCl 
1 mM EDTA  
5% glycerol 
1 mM DTT 
0.1 mg/ml tRNA 
Complete mini EDTA free tablets (ROCHE) 
 
 
 
 
 
 
 
RNA structure probing 
DMS stock conc = 7.9 M 
CMCT stock conc=40 mg/ml in H2O just before use 
RNase V1 stock conc= 0.1 U/µl 
tRNA 2 mg/ml 
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AMV RT: conc 10 U/µl) 
 
2x DMS buffer 
 40 mM Tris pH 7.5 
 200 mM K Acetate 
 400 mM KCl 
 5 mM MgCl2 
 2 mM DTT 
 
5x CMCT buffer (for CMCT reactions) 
 250 mM Borate-NaOH pH 8.0 
 5 mM EDTA 
 
10x NTP-A10, C10, G10, T10 
 
A10 = 10 µl 10 mM dGTP 
 10 µl 10 mM dCTP 
 10 µl 10 mM dTTP 
 2.5 µl 10 mM dATP 
 H2O to 100 µl   
  
ddATP, ddCTP, ddGTP & ddTTP (all at 50 µM)        
 
2.5 mM dNTP mix      
 10 µl each of 10 mM dATP, dCTP, dGTP and dTTP 
 
Formamide – XC Loading Buffer:  
975 µl Formamide, 25 µl 1% xylene cyanol 
 
 
Sequencing gel 
            
Urea    20g  
 10x TBE    5 ml 
 40% (19:1) Acrylamide/Bis 10 ml (for 8% gel) 12.5 ml (for 10% gel) 
 Water to 50 ml, dissolve, when ready add 
 30% APS    55 µl 
 Temed    55 µl    
 
APPENDIX 2: Solutions 
 
1 M DTT (Dithiothreitol):   1.54 g DTT (Calbiochem 233155) ddH2O to 10 ml (aliquot 
and store at -20
o
C). 
 
0.5 M EDTA, pH 8.0 (disodium ethylenediamine tetraacetate):   186.1 g  Na2EDTA  
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Dissolve in approx. 400 ml ddH2O, adjust pH to 8.0 with 10 N NaOH, and adjust to 1 liter 
final volume with distilled water. 
 
LB Medium:  10 g Bacto-Tryptone (Difco 0123-01-1) 
5 g Bacto-yeast extract (Difco 0127-05-3) 
 10 g NaCl 
 ddH2O to 1 L      adjust the pH to 7.0 and then autoclave to 
sterilize 
  
2X Gel loading buffer  
1M Tris-HCl (pH6.8)    
10% SDS     
Glycerol (100%)     
β-mercaptoethanol    
Bromophenol blue    
    
1 M Tris, pH 8 (F.W. 121.1) 500 ml: 
60.55 g Trizma base 
    400 ml H2O 
Approximately 21.1 ml concentrated HCl (Use pH meter) 
Bring up to volume with H2O 
Sterilize by autoclaving (15 minutes) 
 
1 M Tris, pH 7.6 (F.W. 121.1) 500 ml: 
60.55 g Trizma base 
400 ml H2O 
Approximately 28.5 ml concentrated HCl (Use pH meter) 
 Bring up to volume with H2O. Sterilize by autoclaving  
 
1 M MgCl2 (F.W. 203.30) 100 ml: 
20.33 g MgCl2 
70 ml H2O 
Dissolve, and then bring up to volume with H2O. Sterilize by autoclaving (15 minutes) 
 
 
 
 
1 M CaCl2 (F.W. 147.02) 100 ml: 
14.70 g CaCl2 
90 ml H2O 
Dissolve, and then bring up to volume with H2O  
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APPENDIX 3: Clinical strains of EV71 isolated in the UK. 
 
 
UK EV71 strains  
Isolate   Year Specimen  Clinical details Genogroup  
EP/17728/98  1998 Throat swab  Tonsilitis    C1
  
EP/13372/98  1998 stool   Aseptic Meningitis   C1
   
EP/9027/99  1999 stool   HFMD     C1
   
EP/5622/99  1999 vesicle  Aseptic Meningitis   C2
   
EP/7414/99  1999 NPA   Bronchiolitis    C2
   
EP/449/00  2000 stool   V&D     C1
   
EP/11168/00  2000 vesicle  HFMD     C1
   
EP/2063/01  2001 stool   HFMD     C1
   
EP/2405/01  2001 mouth   HFMD     C1
   
EP/4709/01  2001 stool   Meningitis    C1
   
EP/5746/01  2001 stool   Meningitis    C1
   
EP/8277/01  2001 stool   N/A     C1
   
EP/11052/01  2001 tissue culture fluid N/A     C1
  
EP/12105/01  2001 T/S   Fever, Rash, Cough  C1
  
EP/12081/01  2001 stool   HFMD     C1
  
EP/2353/02  2002 tissue culture fluid N/A     C1
   
EP/3267/02  2002 stool   URTI, rash    C1
   
EP/2826/02  2002 stool   Meningitis    C1
   
EP/8300/04  2004 T/S   HFMD     C1
   
H0-5454-265-05 2005 N/A   Pyrexia, neurological  C1
   
H0-5440-288-05 2005 N/A   Neurological    C1
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H0-6334-528-06 2006 N/A   Meningitis    C1
   
H0-6344-348-06 2006 N/A   Pyrexia, irritable   C1
   
H0-6290-136-06 2006 N/A   Meningitis    C1
   
H0-6314-248-06 2006 N/A   Pyrexia    C1
   
H0-6344-349-06 2006 N/A   Sepsis, V&D    C1
   
H0-6290-135-06 2006 N/A   Pyrexia, irritable   C1
   
H0-6332-439-06 2006 N/A   Meningitis    C2   
H0-6364-255-06 2006 N/A   Irritable, rash    C2   
H0-6438-418-06 2006 N/A   Pyrexia, meningitis   C2
   
H0-6486-445-06 2006 N/A   Difficulty walking   C2
   
STH/MCN/06 2006 CSF   Panencephalitis, Fatal  C2
   
 
291 | P a g e  
 
Hong Kong EV71 strains  
Isolate   Year Specimen   Clinical details 
 Genogroup  
9540   1997 stool   AFP     C2 
20690   1997 stool   n/a     C4 
20981   1998 NPA   n/a     C4
  
13573   1999 brain tissue  fatal case    C4
  
23238   1999 TS   n/a     C4
  
19784   2000 TS   fatal case    C4 
23972   2000 TS   n/a     C4
  
22919   2001 RS   n/a     C4 
27141   2001 NPA   n/a     C4 
11097   2002 TS   n/a     C1 
15611   2002 stool   n/a     C4 
23142   2004 stool   n/a     C4 
36144   2004 stool   AFP     C4 
20256   2005 stool   n/a     C4 
21676   2005 stool   n/a     C4 
51209   2006 stool   n/a     C4 
56209   2006 stool   n/a     C4 
31013   2007 stool   n/a     C4 
32627   2007 stool   n/a     C4 
 
 
T/S = throat swab 
R/S = rectal swab 
NPA = nasopharyngeal wash 
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APPENDIX 4: Restraints table for the prediction of BiP secondary 
 
Constraints 
F 12 0 2 
P 10 0 1 
P 16 0 2 
P 21 0 1 
P 19 0 1 
P 21 0 1 
P 23 0 4 
P 28 0 2 
P 32 0 8 
P 42 0 4 
P 48 0 2 
P 51 0 3 
P 53 0 1 
P 56 0 1 
P 58 0 5 
P 64 0 1 
P 66 0 1 
P 68 0 2 
P 74 0 1 
P 81 0 2 
P 85 0 1 
P 87 0 3 
P 91 0 1 
F 96 0 4 
F 103 0 3 
F 107 0 2 
F 114 0 3 
293 | P a g e  
 
F 117 0 3 
P 119 0 2 
F 121 0 3 
F 128 0 3 
P 133 0 5 
P 162 0 2 
F 164 0 4 
F 169 0 2 
P 173 0 1 
P 175 0 3 
P 179 0 3 
P 184 0 5 
P 188 0 1 
P 190 0 4 
P 193 0 1 
P 197 0 1 
P 199 0 6 
P 200 0 5 
P 207 0 2 
P 212 0 1 
P 214 0 1 
P 217 0 1 
P 220 0 2 
P 223 0 1 
P 225 0 3 
F 228 0 1 
P 230 0 1 
F 232 0 2 
P 233 0 4 
F 238 0 3 
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P 241 0 3 
F 244 0 3 
P 247 0 7 
 
Constraints Information 
F   i   0   k on 1 line in the constraint box force bases i, i+1,...,i+k-1 to be double stranded. 
F   i   j   k on 1 line in the constraint box force consecutive base pairs i.j,i+1.j-1, ...,i+k-1.j-
k+1  
P   i   0   k on 1 line in the constraint box force bases i,i+1,...,i+k-1 to be single stranded.  
. 
P   i   j   k on 1 line in the constraint box prohibit the consecutive base pairs i.j,i+1.j-1, ...,i+k-
1.j-k+. 
P   i-j   k-l on 1 line in the constraint box prohibit bases i to j from pairing with bases k to l. 
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APPENDIX 5: Prediction of BiP RNA Secondary Structure by Energy Minimization 
(m-fold). 
 
 
 
 
